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ABSTRACT
As the necessity to improve in vitro embryo production efficiency is ever increasing, so
too is the prerequisite obligation to improve oocyte competence. The ability of an oocyte to
successfully produce a viable embryo requires that it both completes meiotic maturation and
synchronously achieves cytoplasmic competence; an encompassing term that refers to the
oocytes correct accumulation and storage of mRNAs, proteins and factors as well as the
development and reorganization of organelles and the cytoskeleton. The current research was
designed to analyze those methods that go into oocyte collection and pre-maturation handling to
determine if there are ways to ensure the cohort of oocytes being placed in in vitro maturation
(IVM) are those with the highest potential to develop. It was found that collection during
different phases of the follicular wave had negligible effects on oocyte competence. However
oocytes collected from growing follicles had increased ability to respond to calcium release
signals compared to those recovered from atretic follicles, which was found to be important for
embryo production rates. Oocytes retrieved from post-mortem ovaries exhibited irregular gene
expression in immature oocytes, but expression patterns were more similar to ovum pick-up
(OPU) oocytes following IVM. However, oocytes that were recovered following superstimulation, while initially similar in gene expression to other recovery methods, displayed a
dramatic increase in the level of gene transcripts present in mature oocytes. Looking only at OPU
oocytes, incubation in meiotic delay was not only irreversible in some oocytes but was also only
mildly successful at improving cytoplasmic maturation dynamics. Further, mitochondrial
abnormalities in both distribution (projects 1, 2 and 4) and shape (project 4) were frequent. This
suggests that recovering oocytes prematurely arrests mitochondrial development, which may be a
!v

major factor in low embryo production rates. Current research found that oocyte pre-incubation
is unnecessary, and that oocytes recovered from post-mortem ovaries are likely of the greatest
developmental competence. When recovering oocytes by OPU, timing is unimportant but superstimulation causes irregular gene expression, the long-term effect of which is yet to be
established.
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CHAPTER I
INTRODUCTION
In vitro oocyte maturation is the process of removing an oocyte from an antral follicle,
inducing precocious meiotic maturation and supporting this development through oocyte culture.
Because oocytes are removed from the support and developmental signals provided by the
follicular environment, maturation not only proceeds earlier than natural, but often involves
irregularities that result in in vitro matured oocytes having compromised developmental
competence (Hyttel et al., 1997; Thomas et al., 2004b). Because the organelles, proteins and
factors present in the ooplasm are required for embryo development for the first four days, the
limiting factor in in vitro embryo production is the intrinsic competence of the oocyte itself
(Lonergan et al., 2000). Many of these factors are only gained through interactions with the
follicular milieu in the final stages of oocyte development, or later during final maturation.
As oocytes undergo meiotic maturation, they simultaneously undergo molecular changes,
and organelle and cytoskeletal reorganization collectively termed cytoplasmic maturation. The
successful completion of cytoplasmic maturation, although thus far difficult to measure, has been
identified as one of the leading factors in determining if an oocyte can successfully produce
offspring. As a result, the best practice towards improving in vitro embryo production efficiency
is to improve our ability to both recover and mature highly competent oocytes.
However, there is inconclusive evidence on what best practices for producing the best
oocytes might be. Although it has been recognized that oocytes from larger follicles have
completed a higher degree of development and so are of greater competence, there is conflicting
evidence on the potential effects of exogenous hormones and follicular atresia on oocyte

!1

competence. An improved understanding of which oocyte retrieval processes lead to recovery of
a cohort of oocytes with the greatest cytoplasmic competence, and thus the highest probability of
producing offspring, could be significant for improving the efficiency of reproductive
technologies in bovines. Both researchers and the cattle industry make use of oocyte collection
and in vitro embryo production, and improving the intrinsic competence of the oocytes used
would only stand to increase the efficacy and ultimate usefulness of these procedures.
In an effort to address the requirement for oocytes of optimal competence, these studies
were designed to determine the effect of initial oocyte handling and recovery methods on oocyte
developmental competence and on markers of cytoplasmic maturation. In the first study, oocytes
were exposed to the cyclic adenosine monophosphate (cAMP) modulators IBMX and forskolin
for 2 hours prior to in vitro maturation. It was found that while the pre-maturation protocol was
successful at maintaining oocytes in meiotic arrest and at maintaining gap junction
communication, this did not have an effect on improving either mitochondrial distribution
characteristics of F-actin polymerization in matured oocytes. Results indicated that the meiotic
arrest caused by cAMP modulation was not beneficial in improving cytoplasmic maturation, and
that the meiotic arrest was partially irreversibly decreasing maturation rates rather than
improving maturation characteristics.
The second study was designed to determine the effect of the phase of the follicular wave
at the time of oocyte retrieval on oocyte developmental competence and embryo production
parameters. It was found that oocyte collection during follicular wave growth, peak, or atretic
phases did not affect oocyte recovery rates. However, as determined by measuring inositol 1,4,5trisphosphate receptor 1 expression and mitochondrial location oocytes collected during follicle
!2

atresia were of decreased competence than oocytes recovered during follicle growth or peak
phases.
Finally, in studies three and four differences in oocyte competence, as determined by
embryo production rates, global gene expression patterns and oocyte ultrastructure, were
assessed as functions of the method of oocyte collection. This study was designed to determine if
oocyte recovery method plays a role in the developmental competence of oocytes used for in
vitro embryo production. It was determined that in vitro matured oocytes collected following
super-stimulation with exogenous follicle stimulating hormone had increased transcript
abundance, especially in genes regulating energy production and mitochondrial structure
compared to oocytes collected following unstimulated ovum pick-up (OPU) or those recovered
post-mortem. Oocytes recovered following stimulation had some mitochondrial irregularities,
which were also seen in unstimulated OPU oocytes, but had high embryo production rates
compared to OPU oocytes indicating that the high transcript abundance was beneficial rather
than detrimental to embryo development.

!3

CHAPTER II
REVIEW OF THE LITERATURE
2.1

Overview
Oocytes are produced from primordial germ cells during fetal development in cattle.

After initial propagation, the entire cohort of oocytes is arrested within the ovary of the fetus
throughout the remainder of gestation and pre-pubescent life. Following puberty, oocytes are
activated in small cohorts each estrous cycle, whereupon they complete development. Within
each estrous cycle only one follicle, containing a single oocyte, will achieve dominance,
supporting the oocyte in completing maturation for eventual ovulation and fertilization. The
remaining oocytes from the activated cohort will undergo atresia.
The journey of the oocyte from stasis through to ovulation is a complex event that
requires communication between the oocyte, the surrounding somatic cells and even factors
found within the follicular fluid to properly coordinate the necessary steps of both meiotic and
cytoplasmic maturation. For an oocyte to be fertile and capable of producing an embryo, it is
essential that the proper signals be received for each of these steps to occur and for the oocyte to
finally garner competence by the completion of maturation, at the time of ovulation.
Oocytes used in reproductive technologies, are harvested using a variety of manners,
most of which involve removing the oocyte from the follicular environment prior to the
attainment of full competence. This is followed by in vitro culture under conditions that attempt
to simulate physiological conditions but which have been found to fall short of fully supporting
the cytoplasmic changes necessary in attaining full developmental potential. Because so much of
embryo developmental rates are based on the oocyte’s competence, research has been focused on
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methods of recovering those oocytes most likely to have attained a degree of competence that
would allow them to complete maturation and prevail in current in vitro maturation conditions.
2.2

In Vivo Oocyte Development and Folliculogenesis
Oocyte development, or oogenesis, begins in the fetus. In cattle this first occurs at

approximately day 82 of gestation (Bilodeau-Goeseels, 2012), but the journey of oocyte
development and maturation is not completed until after fertilization occurs in the adult animal.
Oocytes are the gametes found in all female animals originating from primordial germ cells
derived from the epithelium of the yolk sac (Byskov, 1986). Once established in the primitive
ovary of the fetus, the oogonia undergo many rounds of mitotic division, multiplying to produce
the animal’s entire lifetime supply of gametes. Following multiplication, they differentiate and
enter meiosis, after which they are termed primary oocytes. Primary oocytes undergo meiotic
arrest at the dictyate stage of prophase one, which is maintained throughout the remainder of
fetal development, and the animal’s life until just prior to ovulation, when meiotic resumption
occurs. Oocytes arrested in the dictyate stage are referred to as being in the germinal vesicle
stage, as the nucleus is still compact and contained within a nuclear membrane.
Even before final maturation begins, oocytes gradually and sequentially acquire the
capacity to mature, become fertilized and to support early embryonic development, throughout
the oocyte growth phase (Eppig et al., 1994; Mermillod et al., 1999; Brevini Gandolfi and
Gandolfi, 2001; Krisher, 2004; Hussein et al., 2006; Sirard et al., 2006a). Oocyte growth is
largely controlled by interactions between the oocyte, granulosa cells, and factors found within
the follicular fluid (Reader et al., 2017). Oocyte growth begins in primordial follicles and ends
prior to ovulation, with the initiation of maturation. During this time they undergo many changes
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necessary for supporting oocyte activation and early embryonic development including;
organelle replication and accumulation of proteins and RNAs (Fair et al., 1997; Swain and Pool,
2008). For this reason, oocytes recovered from larger follicles are more fully developed and
more competent to produce embryos (Blondin and Sirard, 1995; Hagemann, 1999). Alternately,
oocytes from prepubertal animals have not received adequate support from follicular fluid, or
granulosa cells to stimulate growth, and as a result even those oocytes harvested for in vitro
maturation have poor developmental competence when recovered from prepubertal animals
(Armstrong, 2001; Reader et al., 2017).
The granulosa cells directly surrounding the oocyte take on special functions, involving
many close interactions with the oocytes, and are referred to as cumulus cells (CCs). Cumulus
cells have significant influence on oocyte development through the supply of nutrients and small
molecules involved in regulating oocyte meiotic maturation and metabolism (Chian and Sirard,
1995; Dunning et al., 2015; Brown et al., 2017). Cumulus cells are also responsible for
delivering cytoplasmic signaling molecules that are necessary for oocyte development, for
inducing sperm penetration and capacitation (Brown et al., 2017) (Dode and Graves, 2002) and
for regulating the diffusion of metabolites and nutrients from the surrounding milieu into the
oocyte (Dunning et al., 2012). Communication is bi-directional between CCs and the oocyte
through gap junctions, a type of trans-membrane channel. This communication also plays an
active role in controlling CC function, growth, differentiation and metabolism through release of
oocyte secreted factors (Gilula et al., 1978; Gilchrist et al., 2004; Krisher, 2004; Thomas et al.,
2004b; Hussein et al., 2006; Gilchrist and Thompson, 2007). Either removal of the cumulus cells
or the disruption of their communication with the oocyte prior to completion of maturation has a
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significant effect on decreasing the developmental competence of the oocytes (Zhang et al.,
1995; Fatehi et al., 2002; Gilchrist and Thompson, 2007; Brown et al., 2017).
Because of the importance of cumulus cells in regulating oocyte development, one of the
best indicators of oocyte competence is the presence of cumulus cells completely surrounding
the oocyte. Oocytes recovered with few to no associated cumulus cells have a significantly
decreased chance at normal maturation and fertilization (Shioya et al., 1988). Oocytes with few
cumulus cells are most frequently recovered from large follicles, which is believed to be
indicative of follicular atresia (Fukui and Sakuma, 1980). However, even in cumulus-oocyte
complexes (COCs) with a normal cumulus cell investment, the connection between the oocyte
and cumulus cells changes as maturation proceeds, in fact is necessary for maturation completion
(Larsen et al., 1986). As meiotic maturation advances, the gap junctions permitting
communication between the oocyte and cumulus cells are broken down, severing the connection
completely by 13 to 24 hours in IVM, before the oocyte reaches metaphase II (Hyttel, 1987).
This gap junction breakdown is critical for successful maturation, as cumulus cells produce and
secrete meiosis arresting factors and when the oocyte fails to receive these signals meiotic
maturation resumes. Throughout oocyte growth, factors found within follicular fluid and
cumulus cells maintain the oocyte in a state of meiotic arrest. Immediately prior to ovulation, the
luteinizing hormone surge causes an increase in secretion of epidermal growth factor-like
peptides from mural granulosa cells (Leibfried-Rutledge et al., 1987; Bilodeau-Goeseels, 2012).
These factors stimulate the oocyte to resume meiosis and undergo meiotic maturation in
preparation for fertilization (Gilchrist and Thompson, 2007; Bilodeau-Goeseels, 2011).
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While oocytes are maintained in meiotic arrest, in prophase I, throughout the entirety of
growth and development, oocyte maturation is primarily characterized by their release from
meiotic arrest. At this point, oocytes resume meiosis, progressing to metaphase II where a second
arrest occurs until fertilization and activation takes place to stimulate the completion of the
second stage of meiosis. The primary indicator of oocytes having successfully completed
maturation is the progression from the germinal vesicle stage to the second post-ovulatory arrest
at metaphase II, following extrusion of the first polar body. Based on the ease of polar body
identification and the absolute necessity of its extrusion prior to fertilization, this is the most
frequently used method of identifying mature oocytes. Successful nuclear maturation requires
formation of the meiotic spindle and centrosomal proteins to guide chromosomal segregation
(Reader et al., 2017).
Following ovulation and completion of maturation, meiosis is arrested a second time in
metaphase II until the oocyte is stimulated to undergo meiotic division. This second activation is
achieved through penetration of the oolemma with a spermatozoan and initiates activation of the
oocyte to prevent polyspermy, and initiate meiotic completion followed by embryo development
(Bilodeau-Goeseels, 2012).
2.2

Cytoplasmic Maturation
Oocyte maturation occurs in vivo in response to a surge of gonadotropins, and involves

cytoplasmic changes in addition to the nuclear changes involved in meiotic completion (Hyttel et
al., 1989a, b). Cytoplasmic maturation refers to the many non-chromosomal changes that occur
within the oocyte, prior to ovulation that are necessary for the oocyte to acquire competence to
develop to a viable embryo, primarily necessary molecular changes, and the reorganization of the
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cytoskeleton and organelles (Ferreira et al., 2009). While cytoplasmic maturation naturally
occurs concurrent to nuclear maturation, these processes are independent and often become
disjointed in in vitro maturation protocols (Krisher, 2004). Markers of cytoplasmic maturation
include; storage of mRNA, proteins, lipids and transcription factor as well as the reorganization
of organelles (Krisher, 2004; Swain and Pool, 2008; Ferreira et al., 2009; Mao et al., 2014;
Reader et al., 2017). As follicles grow and oocytes develop, the oocytes are highly active in
synthesizing proteins and organelles but as the oocyte approaches ovulation, the oocyte reaches a
state of quiescence (Thomas et al., 2004b). In order for an oocyte to be fully competent to
support embryonic development, all of the necessary factors need to be in place prior to the
completion of maturation and the achievement of oocyte quiescence (Thomas et al., 2004b).
However, although many of the changes involved in cytoplasmic maturation have been
identified, there are suspected others as yet undefined, and those that are recognized have proven
difficult to define (Swain and Pool, 2008).
2.2.1

Calcium
Successful fertilization requires that oocytes have not only sequestered large amounts of

calcium, but also that there be pathways in place to control calcium release (Dumollard et al.,
2007). Calcium is stored within the endoplasmic reticulum (ER) of oocytes, so proper release of
calcium is highly reliant on changes within the ER. Oocyte maturation requires that ER not only
relocalize to the suboolemma region, but it also requires reorganization of the ER to facilitate
calcium signaling (Coticchio et al., 2015). Smooth ER must be in close proximity to
mitochondria, as calcium levels within the oocyte are regulated by cross-talk between
mitochondria and ooplasmic membranes (Nottola et al., 2016).
!9

2.2.2

Cortical Granules
Cortical granules are produced from the Golgi complex during oocyte growth, and

develop as secretory organelles whose primary role is in preventing polyspermic fertilization
(Cran et al., 1980; Abbott and Ducibella, 2001). In immature oocytes, the cortical granules are
found randomly dispersed primarily within the most central regions of the cytoplasm (Hosoe and
Shioya, 1997; Coticchio et al., 2016). As oocytes mature, these relocate first to clusters near the
oocyte periphery (Kafi et al., 2005) and later to become concentrated directly below the
oolemma, in one or two continuous rows (Cran et al., 1980; Szollosi et al., 1988; Hosoe and
Shioya, 1997; Petr et al., 2001; Coticchio et al., 2015, 2016; Nottola et al., 2016). This migration
is mitigated by micro-filaments within the cytoskeleton (Connors et al., 1998; Liu et al., 2010).
As maturation proceeds, cortical granules also increase in quantity, size and density (Kafi et al.,
2005). When oocytes are fertilized, the consequent increase in calcium stimulates exocytosis of
the cortical granules, which then release their contents, stimulating oolemma hardening and
preventing polyspermic fertilization (Cran et al., 1988; Kline and Kline, 1992; Coticchio et al.,
2015). Abundance of cortical granules in mature oocytes is thus important in ensuring successful
monospermic fertilization and oocyte activation.
2.2.3

Mitochondria
Mitochondria, are the organelle that perhaps undergo the most notable change as

maturation proceeds. Oocyte developmental competence is highly reliant not only on the number
of mitochondria present, but also on the mitochondrial membrane potential and their distribution
throughout the ooplasm (El Shourbagy et al., 2006; Tarazona et al., 2006; Van Blerkom, 2009;
Reader et al., 2015). Those oocytes with increased numbers of mitochondria, and mitochondria
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with increased membrane potential are considered to be more competent. Uniform mitochondrial
distribution within the ooplasm further increases embryo production potential (El Shourbagy et
al., 2006; Tarazona et al., 2006; Van Blerkom, 2009). While mitochondria should be found
evenly distributed throughout the ooplasm, they do tend to be concentrated somewhat more
heavily in areas where high levels of energy (ATP) or calcium signaling are necessary (Campello
et al., 2006; Reader et al., 2017). As part of energy production requirements, and facilitation of
transporting fatty acids into mitochondria for beta-oxidation, mitochondria are often found colocated with lipid droplets in highly competent oocytes (Warzych et al., 2017).
In the immature oocyte, mitochondria are spherical in shape with few cristae,
representing an inactive form (Cran et al., 1980; Fair et al., 1997; Reader et al., 2017). Many
mitochondria exhibit unique shapes, wherein they may appear to be hooded or vacuolated(Cran
et al., 1980; Fair et al., 1997; Hyttel, 2011; Reader et al., 2015, 2017). Mitochondria are
primarily found in peripheral regions in immature oocytes and migrate to become evenly
distributed within the ooplasm, and commonly associated with smooth endoplasmic reticulum in
fully matured oocytes (Cran et al., 1980; Cran, 1985; Hyttel et al., 1986; Reader et al., 2015).
Hooded mitochondria are generally believed to be in a state of inactivity. These are found
commonly in oocytes of sheep and cattle during later stages of oocyte growth and in increasing
frequency as maturation proceeds (Cran et al., 1980; Fair et al., 1997; Reader et al., 2015).
However, other studies have shown that overall mitochondrial activity and ATP production
increase as oocyte maturation proceeds (Stojkovic et al., 2001; Tarazona et al., 2006; Abdoon et
al., 2011; Matchatkova et al., 2012; Gutnisky et al., 2013). Mitochondrial ATP production
decreases following oocyte growth completion in germinal vesicle stage oocytes, and increases
1! 1

again by the time oocytes reach metaphase two (Nagano et al., 2006; Abdoon et al., 2011). Those
mitochondria aggregated with smooth endoplasmic reticulum (SER) are more active, than those
that are isolated and it is understood that mitochondria-SER aggregates are not only key to
regulating ATP production but also free calcium levels (Nottola et al., 2016).
While the change in mitochondrial location and activity with oocyte maturation are
essential for competence, there is little to no change in mitochondrial numbers as maturation
proceeds (Barritt et al., 2002; May-Panloup et al., 2005; Clarke, 2012; Cotterill et al., 2013).
Mitochondrondrial replication occurs during oocyte growth and should be completed before
antral follicle development, and final oocyte maturation (Piko and Taylor, 1987; Thundathil et
al., 2005). However, mitochondrial copy number is an important indicator of oocyte
developmental competence, with oocytes containing more copies of mitochondrial DNA, and
thus more mitochondria, having higher developmental competence (Barritt et al., 2002; MayPanloup et al., 2005; Clarke, 2012; Cotterill et al., 2013).
Overall; the redistribution of mitochondria, and their activation to ensure ATP production
and energy accumulation are necessary for oocyte activation and for successful embryo
development (Thompson et al., 2000; Luberda, 2005; Gasparrini et al., 2006).
2.2.4

Gene Expression, Protein and Factor Accumulation
Although it is well recognized that gene expression changes as oocytes progress through

maturation, there is not currently a clearly defined set of genes whose expression is required for
oocyte competence (Brevini et al., 2007; Labrecque and Sirard, 2014). However, it is widely
accepted that the acquisition of developmental competence requires that oocytes produce and
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store the mRNAs and proteins necessary for early embryonic development, prior to the
completion of maturation.
As oocytes grow and mature, they produce a large quantity of a set of factors referred to
as ‘oocyte secreted factors’ (OSFs). These OSFs, including growth differentiation factor-9
(GDF-9) and bone morphogenetic protein-6 (BMP-6), are critical to oocyte competence as they
regulate a broad spectrum of cumulus cell functions including; growth, survival, steroidogenesis
and metabolism (Gilchrist et al., 2004; Bilodeau-Goeseels, 2012). Through controlling functions
of the cumulus cells, OSFs indirectly control the viability and competence of the oocyte as well.
2.2.5

Other Cytoplasmic Factors
Oocyte maturation also requires changes in many other factors in order for embryonic

development to occur. Included amongst these are production of adequate ATP and redox
homeostasis (Dumollard et al., 2007).
Energy production is also critical to oocyte developmental competence. Oocytes of
greater developmental competence, have increased glucose metabolism rates, through both
glycolysis and the pentose phosphate pathway (Sutton-McDowall et al., 2006). This is
particularly true of mature oocytes, and it is common to find higher levels of ATP and lower
concentrations of glutathione in metaphase II oocytes than in germinal vesicle (GV) stage
oocytes (Abdoon et al., 2011). Meanwhile, glycolytic deficiencies have been shown to have a
negative effect on oocyte developmental potential (Brown et al., 2017). Oocytes are extremely
active, producing energy while undergoing growth. As they complete growth, energy production
decreases. One method that this is visualized is as a decrease in glucose-6-phosphate
dehydrogenase activity (El Shourbagy et al., 2006).
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Mammalian oocytes contain high quantities of stored lipids, used for β-oxidation and
energy production (Dunning et al., 2010; Reader et al., 2017). To ease fatty acid transport for βoxidation, mitochondria and lipid droplets are often found co-located in highly competent
oocytes (Reader et al., 2017). As such, lipid droplets are commonly found in a relatively
peripheral orientation in immature oocytes, and become more evenly distributed throughout the
ooplasm as maturation proceeds (Jeong et al., 2009). Lipids appear dark on a light microscope,
and an oocyte containing a large volume of homogeneously distributed lipid should thus have an
evenly dark cytoplasm (Jeong et al., 2009; Reader et al., 2017). Because lipidation is an indicator
of oocyte competence, gross cytoplasm appearance is often used as a simple method of
estimating oocyte developmental competence (Jeong et al., 2009).
Oocytes also contain a large number of vesicles, occupying 15-35% of the cytoplasm
(Cran, 1985; O’Brien et al., 1996; Reader et al., 2015). As maturation proceeds, vesicles increase
in size and are found in increasingly large groups along with those mitochondria not at the
immediate oocyte periphery (Kafi et al., 2005). However, overall vesicle volume tends to
decrease as oocytes mature, possibly due to the oocyte metabolizing the vesicle content
throughout maturation (Auclair et al., 2013). Due to the large volume that they occupy, vesicles
are found approximately evenly distributed throughout the entire ooplasm with the exception of
the most peripheral regions in immature oocytes (Reader et al., 2015). As maturation proceeds,
vesicles migrate to a more peripheral distribution (Pederson et al., 2016). On transmission
electron microcopy, these vesicles appear translucent, but may contain membranous material, in
addition to large quantities of metabolites used in oocyte maturation and embryonic development
(Reader et al., 2017). As such high quantities of vesicles in immature oocytes are necessary for
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competence, while lower vesicle volume following maturation indicates a metabolically active
oocyte of high developmental competence.
Vacuoles, on the other hand, are rare or entirely absent in competent mature oocytes, and
when identified are found to be empty but associated with lysosomes (Coticchio et al., 2016;
Nottola et al., 2016). These are likely derived from swelling of Golgi and SER membranes and
by cytoskeletal defects (Sathananthan et al., 1987; Nottala et al., 2008). In human oocytes, high
numbers of vacuoles have been correlated with early degeneration and oocyte aging and is
associated with failure of fertilization in vitro (Nottala et al., 2007, 2008, 2009; Coticchio et al.,
2010; Bianchi et al., 2014; Nottola et al., 2016).
In general, the ooplasm of highly competent oocytes should be relatively homogenous,
and organelles not mentioned above should be evenly distributed throughout (Shahedi et al.,
2013; Nottola et al., 2016). The oolemma is continuous, with numerous long microvilli
projecting into the perivitelline space in highly competent oocytes (Shahedi et al., 2013; Nottola
et al., 2016). As maturation proceeds, the perivitelline space becomes larger, and the microvilli
both increase in number and change shape to become longer and thinner (Kafi et al., 2005).
Cytoskeletal microtubules are distributed in a largely uniform manner throughout the cytoplasm
of the oocyte at GV, and micofilaments are sparsely scattered (Sun and H, 2006). Following
maturation, both microfilaments and mirotubules are primarily found in the cortical regions of
the cytoplasm (Sun and H, 2006; Verlhac, 2011). The redistribution of these cytoskeletal
polymers is critical for oocyte competence as they are both involved in maintaining oocyte
structure and, microtubules are involved in mediating the relocalization of other organelles while
microfilaments play a key role in chromosome migration and polar body extrusion (Sun and H,
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2006). Finally, oocytes that have a greater diameter are believed to be more competent, as this
indicates that they are further through the growth phase and are more likely to have undergone
the above listed changes that occur during this phase (Fair et al., 1995).
Table 2.1. Summary of organelle features in highly competent oocytes. Adapted from (Ferreira
et al., 2009; Mao et al., 2014; Reader et al., 2017).
Organelle

Germinal Vessicle

Metaphase II

Low Competence MII
Oocyte

Cortical Granule
Distribution

Distributed sparsely
throughout cytoplasm

Peripheral

Clustered or even
throughout ooplasm

Endoplasmic
Reticulum

Uniformly distributed
through cytoplasm

Forms clusters

—-

Golgi Network

Present as fragments

Largely transformed into
vesicles

—-

Lipid Volume

High

High

Low

Lipid Distribution

Peripheral

Even

Peripheral

Mitochondrial
Distribution

Peripheral

Even

Peripheral

Mitochondrial
Morphology

Spherical or hooded, light
matrix

Light matrix, hooded, few
vacuoles or granules

Dense matrix, vacuoles and
granules

Ribosomes

Many, associated with
endoplasmic reticulum

Few- dissociate

—-

Vacuole Volume

Low

Low

High

Vesicle Volume

Low

High

Low

2.3

Oocyte Retrieval Methods
In the cattle industry there are multiple methods of retrieving oocytes from follicles, each

with its own set of benefits and drawbacks. The two primary methods of oocyte collection can be
differentiated based on whether the donor cow is living or not. Oocytes can be recovered by
either scraping or aspirating follicles from ovaries that are collected within the first four hours
post-mortem (Blondin and Sirard, 1995). Since cattle are slaughtered for meat regularly, and ~20
to 60 oocytes can be recovered from a single ovary, these make a reliable method of retrieving

!16

large numbers of oocytes with minimal cost compared to other oocyte collection methods
(Hamano and Kuwayama, 1993). However, the greatest drawback is that collection can only be
performed on either termination or ovariectomy of the cows, and so is a single opportunity per
animal. While post-mortem ovary harvesting can provide a reliable supply of oocytes for
research, where genetics are relatively unimportant, or as a last-ditch effort to recover gametes
from an individual, this is not an ongoing opportunity to produce increased offspring from
females of genetic merit. As a result, abattoir-derived oocytes are commonly used in research but
are only rarely applicable to commercial cattle production systems.
Of use for more applications where individual genetic input is important, oocytes can also
be collected from live animals, using a technique called ovum pick-up (OPU). This has the
increased cost of maintaining the cows, but the advantage that oocytes can be harvested as
frequently as twice weekly throughout much of the cows adult lifespan, with an average of five
oocytes recovered per ovary (Broadbent et al., 1997). Because of this, this method of oocyte
collection is commonly used to increase the number of offspring generated from genetically
valuable females. In many species, live animal oocyte recovery requires that, at the least
invasive, a laparoscopic surgery be performed to access the ovaries and aspirate follicles.
However, the large size of cattle, permitted the design of a transvaginal oocyte collection
technique, termed transvaginal ultrasound-guided oocyte aspiration (TUGA) , in the late 1980s
(Pieterse et al., 1988). Using this method, ovaries are grasped transrectally, and held in place
against the vaginal wall. An ultrasound probe, fitted with an aspiration needle, is inserted
vaginally and used to visualize and aspirate antral follicles. Oocytes are aspirated along with the
follicular fluid (Pieterse et al., 1988; Looney et al., 1994; Hasler et al., 1995).
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2.4

In Vitro Oocyte Maturation
In vitro maturation is the process of removing germinal vesicle stage oocytes from the

follicular environment prior to the luteinizing hormone surge initiating maturation. Oocytes are
instead incubated in a laboratory to facilitate the completion of maturation. This is becoming
increasingly common, both in research and in reproductive assistance for human fertility and that
of many animal species, as it is the first step in production of embryos in vitro. There are two
primary ways in which in vivo and in vitro oocyte maturation differ;
1.

Cumulus-oocyte-complexes (COCs) used in IVM are often collected from mid-

sized antral follicles, at an earlier stage of development than they would naturally be ovulated.
2.

Having been removed from the follicular environment, COCs used in IVM are

removed from natural meiosis inhibiting factors and spontaneously resume meiotic maturation,
independent of a gonadotropin surge and despite potentially not having completed cytoplasmic
maturation (Gilchrist and Thompson, 2007; Bilodeau-Goeseels, 2012).
This issue becomes particularly apparent in oocytes collected from small to mid-sized
follicles (2-6mm), which would naturally remain in meiotic arrest for another four days, while
continuing to undergo cytoplasmic changes necessary to support development, before the follicle
would become pre-ovulatory and a gonadotropin surge would occur to stimulate in vivo
maturation (Bilodeau-Goeseels, 2012). Oocytes recovered from mid-sized to larger follicles have
had more time to receive necessary developmental cues and are more likely to be of higher
competence than those recovered from small follicles (Pavlok et al., 1992).
Current IVM culture media, while complex, is not an optimal media to simulate follicular
fluid, and is instead based off of somatic cell culture media (Gilchrist and Thompson, 2007). The
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composition of IVM media, and thus the environment that these oocytes are exposed to, is
significantly different from the fluid environment oocytes would naturally be maturing in within
follicles (Sutton et al., 2003; Sutton-McDowall et al., 2005; Gilchrist and Thompson, 2007;
Salhab et al., 2013). These environmental differences caused by IVM media shortcomings, are
one factor driving the often reported decreased developmental competence seen in in vitro
matured oocytes compared to their in vivo matured counterparts (Greve et al., 1987; Rizos et al.,
2002; Sutton et al., 2003; Thompson, 2006; Phongnimitr et al., 2013).
An optimal media has not yet been devised, and as a result there are many variations on
the market in which to mature oocytes. However, all contain the same base constiuents; a
balanced salt solution to maintain appropriate osmolality between 265 to 300 mOsmol(Wright
and Bondioli, 1981; Rosenkrans et al., 1993), amino acids, a pH buffer system to maintain
consistent pH of 7.2 to 7.4, and an energy source; most commonly pyruvate, all in a purified
water base. Bovine COCs are placed in the desired balanced oocyte maturation medium, and
using current protocols are cultured for 18-24 hours before maturation can be expected (Ward et
al., 2002; Lequarre et al., 2005; Agung et al., 2006). Oocytes are cultured in a humidified
incubator at internal body temperature (38.5°C) and a low pCO2 environment (~5%), and low
pO2 (5-7%) to simulate the anticipated conditions within the ovary (Thompson et al., 1990).
Under normal, in vitro, conditions meiotic maturation is completed with the oocyte reaching
metaphase II by 18 to 24 hours of culture, and it can be expected that 80% of cultured oocytes
will successfully complete maturation (Suss et al., 1988; Sirard et al., 1989). However, overall in
vitro matured oocytes are noted to be less competent than those produced in vivo, with decreased
embryo production rates resulting (Rizos et al., 2002; Krisher, 2004; Walls et al., 2012, 2015).
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Ultrastructural comparisons between in vivo and in vitro matured oocytes show general
similarity (Coticchio et al., 2016), but it is not uncommon to find abnormalities in oocyte
maturation, due to IVM, especially in indicators of cytoplasmic maturation and oocyte
competence. IVM oocytes frequently exhibit aberrations in mitochondria-smooth endoplasmic
reticulum (SER) aggregates, with mitochondria being found isolated or in association with the
oocyte membrane rather than in close proximity to SER (Coticchio et al., 2016). In vitro matured
bovine oocytes tend to have decreased lipid levels compared to in vivo matured oocytes (Auclair
et al., 2013; Warzych et al., 2017). Although the number of mitochondria do not generally differ
between in vivo and in vitro matured oocytes (Coticchio et al., 2016), IVM oocytes often show
aberrations in the mitochondrial distribution, with increased probabilities of mitochondrial
clustering throughout the ooplasm (Abdoon et al., 2011). It is probable that one reason for these
abnormalities found in in vitro matured oocytes, is due to irregularities in cumulus cell function,
resulting in oocyte exposure to dysregulated metabolites and signaling molecules during
maturation (Brown et al., 2017).
Although IVM has not yet been optimized for cytoplasmic maturation, parameters for
meiotic maturation are well known. Within 16-20 hours of IVM most oocytes will reach
metaphase II (Lequarre et al., 2005; Agung et al., 2006). When the IVM culture period exceeds
20-24 hours oocyte competence is decreased, resulting in impaired development and decreased
embryo production rates (Ward et al., 2002; Lequarre et al., 2005; Agung et al., 2006). However,
so long as the maturation period is within this critical range, oocyte competence is not hindered
and oocytes collected during a single OPU session can be fertilized together, despite the potential
for oocytes having matured at different times (Merton et al., 2012). Still, with current practices,
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although IVM increases the number of oocytes that can be recovered and fertilized, only a small
portion of those oocytes that mature to metaphase two have the potential to produce fully
competent embryos (Schroeder and Eppig, 1984).
2.5

Advancing Technologies in Oocyte Maturation
Studies attempting in vitro fertilization (IVF) in cattle began in the 1970s (Sreenan, 1970;

Hunter et al., 1972), with the first successful bovine IVF being reported in 1977 (Iritani and
Niwa, 1977). Progress continued rather rapidly in the initial years, and the first calf was born
following embryo transfer of an in vitro matured oocyte in 1982 (BG et al., 1982), followed by
continued successes throughout the 1980s (Critser et al., 1986; Hanada et al., 1986; Lu et al.,
1987).
Based on meiotic progression, IVM rates are currently high, approaching 90% (Leal et
al., 2012). However, with current protocols, although in vitro embryo production (IVP) does
increase embryo production rates compared to in vivo development, IVP is still quite inefficient.
While 30-40% of matured bovine oocytes successfully develop to the blastocyst stage in vitro
(Lonergan et al., 2000; Bilodeau-Goeseels, 2012), only 20-30% of retrieved oocytes develop into
highly competent, transferable embryos (Van Wagtendonk-de Leeuw, 2006). This is suggestive
of a deficiency in the developmental competence of in vitro matured oocytes, be it an innate
oocyte competence issue or one caused by suboptimal culture conditions (Trounson et al., 2001;
Jurema and Nogueira, 2006).
Regardless, in vitro oocyte maturation has the potential to be a revolutionary reproductive
technology. This allows the female reproductive capacity to be maximized through recovering
the entire supply of oocytes available within an ovary at any given time point (either living or
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post-mortem) for genetic preservation, or production of multiple offspring (Gilchrist and
Thompson, 2007). In recent years, the focus has been directed towards improving the efficiency
of in vitro embryo production by attempting to delay meiotic maturation of oocytes, while
allowing cytoplasmic maturation to proceed. In theory, this would result in oocytes more similar
to those matured in vivo, and hence more developmentally competent (Wu et al., 2006). The
primary method of delaying meiotic maturation has been through artificially maintaining high
cAMP levels within the oocyte, blocking the pathway resulting in M phase promoting factor
(MPF) activation, and hence reversibly preventing oocyte maturation. Meiotic resumption is
largely controlled by the activity of M phase promoting factor (MPF), which is composed of a
regulatory subunit; cyclin B, and a catalytic subunit; CDK1 (Bilodeau-Goeseels, 2012). Methods
to delay maturation, look at preventing activation of MPF, through maintaining high levels of its
primary inhibitor, cyclic adenosine monophosphate (cAMP) (Homa, 1988; Bilodeau-Goeseels,
2012). Common methods of doing so are either the inhibition of specific cyclin-dependent
kinases to prevent activation of oocyte MPF (Gilchrist and Thompson, 2007), or the use of
cAMP promoting/elevating agents to similarly inhibit meiotic resumption (Sirard and First,
1988; Bilodeau-Goeseels, 2003a, b, 2012). Artificially elevating cAMP will temporarily block
meiotic resumption in ungulates, and has a longer-lasting effect in mice and humans (Sirard and
First, 1988; Thomas et al., 2002, 2004a). Cyclic AMP works by activating protein kinase A
(PKA) when cAMP levels are high. Protein kinase A inactivates CDC25b preventing its action
and activates WEE1B which in turn phosphorylates CDK1 and inactivates the MPF complex.
When cAMP levels drop, PKA inactivates WEE1B, and activates CDC25b which then acts to
dephosphorylate CDK1, activating MPF and allowing meiosis to proceed (Bilodeau-Goeseels,
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2012). Thus, artificially maintaining high levels of cAMP will block the meiotic activation
pathway by preventing MPF phosphorylation. Although use of cAMP, or other chemicals aimed
at altering the above pathway to inhibit MPF, have shown success at delaying maturation, there
has not been an associated increase in embryo production (Kulbeka et al., 2000; Lonergan et al.,
2000; Ponderato et al., 2001; Hashimoto et al., 2002; Ponderato et al., 2002).
A second method of delaying meiotic maturation in bovine oocytes is to prevent germinal
vesicle breakdown, through inhibition of the protein synthesis necessary for MPF activation
(Sirard et al., 1989; Lonergan et al., 1997; Avery et al., 1998). Cyclohexamide is one such protein
synthesis inhibitor, and is commonly and successfully used in inhibiting meiosis in oocytes
(Kastrop et al., 1991; Saeki et al., 1997). As with cAMP, inhibition with cyclohexamide is
reversible and oocytes will resume meiosis when they are moved to a maturation promoting
medium free of inhibitors (Lonergan et al., 1997). Although cycloheximide has been used in the
past to successfully delay maturation, the resultant embryo production rates are decreased
compared to those from oocytes subjected to conventional IVM, suggesting that this treatment is
otherwise decreasing oocyte competence (Kastrop et al., 1991; Saeki et al., 1997).
There are three different methods of cAMP modulation in use; adenylate cyclase
activators (Thomas et al., 2002), cAMP analogues(Homa, 1988), and phosphodiesterase
inhibitors (Bilodeau-Goeseels, 2003a). However, research to date has been inconclusive as to the
benefits of cAMP modulators, wether alone or in combination. Meiosis is largely only transiently
inhibited in bovines, yet many studies continue to find insignificant differences in blastocyst
development rates between conventionally matured oocytes and those pre-incubated for meiotic
delay (Bagg et al., 2006, 2007; Luciano et al., 2011; Gharibi et al., 2013).
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In regards to oocyte collection, there is also dispute as to the best method for retrieving
oocytes of the greatest innate competence. There has been evidence from recent research that
oocytes recovered from ovaries four hours post-mortem are of optimal competence due to early
atretic factors (Blondin et al., 1997). Based off of this understanding, super-stimulation protocols
currently in use, and with the greatest degree of success, rely on a 24-48 hour coasting period
following the last follicle stimulating hormone (FSH) injection, before oocytes are recovered.
This coasting period causes atresia to begin without progressing far enough to be detrimental to
oocyte competence (Sirard et al., 1999).
One of the greatest challenges in improving IVM is to first improve our understanding of
oocyte cytoplasmic maturation in order to best determine which factors are most influential on
oocyte competence (Gilchrist and Thompson, 2007). From there, being able to collect and
mature oocytes with the greatest degree of competence would be making great strides towards
improving in vitro embryo production efficiency, and eventually applicability. The current study
was geared towards using a variety of cytoplasmic markers to identify those oocytes of the
greatest developmental competence, applied towards selecting between different oocyte
collection and maturation treatments in determining those best able to provide highly competent
oocytes.
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CHAPTER III
THE EFFECT OF DELAYING MATURATION ON BOVINE OOCYTE
CYTOPLASMIC MATURATION
3.1

Introduction
One of the biggest failings of in vitro maturation is that oocytes are released from

follicular fluid, and the natural meiotic inhibiting factors found within, prior to completion of
development. This induces oocytes to undergo spontaneous meiotic maturation without first
accumulating all of the cytoplasmic factors necessary to sustain early embryonic development
(Pincus and Enzmann, 1935; Edwards, 1965). Exacerbating this issue is the fact that while 24hour maturation is designed to promote nuclear maturation (Merton et al., 2012), conditions are
still sub-optimal for cytoplasmic maturation completion (Hagemann, 1999). Because an oocyte
cannot be held in the mature state without risking degeneration, there has been an emphasis on
research into methods for temporarily inhibiting spontaneous meiotic maturation, allowing
cytoplasmic maturation to proceed and “catch up” first. It is believed that doing so will allow
oocytes more time in communication with cumulus cells to accumulate and store molecules
necessary for embryonic development, before meiotic maturation resumes and the connections
are broken (Bilodeau-Goeseels, 2012). However current knowledge of how of how meiotic arrest
is maintained in vivo is limited and so methods in vitro are based on delaying meiotic resumption
instead (Bilodeau-Goeseels, 2011).
There are three different methods of cAMP modulation in use; adenylate cyclase
activators (eg; forskolin) (Thomas et al., 2002), cAMP analogues (eg; dibutyryl cAMP) (Homa,
1988), and phosphodiesterase inhibitors (eg; 3-isobutyl-1-methylxanthine) (Bilodeau-Goeseels,
2003a). However, research to date has been inconclusive as to the benefits of cAMP modulators.
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While meiosis is only transiently inhibited and gap junctional communication is maintained,
theoretically supporting cytoplasmic maturation, studies continue to find insignificant differences
in blastocyst development rates between conventionally matured oocytes and those pre-incubated
for meiotic delay (Bagg et al., 2006, 2007; Luciano et al., 2011; Gharibi et al., 2013).
One current practice, referred to as “simulated physiological oocyte maturation” (SPOM),
maintains meiotic arrest through combining two methods of cAMP maintenance (Albuz et al.,
2010). Incubation of oocytes for two hours in a pre-maturation medium containing a combination
of both IBMX and forskolin causes nearly a 67-fold spike in cAMP within the oocyte (from 3
fmol to 200 fmol), effectively preventing meiotic resumption by mimicking the increase in
cAMP levels that occur during the pre-ovulatory gonadotropin surge (Albuz et al., 2010). The
combined effect both increases cAMP production (forskolin) and prevents cAMP degradation
(IBMX), to maintain maximal cAMP levels. Once removed from this pre-maturation medium,
oocytes in the SPOM protocol are cultured in an extended maturation of 30 hours, where the
IVM medium is supplemented with another cAMP modulator (cilostamide, allowing only
gradual cAMP degradation) with the aim of meiotic resumption being restricted to a decreased
rate. The SPOM system has increased bovine embryo production rates compared to IVM (26%
and 8% respectively) as well as implantation rates (53% cf 28%).
One of the major problems associated with the use of meiosis promoting factor (MPF)
inhibitors, is that they have been shown to cause changes in the oocyte ultra-structure. By
interrupting cumulus cell-oocyte communication, and causing organelle disruptions the effects of
MPF inhibitors may be long-lasting and debilitating for oocyte competence towards embryo
development (Fair et al., 2002; Lonergan et al., 2003). To date, however, those factors that work
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by directly maintaining cAMP levels, cAMP modulators, appear to be the best candidate for
delaying meiotic maturation, potentially causing fewer aberrations than do other methods of
MPF inhibition (Bilodeau-Goeseels, 2003a, b).
This project compared oocytes that were matured using a conventional 24-hour
maturation, and those using a modified SPOM method, with a 2-hour pre-incubation and a 24hour maturation period to determine the effects of cycloheximide and IBMX on select oocyte
cytoplasmic maturation indicators. The hypotheses were that; 1) holding oocytes in cAMP
modulators would reversibly maintain both meiotic arrest and gap junction communication and
that cytoplasmic maturation would proceed during this period. 2) Oocytes undergoing extending
IVM, including both pre-maturation and IVM, would have more complete cytoplasmic
maturation than those oocytes undergoing conventional IVM. The aim was to determine if the 2hour pre-incubation period was, in fact, adequate at maintaining gap junction-mediated
communication between cumulus cells and oocytes for a long enough period to improve
cytoplasmic maturation, and thus oocyte competence.
3.2

Methods
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Chemical Co.

(St. Louis, MO, USA).
3.2.1

Animals
All procedures in this experiment were approved by the Louisiana State University

Agricultural Center’s Institutional Animal Care and Use Committee and were carried out at the
LSU Reproductive Biology Center, St. Gabriel, LA, USA. Thirty-five mixed breed beef cows,
housed on pasture with ad libitum access to mixed native grasses supplemented with hay and full
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access water were used for intermittent oocyte collection throughout autumn 2014 and spring
2015.
3.2.2

Experimental Design
The effect of in vitro maturation system on completion of oocyte cytoplasmic maturation

was assessed through comparison of immature oocytes to oocytes at different stages of in vitro
maturation. Oocytes were recovered via transrectal ultrasound-guided oocyte aspiration on 12
days, and were randomly assigned by day to one of four treatment groups (Table 3.1).
Table 3.1 Treatment groups for analysis of the effect of in vitro maturation protocols on
completion of oocyte cytoplasmic maturation
Control

Pre-Maturation

Immature (GV)

1; Immediate Fixation (n=285)

2; Pre-maturation (n=280)

Mature (MII)

3; Conventional IVM (n=300)

4; Extended IVM (n=290)

3.2.3

Oocyte Retrieval
Oocytes were recovered, as cumulus-oocyte complexes (COCs), from live cattle using

ovum pick-up (OPU, Figure 3.1). Methods were adapted from those used by Bailey (Bailey,
2014). For oocyte recovery, cows were restrained in a manual squeeze chute and were
administered 30 mg xylazine (XylamedTm, VetOne®, Boise, ID, USA) intramuscularly, as a mild
general sedative. They were then given a 5mL, 2% lidocaine (VetOne®, Boise, ID, USA)
epidural as a local anesthetic. Ovaries were palpated rectally and held against the vaginal wall so
follicles could be visualized on ultrasound. The ultrasound probe, an 8.5MHz convex transducer,
within a hard plastic needle guide (Boland Vet Sales, Keller, TX, USA), and connected to a
SonoSite® MicroMaxx® ultrasound, was inserted through the vaginal canal and held against the
vaginal wall against the ovary. Once follicles were visualized all follicles greater than 3 mm in
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diameter were aspirated, using an 18-guage, three inch long disposable needle (AirTite Products
N183) connected to the ultrasound through the needle guide system. Aspiration was performed
using negative pressure, achieved by connecting a vacuum pump (Cook Veterinary Products,

monitor and follicles are located. An 18-gauge disposable collection needle, located inside the

Australia).
needle
was connected
to an embryo
collection
filter tubing.
(AgtechThe
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Manhattan, KS,
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are rinsed with collection medium (D-PBS with 0.1% heparin and 1% BCS), and the follicular

lines. The needle was replaced, and ultrasound probe cleaned after each cow. Once recovered,
fluid and oocytes are deposited into an embryo collection filter (Agtech Inc., Manhattan, KS,

oocytes were placed in Hepes-TALP (Appendix) at 38.5°C until further processing.
USA). All media used during collection is maintained at 39°C.

Figure3.1.
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aspiration procedure (Godke et al., 2014).
3.2.4

Pre-Maturation

Oocyte Culture:
Oocytes in treatment groups 2 and 4 were incubated for two hours in a pre-maturation
Oocytes in treatment 1 were washed four times through standard IVM medium, and

medium, at 38°C in a non-CO2 incubator prior to further processing. This medium was based on
were divided evenly into four groups for the 8, 13, 18, and 23-hour time samples. Individual four-

Hepes-TALP, supplemented with 0.1µM Forskolin and 0.5µM IBMX (3-Isobutyl-1-

well plates were previously prepared and labelled for each of these time samples, and

methylxanthine)
(Appendix). Oocytes were then removed from the cAMP modulating medium,
contained nine to twelve oocytes in each 35 µL drop. Oocytes were cultured in 5% CO at 39°C
2

for the required times, ranging from 8 to 23 hours.
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Oocytes in treatment 2 (extended IVM) were washed four times through the pre-IVM
medium with FSK and IBMX, and then left in this medium for two hours in a non-CO2 incubator

and washed three times in Hepes-TALP before being moved to either IVM medium (Treatment
4) or proceeding with the staining protocol (Treatment 2).
3.2.5

Oocyte Culture
Oocytes in treatments 3 and 4 were put through a standard in vitro maturation (IVM)

protocol. Those oocytes in treatment 3 were placed immediately into IVM following retrieval,
while those in treatment 4 had a 2-hour pre-maturation incubation described above prior to IVM.
Oocytes were washed 3 times in IVM medium (Appendix) before being split into cohorts
of 8-12 and placed into 35µL drops of IVM medium under oil. IVM dishes were then placed in a
humidified incubator at 38.5°C under 5% CO2 for 22 hours.
3.2.6

Staining and Fixation
Oocytes in each treatment group (one through four) were split into two different analysis

methods, such that half of the oocytes for each treatment were analyzed by each method.
In analysis method A, oocytes were stained with Calcein AM to identify gap junction
closure between the oocyte and the surrounding cumulus cells. Cumulus-oocyte complexes were
incubated in 0.1µg/mL Calcien AM (Life Technologies, Eugene OR) for 15 minutes. Following
this oocytes were vortexed for two minutes in 1mg/mL hyaluronidase in Hepes-TALP to remove
cumulus cells. Denuded oocytes were then incubated for 30 minutes at 38°C in 1µg/mL Hoechst
33342 (Life Technologies) for nuclear identification. The stained oocytes were mounted on slides
under 10µL of vectashield antifade mounting medium (Vector Laboratories, Burlingame, CA,
USA). Slides were viewed on a wide field fluorescent microscope at 400X magnification and
images were saved for each oocyte (Figure 3.2).
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A

3

B

3

2

1
2

1

Figure 3.2. Calcein AM staining of oocytes. A. Six oocytes stained after a two-hour preincubation period in IBMX and forskolin. B. Eight oocytes stained after extended in vitro
maturation, including a two-hour preincubation and 24-hour maturation. In both A and B, arrows
indicate gap junction functional status as below; 1- open, 2- partially open, 3- closed.
Oocytes assigned to analysis method B were denuded using the above mentioned
protocols prior to staining. They were then incubated for 40 minutes in 400nM MitoTracker deep
red (Life Technologies, M22426), diluted in Hepes-TALP at 38°C in a non-CO2 environment
(Figure 3.3). MitoTracker stained oocytes were rinsed and fixed in 4% paraformaldehyde for one
hour at room temperature. They were then placed in an 0.5% Triton X-100 blocking solution for
30 minutes at room temperature before being incubated for 30 minutes at 38.5°C with 1µg/mL
Alexa Flour 488 conjugated Phalloidin (Life Technologies) stain, for identification of F actin
(Figure 3.4). Finally, oocytes were washed for 10 minutes and stained with 1µg/mL Hoechst
33342 for 30 minutes before rinsing and mounting on slides under 10µL of Vectashield anti-fade
mounting medium. Oocyte staining was analyzed on a wide field fluorescent microscope (Nikon
H600L equipped with a Zyla SCMOS camera) at 600X magnification and images were saved for
each oocyte.
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A

B

C

Figure 3.3. Mitotracker Deep red staining of oocyte mitochondria. A. An oocyte displaying
peripheral mitochondria. B. An oocyte with mitochondria found in diffuse clusters throughout
ooplasm. C. An oocyte with mitochondria evenly diffuse throughout ooplasm.
A

B

C

Figure 3.4. Phalloidin staining of oocyte F-actin, representing tubulin aggregation. A. An oocyte
with diffuse, unpolymerized F-actin. B. An oocyte with disaggregated F-actin forming short
polymers. C. An oocyte displaying fully networked, densely aggregated F-actin.

Images from both analysis methods were later analyzed by an observer blinded to
treatment, and numerically coded for stain parameters (Table 3.2) that corresponded to
previously documented indications of oocyte maturity (Thomas et al., 2004b, b; Adona et al.,
2008; Abdoon et al., 2011; Matchatkova et al., 2012).
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Table 3.2

Criteria for classification of oocyte maturation status for each parameter analyzed.
Assigned Score

Meiotic Status

Gap Junctions

Mitochondria

F-Actin

Immature

1

Germinal
vesicle

Open

Peripheral

Disaggregated

Maturing

2

Metaphase I

Partially open

Diffuse

Partially
aggregated

Mature

3

Metaphase II

Closed

Diffuse clusters

Polymerized
network

3.2.7

Statistics
All statistical tests were performed in RStudio (Team, 2016). Results for analysis method

A were compared using chi square analysis to determine if there were any differences in the
proportion of oocytes at each level of gap junction communication between treatments and
meiotic maturation. Results for analysis method B were assessed to determine significant
interactions between treatment, meiotic maturation, mitochondrial location and F-actin
aggregation, using chi square analysis of the proportion of oocytes representing each
characteristic. Specific differences were determined using the Kruskal-Wallis Nemenyi post-hoc
test. Significance was set at P<0.05.
3.3

Results
The majority of oocytes that were fixed immediately following retrieval were found in

the germinal vesicle (GV) stage of meiotic arrest, and this was not changed over the course of the
2 hour pre-incubation period (P=0.62). Oocytes in both groups that underwent in vitro maturation
(IVM) progressed through meiosis, with oocytes that underwent conventional meiosis having a
slightly higher proportion of oocytes completing meiosis than those that were held in preincubation prior to IVM (63% and 54% of oocytes reaching metaphase II, respectively). Results
outlined in Table 3.3 show that treatment had an overall significant effect on meiotic stage
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(P<0.001). Both methods of maturation showed significantly different maturation profiles than
did immature fixed oocytes or oocytes exposed to a pre-maturation period only (P< 2e-16 for all
comparisons). It is important to note that there was a significant difference in maturation profiles
between conventional and extended IVM groups as well (P=0.0042) with conventional IVM
having a slightly improved maturation rate.
Table 3.3. Proportion table depicting the meiotic status of oocytes in each treatment group and
the overall average meiotic phase within each treatment.
Meiotic Status

Immediate
Fixation (n)

PreMaturation
(n)

Conventional Extended
IVM (n)
IVM (n)

Total (n)

GV

0.77 (219)

0.79 (221)

0.11 (33)

0.12 (35)

0.44 (508)

MI

0.11 (31)

0.08 (22)

0.15 (45)

0.2 (58)

0.14 (162)

MII

0.05 (14)

0.02 (6)

0.63 (189)

0.54 (157)

0.32 (370)

Unknown/ Degenerate

0.05 (14)

0.11 (31)

0.11 (33)

0.14 (41)

0.1 (115)

Most Frequently Occurring
Meiotic Stage

GVA

GVA

MIB

MIIC

Superscripts(A,B,C) indicate significant differences in the overall distribution of oocyte meiotic
status between treatments at p<0.005.
Gap junctions were found to be open in the majority of immature fixed oocytes. This
function was maintained, though not entirely throughout the pre-maturation incubation
(P=0.0036) with a 13% increase in the number of oocytes with closed gap junctions occurring
following the pre-incubation (Table 3.4). Following extended IVM, gap junctions continued to
close showing a lower proportion with open gap junctions than immediately following prematuration (34% and 40% open, respectively), but without a significant change to the overall
average profile (P=0.79 and P=0.0021 for comparison to pre-incubation and immature,
respectively). When compared to all other treatment groups, oocytes cultured in a conventional
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IVM treatment were the most likely to have completely closed gap junctions (43%), which was
significantly different from all other treatments (P=2.6e-9, P=0.0038, and P=0.0066 for immediate
fixation, pre-maturation and extended IVM, respectively). As well as treatment having a
significant overall effect (P<0.001) on gap junction functional status, meiotic phase (P=1.43e-13)
and the interaction between treatment and meiotic phase (P=7.68e-6) were also significantly
correlated to gap junction closure, with mature, MII, oocytes being the most likely to have closed
gap junctions.
Table 3.4. Proportion table depicting the functional status of gap junctions of oocytes in each
treatment group and the overall average gap junction function level within each treatment.
Gap Junction
Communication

Immediate
Fixation

Pre-Maturation

Conventional
IVM

Extended IVM

Total

Open

0.59 (77)

0.4 (50)

0.2 (26)

0.34 (44)

0.38 (196)

Partially Open

0.22 (28)

0.32 (40)

0.37 (48)

0.4 (57)

0.32 (165)

Closed

0.19 (25)

0.32 (40)

0.43 (56)

0.26 (34)

0.3 (154)

OpenB

ClosedC

PartialB

Most Frequently OpenA
Occurring GJ
Status

Superscripts(A,B,C) indicate significant differences in the overall distribution of oocyte gap
junction functional status between treatments at p<0.01.
All three distinct patterns in mitochondrial distribution were found within each treatment
group, and while treatment did have an overall effect on mitochondrial location within the
ooplasm (P<0.001), pairwise post-hoc comparisons found no significant differences between the
proportion tables of any two specific treatments (P>0.1). The most frequently observed
orientation for all treatments groups was for mitochondria to be found in clusters throughout the
entire ooplasm, however oocytes subjected to pre-maturation alone showed the highest
proportion of oocytes with clustered, diffuse mitochondrial patterning (48%, compared to
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33-43%, Table 3.5). As with gap junction closure, the interaction between treatment and meiotic
completion had a significant impact (P=0.0072) on mitochondrial translocation, although nuclear
status alone was an insignificant factor (P=0.45). Treatment with conventional IVM did result in
oocytes with the lowest incidence of both peripheral mitochondria and limited mitochondrial
numbers, indicating that this treatment had the greatest effect on supporting mitochondrial
maturation.
Table 3.5. Proportion table depicting the mitochondrial location patterns found in oocytes in
each treatment group and the overall average mitochondrial location within each treatment.
Mitochondrial Location

Immediate
Fixation

PreMaturation

Conventional
IVM

Extended IVM Total

Peripheral

0.07 (11)

0.12 (19)

0.05 (9)

0.17 (27)

0.11 (70)

Diffuse

0.23 (36)

0.15 (23)

0.42 (71)

0.23 (37)

0.26 (166)

Diffuse Clusters

0.37 (57)

0.48 (74)

0.43 (73)

0.33 (53)

0.41 (262)

Unknown

0.33 (51)

0.25 (39)

0.1 (17)

0.27 (43)

0.22 (141)

Most Frequently
Occurring
Mitochondrial Location

Diffuse
ClustersA

Diffuse
ClustersA

Diffuse
ClustersA

Diffuse
ClustersA

Superscripts(A) indicate significant differences in the overall distribution of oocyte mitochondrial
location between treatments at p<0.05. There was no significant difference found between
treatment groups.
Tubulin patterns, as represented by F-actin staining, primarily changed in aggregation
rather than distribution patterns. Regardless of treatment, few oocytes had tubulin in its
aggregated form of long filamentous networks, but this was most frequently seen following
extended IVM (23% cf 9-13%, Table 3.6). Treatment did have a significant effect on the changes
in tubulin (P<0.01), but the only treatment that showed a significant difference in patterns was
extended IVM. Oocytes in extended IVM had similar tubulin characteristics to those that were
fixed immediately in the GV stage (P=0.23) but different characteristics from either oocytes that
!36

had been pre-incubated only (P=0.0047), or cultured in conventional IVM without preincubation (P=0.010).
Table 3.6. Proportion table depicting the tubulin aggregation patterns in oocytes in each
treatment group and the overall average tubulin patterns within each treatment.
Tubulin
Aggregation

Immediate
Fixation

PreMaturation

Conventional
IVM

Extended IVM

Total

Disaggregated

0.35 (54)

0.49 (76)

0.51 (87)

0.31 (48)

0.43 (275)

Partially
Aggregated

0.44 (68)

0.35 (54)

0.34 (58)

0.43 (69)

0.38 (243)

Filamentous
Network

0.09 (14)

0.11 (17)

0.13 (22)

0.23 (37)

0.14 (90)

Unknown

0.12 (19)

0.05 (8)

0.02 (3)

0.03 (5)

0.05 (32)

Most Frequently
Occurring Tubulin
Aggregation

Partially
AggregatedAB

DisaggregatedB DisaggregatedB

Partially
AggregatedA

Superscripts(A,B) indicate significant differences in the overall distribution of oocyte tubulin
aggregation patterns between treatments at p<0.005.
3.4

Discussion
Since so much of oocyte competence is determined by successful, and concurrent,

meiotic and cytoplasmic maturation, and since in vitro maturation results in maturation occurring
in an environment quite different from that naturally occurring within the follicle, it is not
unexpected that the in vitro maturation system is considered to be one of the most critical factors
in determining the competence of IVM oocytes (Kafi et al., 2005). Although the effect of low
concentrations of cAMP is transient in bovines and has been shown to improve overall meiotic
maturation rates and resultant blastocyst rates by as much as 30% over traditional IVM alone
(Thomas et al., 2004b), including a high concentration either before or during IVM could
decrease oocyte developmental competence (Luciano et al., 1999).
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A previous study in our lab found that this pre-maturation protocol delayed meiotic
maturation with 85% of oocytes having already resumed meiosis at the start of conventional
IVM, and only 25% when cAMP modulators were present (Farmer, 2014). However, this meiotic
inhibition was found to be largely irreversible, with 80.6% of oocytes reaching MII by
completion of conventional IVM, and only 43.8% of oocytes in extended IVM completing
meiotic maturation (Farmer, 2014), with similar results seen in other studies (Gharibi et al.,
2013). Results in this study were in agreement with these previous studies, in that meiotic
maturation rates were decreased after exposure to IBMX and Forskolin. These results
corroborate the belief that cAMP modulation may be less reversible in the bovine than was
originally believed. However, meiotic maturation rates were universally lower than anticipated in
this study, indicating that there may have been unrecognized confounding effects decreasing the
oocyte competence.
The goal of exposing oocytes to cAMP modulators is that by blocking the MPF pathway,
gap junctions between oocytes and cumulus cells will be maintained (Thomas et al., 2004b). This
will allow continued communication, while holding oocytes in meiotic stasis, which should
encourage oocyte cytoplasmic changes necessary for early embryonic development to occur
(Thomas et al., 2004b). However, results of the current study indicated that incubation in IBMX
and forskolin was only partially successful at maintaining gap junctional communication and that
this was largely irreversible. There was a significant decrease in the proportion of oocytes with
open gap junctions between post-collection and following the pre-maturation incubation, but no
notable difference in gap junction function between incubation and following IVM after the preincubation protocol. This was significantly different from the results seen for oocytes that were
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matured in vitro without a pre-incubation, which experienced a more extensive cessation of gap
junctional communication. These results suggest that cAMP modulators, specifically IBMX and
forskolin, may be less effective than intended for improving oocyte competence. These results
are in corroboration with those published by Razza et al, wherein oocytes cultured in extended
IVM were found to exhibit ultrastructural characteristics more similar to immature oocytes than
to conventionally in vitro matured oocytes (Razza et al., 2015). Oocytes exposed to IBMX and
forskolin had decreased smooth endoplasmic reticulum, mitochondrial and lipid volume than
IVM oocytes, but increased vesicle volume (Razza et al., 2015).
The major problem with gap junctions closing is that molecules and factors from cumulus
cells that are necessary for oocyte cytoplasmic maturation are blocked from entry into the oocyte
(Thomas et al., 2004b). The two cytoplasmic factors analyzed in this study, mitochondrial
relocation and F-actin polymerization, both showed insignificant improvements in measurable
maturation following the pre-incubation protocol.
One unexpected result of this study is that a high degree of vacuolization was viewed
within the oocytes, recognizable as well defined roughly circular areas within the cytoplasm that
were unstained with either Mitotracker to Phalloidin (Figure 3.4). While vacuoles were present in
large numbers in oocytes of all treatment groups, they appeared to be far more common in
matured oocytes, both those with and without the pre-incubation prior to maturation. High levels
of vacuoles have previously been associated with oocytes of decreased developmental
competence (Coticchio et al., 2016; Nottola et al., 2016). The fact that these are developing over
the course of maturation, and not present in high numbers in immature oocytes, may be further
indicative of sub-optimal maturation conditions resulting in declining oocyte competence.
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Further, it is possible that the development of this high degree of vacuolization may be
interfering with proper migration of organelles, disrupting measurement of these cytoplasmic
maturation parameters.

Figure 3.5. Image of an oocyte stained with phalloidin, showing a high degree of vacuolization
visible as dark unstained circles within ooplasm.
Overall, results indicate that a two-hour incubation in forskolin and IBMX is likely to be
insufficient for increasing in vitro embryo yield. Although gap junctions are maintained and
meiotic stasis is achieved in some oocytes, both results are only achieved in a small proportion of
oocytes, and both are seen to be largely irreversible, preventing proper resumption of meiosis
and development following removal of cAMP modulators. Further, the inability of modulators to
maintain full gap junction communication results in irregular results at permitting cytoplasmic
maturation as indicated by the fact that neither mitochondrial migration nor tubulin aggregation
was significantly improved by the pre-maturation protocol. Finally, the formation of vacuoles
during both IVM protocols is further proof that current in vitro culture conditions are suboptimal
and must be improved upon before we will see increased embryo production rates.
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CHAPTER IV
THE EFFECT OF FOLLICULAR WAVE PHASE AT TIME OF OPU ON
BOVINE OOCYTE CYTOPLASMIC MATURATION AND
DEVELOPMENTAL COMPETENCE
4.1

Introduction
Success of any in vitro embryo production program requires first that oocytes collected

be not only numerous, but of optimal developmental competence (Seneda et al., 2001). The
follicular environment may play a key role in regulating oocyte growth and development. As
such, oocytes recovered from larger follicles, which have had more time to grow and receive
developmental signals from follicular fluid and granulosa cells, are considered to be more
competent, producing 5-10% more embryos, than those recovered from small growing follicles
(Fair et al., 1995; Hagemann et al., 1999; Hagemann, 1999). As the follicle continues to grow
and becomes dominant, it produces estradiol and inhibin, both of which exert negative feedback
activity on follicle stimulating hormone (FSH), causing apoptosis and regression of subordinate
follicles (Ireland et al., 1984; Kaneko et al., 1997; Ginther et al., 2000; Bleach et al., 2001). The
follicular wave is commonly divided into three distinct phases; at the start of the wave all
follicles are growing together (follicle growth), but by mid-wave (peak) a single dominant
follicle has emerged which deviates and grows to pre-ovulatory sizes while inhibiting further
development of subordinate follicles (Sunderland et al., 1994). The third phase, referred to as the
atretic phase, is dominated by regression of all subordinate follicles. These effects combine to
have the result that both the total number, and average developmental competence of oocytes
recovered can vary greatly based on follicle wave phase at the time of collection (Seneda et al.,
2001).
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Despite the benefits of waiting to collect oocytes from large pre-ovulatory follicles,
previous studies have found that oocytes collected during the follicle growth phase had a higher
degree of competence than those collected during the dominance phase (Hagemann et al., 1999;
Seneda et al., 2001; Machatkova et al., 2004). In fact, the presence of a dominant follicle has
been found to not only decrease the competence of oocytes recovered from subordinate follicles
but also from the oocytes within the dominant follicles themselves (Hagemann, 1999). Oocytes
collected during the regression phase were not necessarily of depressed competence, and even a
high degree of follicle atresia had no negative impact on oocyte competence (Hagemann et al.,
1999). However, oocytes collected during the growth phase of follicular waves, when there is no
atresia present, have been shown to be of an overall greater competence, as well as improved
recovery rates (Seneda et al., 2001; Machatkova et al., 2004).
Despite this understanding, most commercial oocyte collection programs rely on
performing follicular aspirations on random days of the cows’ estrous cycles, rather than
employing a system to time oocyte recovery (Morotti et al., 2014; Cavalieri et al., 2017). In
practices that do try to perform timed oocyte pick-up (OPU), there is disagreement on whether or
not follicular atresia has negative effects on oocyte competence. As such, there is a lack of
consensus on when OPU is best performed for maximal oocyte competence and quantity. This
project was designed with the objective of determining the role of follicular wave phase and
ovarian dynamics on oocyte collection rates, and oocyte cytoplasmic competence. The
hypotheses were that; 1) Oocyte recovery rates would be lowest at wave peak but that oocyte
competence would be lowest during follicle atresia. 2) Oocytes recovered during wave peak
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would be of greater developmental competence than those collected from either growing or
atretic follicles.
4.2

Methods
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Chemical Co.

(St. Louis, MO, USA).
4.2.1

Animals
All procedures in this experiment were approved by the Louisiana State University

Agricultural Center’s Institutional Animal Care and Use Committee and were carried out at the
LSU Reproductive Biology Center, St. Gabriel, LA, USA. Thirty-six mixed breed beef cows,
housed on pasture with ad libitum access to mixed native grasses supplemented with hay and full
access water were used for oocyte collections from June 2016 through March 2017.
4.2.2

Experimental Design
This project was designed as a repeated measures, treatment cross-over design. Oocytes

were collected from live cattle, at 3 different points within the follicular wave to represent the
cohort of oocytes available during follicle growth (day-4 of a new wave), peak (day-8), and
atresia (day-12). Each cow was used on three sequential cycles, so that collections would occur
during each wave phase for every cow. The entire project was repeated twice with different
groups of cows.
Stimulation of a new follicular wave was achieved through performing a dominant
follicle removal (DFR) on all cows. During the DFR, follicles greater than 6 mm in diameter
were aspirated using the same transvaginal ultrasound-guided follicle aspiration (TUGA)
techniques as for oocyte collection. Cows were then randomly assigned to one of three groups, to
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determine oocyte collection day, though all cows were housed on the same pasture. Using a
cross-over design, this DFR followed by oocyte retrieval was repeated three times so that each
cow was collected during each follicular phase.
4.2.3

Oocyte Retrieval
Cumulus-oocyte complexes (COCs), from live cattle using transrectal ultrasound-guided

oocyte aspiration, using methods described above in section 3. Cows were restrained in a manual
squeeze chute, administered 30 mg xylazine and given a 5mL, 2% lidocaine epidural. Ovaries
were palpated rectally and held against the vaginal wall so follicles could be visualized on
ultrasound and aspirated using an ultrasound probe that had been inserted vaginally. Once
follicles were visualized all follicles greater than three mm in diameter were aspirated. Follicular
fluid was aspirated directly into a 50mL FalconTM tube that had been primed with collection
medium. Tubes were labelled with each cow’s identification number and a new collection tube
was used for each cow. The aspiration system was rinsed with collection medium after each
ovary to prevent oocytes from being held in the aspiration lines.
During the oocyte retrieval process, parameters for each ovary were recorded including;
the number of follicles aspirated and the average size of follicle present, whether or not a
dominant follicle was present and its size if noted, and whether or not a corpus luteum was
present. Once recovered, oocytes were placed in Hepes-TALP at 38.5°C until further processing.
The total number of oocytes recovered per cow was recorded as well as their visible grade, based
on cumulus cell enclosure and cytoplasm appearance. All oocytes for each treatment from a
single day were pooled at the end of the recovery process for all allotted cows, and were then
randomly divided into level two treatment groups.
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4.2.4

Oocyte Maturation
One-third of the recovered oocytes were fixed immediately following retrieval to

represent germinal vesicle stage oocytes for the staining analyses. The remaining two-thirds of
the recovered oocytes were put through a standard in vitro maturation (IVM) protocol following
retrieval. Oocytes were washed 3 times in TCM-199 based IVM medium (Appendix) before
being split into cohorts of 8-12 and placed into 35µL drops of IVM medium under oil. IVM
dishes were then placed in a humidified incubator at 38.5°C under 5% CO2 for 22 hours.
Following maturation, half of the matured oocytes were fixed and stained using the same
protocols as for the immature oocytes. The remaining oocytes were subjected to parthenogenetic
activation and were cultured to determine embryo production rates.
4.2.5

Parthenogenetic Activation and Embryo Culture
Following completion of maturation, cumulus-oocyte complexes were rinsed in Hepes-

TALP before being denuded by vortexing for two minutes in 1mg/mL hyaluronidase. Denuded
oocytes were recovered from hyaluronidase, rinsed three more times in Hepes-TALP and stained
in 5µM Fluo 3-AM (Molecular Probes, F1242), to identify free cytoplasmic calcium. Oocytes
were incubated in 20µL droplets of Fluo 3-AM under oil for 45 minutes at 38.5°C before being
washed in Hepes-TALP again. Pre-activation images were taken on an inverted microscope
(Nikon Eclipse TE200 equipped with a Hitachi camera) at 400X magnification.
Oocytes were then chemically activated in a 20µL droplet of 20µM ionomycin for five
minutes. They were washed again in Hepes-TALP and post-activation images were taken, and
staining intensity recorded. Oocytes were cultured for four hours in 30µL drops of 200mM
DMAP under oil and at 38.5°C, to complete activation. Activated parthenotes, were rinsed in
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synthetic oviductal fluid (SOF) medium (Appendix) before being transferred to fresh 35µL drops
of SOF under oil. Presumptive embryo were cultured at 38.5°C, in a 5% CO2 humidified
incubator for 7 days. Embryo cleavage was recorded on day-2 of culture, development to the 8cell stage was recorded on day-4.
Fluo 3-AM images were coded on a 0 to 4 scale based on staining intensity, with 0
indicating no fluorescence visible, and 4 representing high intensity fluorescence throughout the
entire cytoplasm. Fluorescence was compared between oocytes pre- and post-ionomycin
activation, and average fluorescence levels at both time points were compared across the
different treatment groups (follicular phases at time of oocyte recovery). Oocytes were separated
into different culture drops based on their post-activation staining intensity, so effect of
cytoplasmic calcium levels on embryo development rates could be tracked.

1
2

Figure 4.1. Staining reference for Fluo3-AM levels. Image 1 on the left represents an oocyte
graded “1” or “slight” and image 2 on the left represents an oocyte graded “3” or “high”
fluorescence.
4.2.6

Staining and Fixation
Both immature and mature oocytes, with the exception of those that were

parthenogenetically activated for embryo production, underwent the same fixation and staining
protocol (Appendix for detailed protocol). Cumulus-oocyte complexes were denuded either
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immediately following collection (germinal vesicle stage) or following 22-hours of IVM (MII
stage), by vortexing in 200mL of 1mg/mL hyaluronidase in a 1.5mL microcentrifuge tube for 2
minutes. Denuded oocytes were stained with 400nM Mitotracker deep red (Molecular Probes,
M22426) for 30 minutes at 38.5°C before fixation in 2% paraformaldehyde. Inositol 1,4,5trisphosphate receptor 1 (IP3R1) identification was performed using a permeabilization protocol
followed by a one hour incubation at 38.5°C in a primary antibody against IP3R1 (1:500, Abcam,
5804). Oocytes were then washed followed by incubation in a secondary goat antibody against
rabbit IgG and conjugated with Alexa Fluor 488 (1:500, Abcam, 150077). Finally oocytes were
mounted on slides under 10µL of Vectashield containing DAPI. Oocytes were viewed on a widefield Nikon microscope at 600X, and images were deconvolved 10 times before being analyzed
by a blinded observer for staining characteristics.
Using similar guidelines to those outlined in section 3, oocytes were coded for meiotic
maturation based on DAPI staining of the chromatin (germinal vesicle, metaphase I or metaphase
II) and for mitochondrial maturation as determined by Mitotracker identification of
mitochondrial location within the ooplasm (peripheral, clustered, diffuse). Inositol 1,4,5trisphosphate receptor 1 expression was measured as total cell fluorescence in Image J, corrected
by subtracting individual image background fluorescence intensity.
4.2.7

Statistics
All statistical tests were performed in RStudio (Team, 2016). Results involving embryo

development rates were compared using chi square tests to determine if there were any
interactions between follicular phase, cytoplasmic calcium, and embryo development. Results of
oocyte staining were assessed to determine significant interactions between follicular wave
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phase, meiotic maturation, mitochondrial location and IP3R1 expression, using linear models
with a step-function analysis of variance (ANOVA) to determine the best model. Chi square
analysis was performed comparing the proportion of oocytes at each mitochondrial maturation
level against follicular wave phase. Pairwise interactions were analyzed using the Kruskal-Wallis
Nemenyi post-hoc test. Included into the step-wise ANOVA model, were factors recorded during
OPU to determine if follicular phase had an effect on apparent oocyte grade or oocyte collection
rates.
B

A

C

Figure 4.2. A. In immature oocyte stained to identify chromatin (blue) and IP3R1 (green). B. A
metaphase II oocyte after 24 hours of IVM stained to identify chromatin (blue) and IP3R1
(green). C. An oocyte stained with Mitotracker deep red to identify chromatin, found in the
diffuse orientation here.
4.3

Results
A total of 1,054 oocytes were collected over the course of this trial (364, 374, and 316 on

day-4, day-8 and day-12 respectively). Of these 812 were used for analysis (Table 4.1), with the
remainder being either lost during handling or discarded for visible degeneration.
Table 4.1. Number of oocytes collected and allocated to each analysis method
Collection Day

Germinal Vesicle

Metaphase II

Embryo Production

Follicle Growth

n=63

n=76

n=107

Follicle Peak

n=86

n=101

n=117

Follicle Atresia

n=96

n=74

n=92
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With the exception of a positive correlation between number of follicles aspirated and
oocyte recovery (recovery rate=61%, P=2e-16, r2=0.75), none of the recorded variables had an
effect on the number of oocytes that were recovered (Table 4.2). Follicular phase did not affect
either the number of follicles present or the number of oocytes recovered, and there was no
tendency for oocytes from larger follicles to be higher grade at the time of recovery (P=0.23,
r2=0.11). Further, follicular wave phase had no bearing on oocyte grade P=0.786).
Table 4.2. Oocyte collection parameters by follicle phase at time of OPU.
Collection Parameters

Follicle Growth

Follicle Peak

Follicle Atresia

Number of Follicles
Present (mean per cow)

17.4

18.1

15.4

Number of Oocytes
10.1
Collected (mean per cow)

10.4

8.8

Proportion of A/B Grade
Oocytes (mean per cow)

0.53

0.45

0.48

Mean Oocyte Recovery
Rate Per Cow

0.65

0.62

0.58

*There were no significant interactions between follicular phase and any of the parameters
measured (P>0.05).
Completion of meiotic maturation was strongly correlated to whether oocytes had been
subjected to IVM or not (P=0.132e-11, r2=0.68), but was not significantly affected by follicle
phase (P=0.9). Mitochondrial migration appeared to occur independently of either IVM status or
meiotic maturation (Table 4.3), but IP3R1 expression significantly increased over the course of
IVM (P=0.013), and in correlation with meiotic completion (P=0.007, Table 4.4). Overall, the
most important factor affecting IP3R1 expression levels was the follicular phase at the time of
OPU (P=0.0056). The highest IP3R1 expression was found in oocytes collected during follicular
growth (day-4 post-DFR) and the lowest expression levels were found in oocytes recovered from
atretic follicles (day-12 post-DFR).
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Table 4.3. The effect of follicular phase and IVM on mitochondrial distribution patterns in
bovine oocytes.
Mitochondrial
Distribution
Proportions

Follicle Growth

Follicle Peak

Follicle Atresia

GV (n)

MII (n)

GV (n)

MII (n)

GV (n)

MII (n)

Peripheral

0.164 (6)

0.169 (9)

0.295 (14)

0.17 (9)

0.215 (13)

0.059 (3)

Diffuse

0.5 (20)

0.677 (37)

0.464 (23)

0.508 (28)

0.545 (34)

0.677 (33)

Clusters

0.064 (2)

0.016 (1)

0.142 (7)

0.152 (8)

0.073 (5)

0.019 (1)

Few
Mitochondria

0.272 (11)

0.138 (7)

0.099 (5)

0.17 (9)

0.167 (10)

0.245 (12)

*Neither maturational status nor follicular phase at the time of OPU had a significant effect on
mitochondrial location (P>0.05).
Table 4.4. The effect of follicular phase and IVM on IP3R1 expression levels in bovine oocytes.
IP3R1 Accumulation

Follicle GrowthA

Follicle PeakAB

Follicle AtresiaB

GV (n)

MII (n)

GV (n)

MII (n)

GV (n)

MII (n)

Low

0.59 (23)

0.407 (22)

0.551 (27)

0.436 (24)

0.468 (29)

0.633 (31)

Slight

0.282 (11)

0.315 (17)

0.347 (17)

0.436 (24)

0.468 (29)

0.245 (12)

Moderate

0.051 (2)

0.204 (11)

0.082 (4)

0.128 (7)

0.064 (4)

0.122 (6)

High

0.077 (3)

0.074 (4)

0.02 (1)

0

0

0

Total (n)

39

54

49

55

62

49

*The interaction between maturation status and follicular phase had an overall significant effect
on IP3R1 expression (P=0.013). Oocyte maturation alone was not a significant factor in IP3R1
expression (P=0.13). ABWhen looking only at the effect of follicular phase, there was a
significant difference in IP3R1 expression between oocytes collected during follicle growth and
atresia (P=0.013), but not between oocytes from follicle peak and either growth or atresia
(P=0.179 and P=0.974 respectively).
Embryo development rates for this project were uniformly low, with cleavage rates of
19.4%, 17.6% and 12.2% for oocytes collected during follicle growth, peak and atresia
respectively (P=0.0.14, Table 4.5). Development beyond the 8-cell stage was also low across all
collection groups at 1.9%, 7.2%, and 2.8% or follicle growth, peak and atresia respectively
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(P=0.44), but was slightly better from oocytes collected during wave peak. However, Fluo 3-AM
fluorescence levels had a significant effect on cleavage rates (P<0.01) and this was maintained
for embryo development rates (P<0.001). Both cleavage and embryo development rates were
higher in oocytes with low to no Fluo 3-AM staining at the time of parthenogenetic activation,
with cleavage rates of 40%, 11%, 20%, and 2% and embryo development rates of 13%, 3%, 2%
and 0% for nil fluorescence, slight, moderate and high fluorescence levels respectively.
Table 4.5. Embryo development rates as a function of follicular phase at the time of OPU, and
oocyte cytoplasmic Fluo 3-AM fluorescence levels at the time of parthenogenetic activation.
No Fluorescence

Slight

Moderate

High

2-Cell (n)

8-Cell (n) 2-Cell (n)

8-Cell (n) 2-Cell (n)

8-Cell (n) 2-Cell (n)

8-Cell (n)

0.2 (3)

0.067 (1)

0.12 (2)

0

0.38 (8)

0

0.06 (1)

0

Follicle Peak 0.6 (26)

0.26 (11)

0.2 (2)

0.1 (1)

0

0

0

0

Follicle
Atresia

0.07 (2)

0

0

0.21 (6)

0.07 (2)

0

0

Follicle
Growth

4.4

0.4 (12)

Discussion
In addition to factors integral to the oocyte itself, previous studies have found that oocyte

competence can be affected by follicle size and estrous cycle stage (Gilchrist et al., 1995).
Estrous cycle synchronization in cows prior to oocyte retrieval through the use of exogenous
gonadotropins to control follicle wave emergence, has been reported to have an overall effect of
improving oocyte quantity and developmental competence, as well as embryo production rates
when compared to unsynchronized cows (Cavalieri et al., 2017). The study presented here aimed
to look at oocytes collected from follicles of similarly staged cohorts, at three specified points in
the follicular wave to analyze the direct effect of the follicular environment prior to OPU, on
oocyte competence. On initial analysis, we didn’t find that a significant effect of follicular phase
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on any of the parameters recorded; oocyte number, recovery rate, or initial grade Presence or
absence of either a corpus luteum or a dominant follicle also failed to significantly affect on
oocyte collection rates or competence. These results suggest that, all other factors being equal,
timing OPU for specific estrous stages may be less beneficial for optimizing oocyte collection
rates and more important for ensuring that follicles are of a homogenous developmental stage.
One early study found that, contrary to more recent studies, neither follicle size nor ovarian
activity at the time of oocyte recovery had any effect on maturation rate (Fukui and Sakuma,
1980). While current studies were in agreement with this, with regard to meiotic maturation,
results of the current study indicated that the effect of follicle size on cytoplasmic maturation and
oocyte competence was rather more complicated. This lends evidence to the concept that while
meiotic maturation occurs early in the maturation process, prior to the completion of oocyte
cytoplasmic maturation and asynchronously with the attainment of full developmental
competence.
Methods were based on the previously reported findings that completion of cytoplasmic
maturation is absolutely required before oocytes acquire the competence to support early
embryonic development (Watson, 2007). Of the many different factors involved in cytoplasmic
maturation, it has not yet been determined if any one is the best indicator of competence, being
acquired last or most reliably (Sirard et al., 2006b). Three cytoplasmic determinants were used as
potential indicators of developmental competence. The changes in mitochondrial distribution that
occur during oocyte maturation are well described (Matchatkova et al., 2012) and the function of
mitochondria in energy production, make their redistribution to ensure equal mitochondrial
allocation to each embryonic cell critical in ensuring developmental competence. It was found
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that follicular phase did not significantly affect mitochondrial distribution patterns, suggesting
that oocytes from all follicular stages are equally competent, in this regard. However, although
insignificant, there was an apparent increase in the number of oocytes with mitochondria
distributed in clusters when they were collected during follicle peak. Of interest, this study also
failed to find a significant difference in mitochondrial allocation between GV and MII stage
oocytes, with the majority of oocytes across all collection days, and both maturational stages
having the mitochondria already spread diffusely throughout the ooplasm, an orientation that is
more commonly associated with partially mature oocytes (Matchatkova et al., 2012). These
results suggest that, while oocyte mitochondrial maturation has already begun by the time
oocytes are recovered, especially when collected from large follicles, IVM conditions are
inadequate to stimulate the completion of mitochondrial redistribution. This result has been
corroborated by past studies, although with the finding that GV oocytes with diffusely distributed
mitochondria were most frequently recovered from larger follicles (Matchatkova et al., 2012).
Inositol 1,4,5-trisphosphate receptor 1 is recognized as undergoing a marked increase in
expression as oocytes mature. Since IP3R1 is expressed on the surface of smooth endoplasmic
reticulum (SER), by measuring the expression of IP3R1, information about the location and
density of the SER network as well as the presence of IP3R1 themselves can be postulated. IP3R1
is a receptor within the SER which, when phosphorylated, initiates release of calcium stores from
the SER (Wakai et al., 2012). This efflux of Ca2+ from the SER results in the increased
cytoplasmic Ca2+ levels responsible for initiating oocyte activation at the time of fertilization
(Malcutt et al., 2006; Whitaker, 2006). As a result, without a high level of IP3R1 expression,
successful fertilization would not be feasible. Oocytes in this study were found to exhibit a
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dramatic and reliable increase in IP3R1 expression as maturation proceeded, across all follicular
phases. However, this increase was the least recognizable in oocytes collected during the atresia
phase. In fact, there was a significant difference in IP3R1 expression across follicular phases,
with oocytes from follicle growth having the highest expression and those from atresia exhibiting
the lowest expression rates. These results indicate that follicle atresia may carry over to have
negative effects on oocyte IP3R1 expression, resulting in oocytes having irregularly high levels
in immature oocytes at the time of recovery, and a lack of increased expression to the normal
levels following completion of IVM.
Fluo 3-AM binds calcium and is often used as a viability marker for cultured cells. The
staining intensity is directly and positively correlated to cytoplasmic calcium levels. Embryo
development rates were found to be significantly, negatively correlated to stain intensity, and as
such lower cytoplasmic calcium levels was indicative of mature oocytes of greater competence.
Because both oocyte activation and successful fertilization rely on calcium signaling pathways, it
is possible, that these low cytoplasmic calcium levels are correlated to higher levels of
sequestered calcium and resultant stronger signaling potential in oocytes with low Fluo 3-AM
stain intensity. Alternately, it is possible that the high cytoplasmic calcium levels indicated by
high-intensity Fluo 3-AM staining, is a signal of calcium leaking either from the endoplasmic
reticulum stores, or through the oolemma from the extracellular media. This calcium leakage
through membranes could be indicative of atresia of the oocytes, which would explain the failed
embryonic development from oocytes with high cytoplasmic calcium levels.
One previous study demonstrated that, while oocyte competence varied with estrous
cycle stage, this was independent of follicle size or atretic status (Hagemann, 1999), while
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another study reported that early atresia has no effect on embryo production rates but that heavily
atretic follicles contain oocytes with decreased developmental potential (de Wit et al., 2000).
This is indicative that systemic hormones may play a role in oocyte competence (Robertson et
al., 1996; de Wit et al., 2000). As such, it is feasible, that stimulation protocols, by altering the
systemic hormones, may have a significant impact on oocyte competence and embryo
production. Results of the current study disagree with previous results on the importance of
follicular environment in ensuring successful oocyte maturation and instead lend credence to the
belief that having a cohort of oocytes at the same developmental stage at the initiation of
maturation may be of the utmost importance in determining success of in vitro embryo
production. However, both IP3R1 and Fluo 3-AM staining, as well as embryo development rates
indicated that oocytes collected during follicular growth had significantly improved
developmental competence over those collected from atretic follicles, and somewhat improved
competence compared to oocytes collected during wave peak.
The biggest downfall to performing oocyte retrieval on random days is that, although
cows with dominant follicles can easily be identified, it is not possible to differentiate between
growth stage and atretic follicles (Cavalieri et al., 2017). This potentially high proportion of
atretic follicles aspirated in unstimulated OPU can effectively decrease the overall average
competence of collected oocytes, decreasing embryo production rates (Machatkova et al., 2004).
Because dominant follicles have a negative effect on competence of oocyte from subordinate
follicles, but there is an apparent increase in oocyte competence as follicles grow, it has been
suggested that the optimal oocyte recovery period is from large follicles just prior to deviation
(Hagemann, 1999). It is possible that the poor results seen in oocytes collected during wave peak
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in this study were due to a heterogenous population of oocytes from dominant follicles and early
atretic follicles.
Another possibility is a result of the slightly increased proportion of A/B grade oocytes
collected during wave emergence, compared to other follicular phases. Initial grades are based
largely on the cumulus cell investiture surrounding the oocytes. As cumulus cells are a major
factor in regulating the signals from the external environment that reach the oocyte, and for
supporting oocyte function (Wrenzycki and Stinshoff, 2013), it is possible that a slight difference
in the number of cumulus cells surrounding an oocyte can have strong effects on resultant
embryonic development rates. As oocytes grow, the number of mitochondria increase from at
few as 10 in germ cells, and 200 in oogonium to an increase to 6,000 mitochondria in primary
oocytes and 100,000 or more by the completion of maturation (Ferreira et al., 2009; Mau et al.,
2014). It is possible that, in correlation with the low grades apparent, the number of oocytes with
few mitochondria present may be indicative of oocytes being retrieved prior to the completion of
the growth phase, lacking the cytoplasmic factors necessary to attain cytoplasmic competence.
However, until these factors can be verified, and a method of reliably collecting large
numbers of pre-deviation oocytes can be determined, results here would indicate that timed OPU
performed frequently enough to collect oocytes only during the follicular growth phase (every 4
days in 2-wave cows) is the best method for ensuring recovery of maximal numbers of highly
competent oocytes.
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CHAPTER V
THE EFFECTS OF RECOVERY METHODS ON GENE EXPRESSION
PROFILES IN BOVINE OOCYTES
5.1

Introduction
As in vitro embryo production (IVP) becomes increasingly more popular, the demand to

improve the efficiency of oocyte recovery also increases. It has become mandatory to not only
maximize the number of oocytes that can be collected but also to ensure that recovered oocytes
are of optimal developmental competence to ensure high developmental competence. Following
the success of exogenous hormone stimulation at improving in vivo embryo production rates,
many different groups have aimed to improve oocyte recovery rates and competence through
manipulating their recovery protocols to incorporate different intervals between OPU sessions or
by using exogenous hormones (Gibbons et al., 1994; Goodhand et al., 1999; Chaubal et al.,
2007). Previous studies have found that use of exogenous hormones to stimulate follicle growth
improves oocyte development and competence (Sirard et al., 2006a; Cavalieri et al., 2017), while
others have found that super-stimulation had no effect on oocyte retrieval rates or oocyte
developmental competence (Oliveira et al., 2016). Super-stimulating females prior to collection
has been shown to increase embryo production rates anywhere from not at all (Oliveira et al.,
2016) to as much as 7.3% as compared to unstimulated collections (Cavalieri et al., 2017).
Oocytes recovered following stimulation are from a more homogenous cohort of follicles, often
further along in development than follicles aspirated in conventional OPU. Thus these superstimulated oocytes are believed to be more developmentally competent and to result in higher
embryo production rates (Cavalieri et al., 2017). However, there is also the potential that the high
doses of exogenous hormones being administered may negatively affect the normal progression
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of oocyte development by hastening follicle growth rates, thus being detrimental to oocyte
competence and embryo production (Lee et al., 2006; Zeng et al., 2009; De los Reyes et al.,
2011).
Meanwhile follicular atresia, such as that seen in ovaries collected post mortem, has been
shown to be potentially beneficial to oocyte competence, but the mechanism is as of yet
undetermined (Blondin and Sirard, 1995; Blondin et al., 1997). It is possible that the beneficial
effect of post-mortem oocyte recovery is simply attributable to the fact that there is more room
for selection of mid- to large-sized follicles and that a larger proportion of oocytes recovered
have a high quality cumulus cell investment when compared to oocytes recovered through ovum
pick-up (OPU) (Souza-Fabjan et al., 2014).
While many proteins found in oocytes, are stored during oocyte growth, the period of
final oocyte maturation is a highly active period during which the oocyte is transcribing mRNA
and producing, modifying and storing proteins, many of which are necessary for embryonic
development (Dielman et al., 2002). It is these mRNAs and proteins, accumulated primarily
during oocyte growth, which drive early embryonic development until the embryonic genome is
activated at the 8-cell stage (Fair et al., 2007; Ferreira et al., 2009). As a result of oocytes
matured in vitro are often removed from the follicular environment prior to the completion of
this mRNA accumulation, in vitro and in vivo matured oocytes have been shown to have not only
differences in the overall transcriptional profiles but primary differences in pathways effecting
early embryonic development (Mamo et al., 2011). However, despite the known potential for
oocyte retrieval interfering with normal developmental dynamics, there is little information
available on the effects of oocyte recovery methods on gene expression. This study was
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designed to answer the query on whether super-stimulation or post-mortem oocyte collection
change the global gene expression of in vitro matured oocytes in comparison to those collected
following conventional OPU. It was anticipated that comparing differences in gene expression
dynamics along with embryo production rates, would help to settle the question of if oocyte
source could impact developmental competence and in vitro survival. It was hypothesized that;
1) Super-stimulation would cause irregular gene expression patterns, but post-mortem oocyte
recovery would not affect transcript profiles. 2) Post-mortem effects will be beneficial for oocyte
developmental competence resulting in increased embryo production rates.
5.2

Methods
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Chemical Co.

(St. Louis, MO, USA).
5.2.1

Animals
All procedures in this experiment were approved by the Louisiana State University

Agricultural Center’s Institutional Animal Care and Use Committee and were carried out at the
LSU Reproductive Biology Center, St. Gabriel, LA, USA. Thirty mixed breed beef cows, housed
on pasture with ad libitum access to mixed native grasses supplemented with hay and full access
water were used for oocyte collections from May through November of 2017.
5.2.2

Experimental Design
Oocytes were collected via three different collection methods in an attempt to determine

if the oocyte source affects gene expression or the innate developmental competence of the
oocytes. Because they are the three most commonly employed methods of oocyte retrieval in
bovine IVP research, oocytes were collected from live cows via ovum pick-up (OPU) either at
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random time points in the estrous cycle (Group 1; OPU), or following a super-stimulation
protocol (Group 2; FSH) and oocytes were retrieved post-mortem from abattoir derived ovaries
(Group 3; PM). Recovered oocytes from all three treatments were then randomly allocated to one
of three treatment groups, where they were either snap frozen immediately at the germinal
vesicle (GV) stage, matured in vitro to the metaphase II (MII) stage and then snap frozen, or
matured and fertilized. Both groups of snap frozen oocytes were subjected to RNA-Seq to allow
comparison of gene expression of both immature and mature oocytes between groups, as well as
the change of gene expression over the course of maturation in each group. Fertilized oocytes
were then cultured to the blastocyst stage as a measure of developmental competence.
In all there were six treatment groups compared for sequencing. Table 5.1 shows coding
for each group.
Table 5.1. Notation for each of the six treatments used in this study.
Collection Method

Germinal Vesicle

Metaphase II

Oocyte Pick-up (OPU)

IO

MO

Super-stimulation (FSH)

IS

MS

Post-mortem (PM)

IP

MP

5.2.3

Super-stimulation
Cows assigned to superstimulation were subjected to a dominant follicle removal (DFR)

where all follicles greater than 6mm in diameter were ablated, using the same methods described
below for transvaginal ultrasound-guided follicle aspiration (TUGA). This ensured all cows were
in the follicular growth phase at the start of the stimulation program. Five mL of prostaglandin
F2α (Lutalyse® , dinoprost tromethamine, 25mg, Zoetis Inc, Kalamazoo, MI, USA ) was
administered intramuscularly (im) to lyse any corpora lutea present, and an intravaginal
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F2α (Lutalyse® , dinoprost tromethamine, 25mg, Zoetis Inc, Kalamazoo, MI, USA ) was
administered intramuscularly (im) to lyse any corpora lutea present, and an intravaginal

progesterone releasing device was inserted (Eazi-BreedTM
CIDR® , Zoetis Laboratories,
progesterone releasing device was inserted (Eazi-BreedTM CIDR® , Zoetis Laboratories,
Kalamazoo, MI, USA). Cows were administered follicle stimulating hormone (FSH,
Kalamazoo, MI, USA). Cows were administered follicle stimulating hormone (FSH,
Folltropin®® -V, Bioniche Animal Health, Athens, GA, USA) im every twelve hours for a total of
Folltropin -V, Bioniche Animal Health, Athens, GA, USA) im every twelve hours for a total of
six doses, beginning 36 hours after DFR. A constant dose schedule was used with injections of
six doses, beginning 36 hours after DFR. A constant dose schedule was used with injections of
1.7 mL each to a total of 200mg FSH per cow (20mg/mL). Twenty-four hours after the last FSH
1.7 mL each to a total of 200mg FSH per cow (20mg/mL). Twenty-four hours after the last FSH
injection CIDRs were removed, and oocyte retrieval was performed 24 hours after CIDR
injection CIDRs were removed, and oocyte retrieval was performed 24 hours after CIDR
removal, allowing a 48-hour coasting period between the last FSH injection and oocyte recovery
removal, allowing a 48-hour coasting period between the last FSH injection and oocyte recovery
(Figure 5.1).
(Figure 5.1).
DFR, PGF2α
Insert CIDR

0

Remove
CIDR OPU

FSH

1

2

3

4
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6

Day

Figure
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forfor
thethe
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5.2.4

Oocyte Retrieval
!63 groups were recovered as cumulus-oocyte
Oocytes collected from both FSH and OPU

complexes (COCs), from live cattle using transrectal ultrasound-guided oocyte aspiration, using
methods described above in section 3.3.3. Cows were restrained in a manual squeeze chute,
administered 30 mg xylazine im and given a 5mL, 2% lidocaine epidural. Ovaries were palpated
rectally and held against the vaginal wall so follicles could be visualized on ultrasound and
aspirated using the aide an ultrasound probe that had been inserted vaginally. Once visualized, all
follicles greater than three mm in diameter were aspirated. Follicular fluid was aspirated directly
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into a 50mL FalconTM tube that had been primed with collection medium. The aspiration system
was rinsed with collection medium after each ovary to prevent oocytes from being held in the
aspiration lines. Once recovered, oocytes were placed in Hepes-TALP at 38.5°C, transported 15
minutes to the lab and held briefly until further processing. The total number of oocytes
recovered was recorded as well as their visible grade, based on cumulus cell enclosure and
cytoplasm appearance (Appendix). All oocytes from a single day were pooled at the end of the
recovery process, and were then randomly separated into cohorts for each analysis method.
For post-mortem collection of oocytes, ovaries were harvested at a local abattoir
following slaughter of cows. They were stored in an insulated cooler to maintain temperature for
a maximum of two hours before being transported 15 minutes to the laboratory. On arrival at the
laboratory, ovaries were trimmed and rinsed three times with warmed saline. All visible follicles
were then aspirated by inserting an 18-guage, 1.5 inch needle connected to a vacuum line. Lines
containing follicular fluid were rinsed with Dulbecco’s phosphate buffered saline to ensure
oocytes were recovered from the collection lines. Once recovered oocytes were rinsed and
moved directly to treatment.
Oocytes from all three retrieval methods that were assigned to analysis at the GV stage
were denuded of cumulus cells by vortexing for two minutes in 200µL of BO-Wash (IVF
Biosciences product #61008) and were snap-frozen as per methods outlined below in section
5.3.6 immediately following initial processing.
5.2.5

Oocyte Maturation and Embryo Culture
Oocytes from both OPU and super-stimulation collection methods (that were assigned to

treatments requiring maturation) were rinsed three times in IVM medium (Appendix) before
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being transferred in groups of 10-12 to fresh 35µL droplets of IVM medium under oil. They were
then cultured for 22 hours in a humidified incubator at 38.5°C and 5% CO2.
Post-mortem recovered oocytes were purchased from a commercial source and shipped in
for further processing. Those assigned to treatments requiring maturation were rinsed three times
before being transferred in groups of 50 to a 2mL FalconTM tube containing IVM medium, that
had been gassed and equilibrated under 5% CO2 They were then transported overnight in a
portable incubator (MiniTube product#19180/0001) and maintained at a constant temperature of
37°C. On arrival in our laboratory, they were transferred to a humidified incubator at 38.5°C,
under 5% CO2 for the remainder of the 22 hour maturation period.
Oocytes from all three treatment groups that were assigned to RNA-Seq at the MII stage
were then denuded and snap frozen following protocols outlined below in section 5.3.6. The
remaining oocytes were used for embryo culture. Oocytes were rinsed three times in drops of
BO-IVF medium (IVF Biosciences, product #61003) before being transferred in groups of up to
50 to fresh 450µL wells of BO-IVF. Meanwhile, a single 0.25mL straw of frozen semen from a
bull of proven fertility was thawed by brief submersion of the sealed straw in a 37°C water bath
and prepared for insemination. Thawed semen was transferred to a 15mL conical tube containing
2mL of BO-Semen prep (IVF Biosciences, product #61004) and centrifuged for 5 minutes at
400G. The sperm pellet was removed, resuspended in 2mL of fresh BO-Semen prep and again
centrifuged for 5 minutes at 400G. The final sperm pellet was resuspended in ~500mL of fresh
BO-Semen prep to a final concentration of 4.0x106/mL. Fifty microliters of sperm suspension
was then aded to each droplet containing oocytes for embryo production. Oocytes and sperm
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were cultured together in BO-IVF in a humidified incubator at 38.5°C under 5% CO2 for 18
hours in in vitro fertilization (IVF).
Following fertilization, cumulus-oocyte complexes were moved to 200µL of 1mg/mL
hyaluronidase and vortexed for 2 minutes to remove all of the surrounding cumulus cells.
Denuded oocytes were then rinsed three times in Hepes-Talp, and washed through three droplets
of BO-IVC medium (IVF Biosciences, product #61001) before being transferred to a fresh drop
of BO-IVC under oil (BO-Oil, IVF Biosciences, product #6200) and returned to the incubator.
Presumptive embryos were checked on day-2, day-4 and day-7 following fertilization and
embryo development was recorded.
5.2.6

RNA Sequencing
Both GV and MII oocytes from all three collection methods were subjected to the same

RNA-Seq protocols. Immediately following completion of oocyte collection (GV) or IVM (MII),
oocytes were denuded of all cumulus cells by vortexing for two minutes in 200µL of BO-Wash
(IVF Biosciences product #61008). Denuded oocytes were rinsed three times in BO-wash and
twice in PBS+1%BSA (Appendix). They were then transferred in pools of four oocytes to 1.5mL
microcentrifuge tubes, in a total volume of 2µL of PBS per tube. Oocytes were snap frozen and
maintained at -80°C until completion of RNA-Seq.
Thawed oocytes were dissociated in lysis buffer and cDNA libraries were prepared using
SMART-Seq v4 (Takara Bio USA) following manufacturers guidelines (Appendix) (Petropoulos
et al., 2016). Following oocyte lysis, cDNA was synthesized first by ligation of the 3’ primer
sequence, SMART-Seq CDS primer IIA, followed by reverse transcription using SMARTScribe
Reverse Transcriptase. Prepared cDNA was then amplified by 16 cycles of PCR using SeqAMP
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DNA Polymerase and was purified using AMPure XP beads. Quality and quantity of cDNA was
measured using Qubit 3.0 and quality was validated on an Agilent TapeStation. One hundred and
fifty nanograms of cDNA was tagmented and sequencing libraries were prepared using a Nextera
XT DNA library preparation kit (Illumina) and multiplexed by Nextera XT Index kit (Illumina).
Finally, sequencing libraries were purified by AMPure XP beads, and quantified by Quibit 3.0
and TapeStation for measurement of concentration and size distribution. Indexed libraries were
diluted to 4nM and equal, pooled samples were sequenced on an Illumina NextSeq 500 Platform
at Pennington’s Biomedical Research Center (Baton Rouge, LA, USA).
5.2.7

Data Analysis
RNA-seq reads were trimmed and aligned to the bovine reference genome (bosTau8)

using STAR (2.5.3). Differentially expressed genes between different treatment groups were
determined using DESeq2 package in R 5.0. In each comparison, genes were deemed
differentially expressed if they showed a false discovery rate adjusted P-value <0.05 and a
confident Log2-fold change (FC) >1. Gene ontology (GO) and Pathways analysis were
performed using IPA (Ingenuity Pathway Analysis, Quiagen).
Embryo production rates were compared across oocyte recovery methods using chi
square analysis in RStudio.
5.3

Results
A total of 232 OPU, 238 FSH and 375 PM oocytes were recovered. Of which, 92 were

used in pools of four, for RNA-Seq (4 replications for each treatment, 3 replications for MII
PM). Three hundred and six were used in IVF, and the remaining oocytes have been maintained
at -80°C for later analysis (Table 5.2).
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Table 5.2. Number of samples allocated to each treatment.
Collection Method

Germinal Vesicle

Metaphase II

Embryo Production

Oocyte Pick-up

4

4

66

Super-stimulation

4

4

80

Post-mortem

4

3

160

A total of 605.8 million raw sequencing reads that passed filtering were obtained and an
average of 26.3 million read pairs per sample were generated (Appendix). Reads were largely of
high quality, and in the majority of samples >90% of reads were correctly aligned to exons.
During gene expression analysis, multi-dimensional scaling (MDS) plots were created to
compare gene expression patterns between all samples (Figure 5.2). When assessed in two
dimensions based on the biological coefficient of variation (BCV), samples were clearly broken
into two groups with different gene expression patterns between immature and mature oocytes,
regardless of treatment group. Within each maturation level, differences were less notable. There
was a high degree of overlap in expression patterns between immature oocytes from all recovery
methods. In in vitro matured oocytes, the oocytes collected following FSH stimulation had a
different expression pattern from oocytes of either other retrieval method, with the exception of
one OPU sample that was more similar to the FSH samples. On further analysis, a heatmap was
created, assessing only the ten most variably expressed genes (Figure 5.3). Of these ten genes,
three are transmembrane proteins, two are involved in cytoskeleton polymer changes, one is a
peptidase and one is a glutathione transferase. Based on expression of these genes, oocytes were
largely clustered in groups by both maturation level and collection method, with only a few
samples having expression patterns dissimilar to others within their treatment. Again IVM
oocytes collected following super-stimulation were on a different hierarchical branch than the
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majority of the other recovered oocytes, suggesting a high degree in difference in transcript
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abundance.
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Figure 5.2. MDS plot depicting overall differences in gene expression patterns between
individual samples of pooled bovine oocytes classified by oocyte recovery method and
maturation level.
Oocytes within each recovery method exhibited a characteristic change in gene
expression over the course of maturation. Nearly 6000 genes had altered expression between
germinal vesicle (GV, immature) stage and metaphase II (MII, mature) oocytes, within each
treatment, with the majority having higher transcript abundance following maturation. However,
once genes were filtered based on both significance (FDR P<0.05) and >2-fold difference in
expression between groups, this pattern changed. Only ~2000 genes per collection method met
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these qualifications, and among them there was a roughly even split between up- and downregulation (Figure 5.4). There was a slight preference for transcript abundance to be increased in
mature oocytes that was most notable in those oocytes recovered following FSH stimulation.
When complete pathway analysis was performed, the pathways most affected by maturation
were those involved in energy production, as was especially true of FSH oocytes.

MGC152484
ENSBTAT00000005618
TNFAIP6
ENSBTAT00000007817
LOC777594
ENSBTAT00000025311
ifitm2
ENSBTAT00000004215
rnf168
ENSBTAT00000009523
ENSBTAT00000043794
TMEM176B
usp8
ENSBTAT00000014744
ENSBTAT00000002556
rtn4
ENSBTAT00000062965
MTUS1

IO-4
IO-3
IO-2
MO-3
IS-3
IS-2
IS-4
IP-3
IP-2
MP-1
MP-3
MP-2
MO-1
MO-4
IP-4
IO-1
IS-1
IP-1
MS-2
MS-1
MO-2
MS-3
MS-4

ENSBTAT00000015809
CSE1L

Figure 5.3. Heatmap showing relative expression levels of the ten genes that were the most
variable in expression level between samples. Oocyte hierarchical clustering, shown along the
top, is based on similarity on expression patterns for these ten genes. Yellow indicates low
expression and Red indicates high expression.
Gene expression differences were also compared between oocytes from the different
recovery methods within each maturation level. Using only those genes that had a two-fold or
greater difference in expression, which were calculated as significantly differentially expressed
(FDR P<0.05), it was found that in GV oocytes, the greatest different was between OPU and PM
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oocytes where 67 genes were up-regulated in PM oocytes compared to OPU, and 105 were
down-regulated (Figure 5.5). Meanwhile, between OPU and FSH oocytes, no genes were
significantly up-regulated in FSH, and only 12 were down-regulated. In the PM:FSH comparison
20 genes were up-regulated in FSH oocytes and 35 were down-regulated. Of those genes that
were significantly different, the most significantly affected pathways were primarily related to
the TCA cycle and ATP synthesis, GnRH receptor pathway and TGF-ß signaling. The OPU:PM
comparison also showed a significant difference in the activity of multiple genes (28) regulating
the zona pellucida and fertilization, all of which had decreased transcript abundance in OPU
oocytes (FDR P<0.05). Genes regulating mitochondrial and organelle structure were found in
greater abundance in OPU oocytes than FSH oocytes (FDR P<0.05).
Up-regulated at MII
Down-regulated at MII

Number of Genes

1000

500

0

OPU

FSH

PM

Oocyte Recovery Method

Figure 5.4. The change in gene expression within each oocyte recovery method over the course
of in vitro maturation. Approximately 2000 genes change expression within each treatment
group. In OPU oocytes there is a relatively even split between up- and down-regulated genes,
while in both FSH and PM oocytes there is a greater number of genes that are down-regulated in
MII oocytes.
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Figure 5.5. Comparison of gene expression in germinal vesicle stage bovine oocytes recovered
by three different methods.
As oocytes matured, the relative gene expression patterns changed rather dramatically
(Figure 5.6). In the comparison between OPU:PM oocytes the apoptosis signaling pathway was
significantly up-regulated in OPU oocytes, as were genes controlling mitochondria and organelle
function, and the electron transport chain. In the FSH:PM comparison there was a significant
increase in the expression of genes involved in the TCA cycle, ATP synthesis, glycolysis and the
pentose phosphate pathway in FSH oocytes. Similarly, in the comparison between FSH and OPU
oocytes, FSH oocytes had increased transcript abundance for genes controlling the TCA cycle,
ATP synthesis, cellular metabolism and the cell cycle but decreased abundance of transcripts
involved in control of organelle structure and function (FDR P<0.05). In all, only 46 genes had
significantly different expression between OPU and PM oocytes (13 up-regulated and 33 downregulated in PM oocytes), while 296 genes had significantly different expression between OPU
and FSH oocytes (269 up-regulated and 27 down-regulated in FSH), and 307 were differentially
expressed between PM and FSH (305 up-regulated and 2 down-regulated in FSH).
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Figure 5.6. Comparison of gene expression in metaphase II bovine oocytes recovered by three
different methods.
Embryo cleavage rates were relatively low especially in OPU oocytes, ranging from 11%
to 29% of oocytes (Table 5.3). Following cleavage, the majority of embryos in FSH and PM
recovery groups continued to develop to the morula stage, while OPU oocytes had decreased
developmental rates, with a high proportion being arrested at the 2- and 4-cell stages (5/7
arrested, compared to only 3/20 for FSH and 8/46 PM). There was a significant difference in
embryo development rates (P<0.01) at the morula stage, with embryo development being
decreased in OPU oocytes, compared to those retrieved by other means. On day-7 when
blastocyst rate was recorded, there was a significant effect of recovery method on the blastocyst
rate, although development rates were low across the board, ranging from 2% from OPU to 14%
from FSH and 17% from PM oocytes (P<0.01). However, when blastocyst development rate was
calculated as the proportion of cleavage stage embryos that continued to develop, the recovery
method was found to have a more notable effect. With only 14% of cleaved zygotes developing
to blastocysts following OPU, but 55% following FSH and 59% following PM retrievals,
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conventional OPU was found to have significantly decreased embryo production rates
(P=0.0067) than either of the other two retrieval methods.
Table 5.3. Embryo production rates as affected by bovine oocyte retrieval method. Superscripts
denote significant differences between values within a column (P=0.0067).
Collection
Method

n

Cleavage (%)

Morula (%)

Blastocyst (%)

% Blastocysts by
Cleaved

Oocyte Pick-up

66

7 (11%)

2 (3%)

1 (2%)

14%A

Superstimulation

80

20 (25%)

17 (21%)

11 (14%)

55%B

Post-mortem

160

46 (29%)

38 (24%)

27 (17%)

59%B

5.4

Discussion
There have been discrepancies in the literature on the effect of follicle atresia on oocyte

competence, with reports suggesting atresia could have anywhere from a positive effect, or no
effect to a strongly negative one (Blondin and Sirard, 1995). However, while follicle atresia has
not been found to be conclusively correlated with oocytes of decreased competence, oocytes
collected during the follicular growth phase, when atresia is not present, have been shown to
result in more competent oocytes and production of a greater number of overall high quality
blastocysts (Hagemann et al., 1999). One suggestion from previous studies is that collecting
oocytes from early atretic follicles results in the highest blastocyst production rate, while
collection from late atretic follicles yields oocytes of decreased competence (Moor and
Trounson, 1977; Blondin and Sirard, 1995). The premise that early atresia can be beneficial has
been seen in collecting both post-mortem oocytes and those following super-stimulation. During
the period between cow death, harvesting ovaries and recovering oocytes from the ovaries,
physiological processes mimicking atresia occur, having a beneficial effect on oocyte
competence for the first four hours post mortem and an increasingly negative effect thereafter
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(Blondin et al., 1997). In ovum pick-up following super-stimulation, it is common to allow a
coasting period following the last FSH injection prior to oocyte collection. This causes the
follicles to undergo FSH starvation and to initiate atresia, improving both oocyte competence and
yield for the first 48-60 hours of coasting and resulting in declining developmental competence
thereafter.
In the current study, both FSH super-stimulation and post-mortem oocyte collection
resulted in increased embryo production compared to oocytes collected following conventional
OPU, in agreement with this theory. However, de Witt et al. (2000) show evidence that the
reasoning behind this apparent improvement in competence is that a greater proportion of
oocytes collected from these follicles had a strong cumulus cell investment, perhaps because the
atretic cells of the follicle had more easily loosened connections with the cumulus-oocyte
complexes (COCs). Oocytes collected via OPU during the current project had a decreased
cumulus investment, resulting in an overall decreased grade compared to oocytes recovered by
other methods (77/232, 136/228 and 360/375 “A” grade oocytes from OPU, FSH and PM,
respectively. Furthermore, perhaps because of the poor cumulus cell support, oocytes collected
by OPU showed the poorest maturation rates. It is possible that this is the primary reason for
failed fertilization in the OPU group oocytes presented above, supporting the hypothesis that the
ease of removing highly competent COC’s from early atretic follicles may play a major role in
improving oocyte developmental competence.
It was found that genes involved in energy production and mitochondrial function were
among those most differentially expressed between the different treatments, especially following
in vitro maturation. It is accepted that oocyte energy production is important to early embryo
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survival, and that irregularities in oocyte mitochondrial function can lead to decreased
developmental rate. In addition, the genes involved in metabolism have been shown to be
amongst those, most differentially expressed between fast and slow developing blastocysts,
indicating that there is significant correlation between the ability of an embryo to produce energy
and its developmental potential (Ispada et al., 2018). Although by the blastocyst stage, the genes
involved in energy production are of the embryonic genome, this is indicative of the importance
of energy production to embryo development and the issues of delayed development that may
occur as a result of even minor aberrations. The design of this study did not allow for comparison
to in vivo matured oocytes to determine which had the most normal gene expression patterns but
the sheer frequency of differences of metabolic gene expressions between oocytes at the same
maturational levels is indicative that the different follicular dynamics and handling methods
involved in the different oocyte retrieval methods are causing metabolic stress on oocytes. The
fact that these differences are maintained, despite oocytes being matured in similar
environments, indicates that the alterations in gene expression are lasting and may have longterm implications in embryonic and fetal development.
One study assessing the differences between immature and in vitro matured oocytes
found that there were a total of 2117 differentially expressed genes, of which 1528 were downregulated following maturation, and 589 were up-regulated (Mamo et al., 2011). Of these, the
majority of the over-expressed genes were involved in pathways related to cell growth and
development, molecular transport, protein synthesis and embryo development (Mamo et al.,
2011). Other studies have corroborated the effects of IVM on altering oocyte gene expression,
interfering with pathways involved in meiotic and mitotic progression and embryonic
!74

development (Eppig et al., 1994; Trounson et al., 2001; Combelles et al., 2002). In comparison to
the present study, in which all oocytes were matured in vitro but were recovered through
different methods, the most frequently aberrantly expressed gene pathways were primarily
related to metabolism, and mitochondrial function. However, few other studies have been
published looking at similar effects to act as direct comparisons to this work. Results of the
current study are in agreement with past studies in that there is a high degree of change in gene
expression between GV and MII oocytes. It is generally expected that the majority of genes
should be down-regulated over the course of maturation. The lack of genome silencing that was
seen in OPU oocytes in this study may be an indication that either oocytes were of poor
developmental competence of that molecular maturation was incomplete. This is in agreement
with the poor embryonic development that was seen in oocytes, especially those recovered by
conventional OPU.
Initially, in GV oocytes both OPU and FSH oocytes were found to have remarkably
similar gene expression to each other, suggesting that the stimulation protocol had no major
effects on molecular development within oocytes. However, PM and OPU oocytes had different
expression patterns, with post-mortem collected oocytes having more active expression than
those collected via OPU. It is possible that the higher degree of metabolic activity in oocytes
collected post-mortem allows for increased energy stores, improving embryo competence even if
the genes are later silenced. It is believed that some of the proteins required for GVBD are only
synthesized in vivo just prior to ovulation, and are not present in antral follicles 2-8 mm
(Bilodeau-Goeseels, 2012). However, many other proteins and mRNAs required for embryonic
development are acquired prior to oocyte maturation, during oocyte growth and folliculogenesis
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(Minami et al., 2007; Wrenzycki et al., 2007) and so should not differ in expression levels
between highly competent immature and mature oocytes. However, because there was less
control in the size of follicles collected by OPU than by either of the other two methods, it is
possible that OPU oocytes would have different gene expression patterns by not having
completed this stage of oocyte development, and that this difference is not necessarily indicative
of competence.
By completion of MII the pattern of gene expression differences between the collection
methods had changed notably from that seen in immature oocytes. In mature oocytes, OPU and
PM oocytes had similar gene expression levels, while FSH oocytes were significantly more
actively transcribing genes than oocytes from either of the other two collection methods, with
over 200 genes over-expressed compared to each of OPU and PM recovered oocytes. Since MII
oocytes are accepted as being transcriptionally quiet compared to GV oocytes, this high level of
gene expression in FSH oocytes could be indicative of failure to complete molecular maturation.
However, an alternate theory is possible. RNA sequencing is based on the presence of mRNA
transcripts, which are normally short-lived within somatic cells. However, in oocytes mRNA is
produced during folliculogenesis and maturation and is then stored for a period of days to
support life-sustaining functions in the early embryo, prior to the initiation of transcription of the
embryonic genome (Sirard et al., 2006a; Watson, 2007). Based on this premise, it is feasible that
oocytes of the highest competence, which have successfully completed meiotic maturation, will
have large mRNA stores. It is possible that these oocytes will artificially appear to be actively
transcribing genes that instead have mRNA stored from prior transcription. In this case apparent
gene up-regulation could be an indication of competence in MII oocytes, a theory that is
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corroborated by the fact that FSH oocytes that had the highest gene expression levels at MII also
had the highest embryo production rates.
A third possibility to specifically explain the increased abundance of transcripts involved
in energy regulation found in oocytes recovered following super-stimulation is the concept that
highly competent, and perhaps also highly competent oocytes, undergo a shift in glucose
metabolism away from the tricarboxylic acid cycle (TCA) and towards the pentose phosphate
pathway (Richard and Sirard, 1996; Krisher and Prather, 2012). This metabolic shift coupled
with overall increased glucose metabolism, mimicking the Warburg effect, could increase the
production of nucleic acids and fatty acids, both necessary for the rapid cell division and
development which occur during early embryogenesis (Wakefield et al., 2011). Previous studies
have shown the benefit of cells exhibiting the Warburg effect towards early embryo
development, and since blastomeres at this stage of development are transcriptionally quiescent,
it is reasonable that increased transcription of genes involved in these processes would be
necessary prior to the completion of oocyte maturation. As such, it is possible that the oocytes
recovered in this study, following super-stimulation may be exhibiting increased transcript
abundance in accordance with the Warburg effect and so may be of higher developmental
competence than oocytes recovered by either unstimulated OPU or those retrieved post-mortem.
Further studies are warranted to determine the metabolic activity and lasting effects of any
differences found in these super-stimulated oocytes.
In all, it is evident that, be it beneficial or detrimental, oocytes recovered following superstimulation have high levels of RNA transcripts present at the MII stage that are not present in
MII oocytes collected post-mortem of by unstimulated OPU. These oocytes, however, have a
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very similar gene expression profile at the GV stage to oocytes collected by OPU. This suggests
that if stimulation has an effect on oocyte genome regulation, it is one that is more visible later in
development though potentially with lasting metabolic effects on the fetus. Meanwhile, oocytes
recovered post-mortem have only slightly irregular gene expression at the GV stage, but this
effect does not seem to be permanent and oocytes exhibit transcript profiles similar to those in
oocytes retrieved by OPU following in vitro maturation.
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CHAPTER VI
THE EFFECT OF BOVINE OOCYTE RECOVERY METHOD ON
OOCYTE ULTRASTRUCTURE
6.1

Introduction
In vitro maturation supports meiotic maturation of oocytes but is often reported as poorly

stimulating cytoplasmic maturation, resulting in mature oocytes with poor developmental
competence (Eppig et al., 1994; Combelles et al., 2002; Salamone et al., 2003; Schramm et al.,
2003; Jimenez-Macedo et al., 2006). In addition to the risk of in vitro maturation causing
aberrations in cytoplasmic maturation, there is also the possibility that superstimulation can be
disruptive to oocyte development, causing abnormal organelle bahavior (Lee et al., 2006; Zeng et
al., 2009; De los Reyes et al., 2011). The accelerated growth rates imposed on follicles by high
doses of follicle stimulating hormone cause aberrations in the external hormonal milieu in which
oocytes are developing. This results in accelerated oocyte development at the risk of missed
developmental steps and the accruement of abnormalities, most especially amongst the
cytoplasmic changes that occur during development in preparation for oocyte cytoplasmic
maturation. This can be largely detrimental to embryo production rates as the reorganization of
organelles and storage of mRNA, proteins and transcription factors involved in cytoplasmic
maturation ensures the proper distribution and cytoplasmic dynamics necessary to activate the
oocyte for fertilization and to support embryonic development (Sirard et al., 2006b; Watson,
2007). Meanwhile, follicular atresia, such as that seen in ovaries collected post mortem, has been
shown to be potentially beneficial to oocyte competence, but the mechanism and the effects on
oocyte cytoplasmic maturation ability are as of yet undetermined (Blondin and Sirard, 1995;
Blondin et al., 1997).
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The importance of completed cytoplasmic maturation for oocyte competence has been
well established and has been broken down into three distinct aspects; molecular maturation, and
the reorganization of cytoskeletal polymers and of the organelles. However, many aspects of
cytoplasmic maturation have proven difficult to characterize, and among those that are well
characterized the relative importance of each factor is uncertain. Although many of the
differences that occur in in vitro matured oocytes compared to their in vivo matured counterparts
are known, the effects that the different oocyte recovery methods have on these differences are as
yet unclear. Since it is believed that follicular environment plays a significant role in driving
oocyte development, it stands to reason that oocytes collected from under the influence follicles
with different, unnatural, dynamics may have notable differences in their own developmental
characteristics.
The current study was designed to use transmission electron microscopy to examine the
effect of three major bovine oocyte retrieval methods (traditional OPU, super-stimulation
followed by OPU, and oocyte recovery post-mortem) on the ultrastructure of immature oocytes.
The ability of oocytes recovered from each method to complete cytoplasmic maturation in vitro
will then also be assessed and compared, assessing the same cytoplasmic parameters. Although
this study was designed to be descriptive in nature, it was hypothesized that 1) organelle
distribution and reorganization would follow patterns characteristic of bovine oocytes. 2) Superstimulation would result in irregularities in oocyte ultrastructure compared to other oocyte
recover methods.
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6.2

Methods
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Chemical Co.

(St. Louis, MO, USA).
6.2.1

Animals
All procedures in this experiment were approved by the Louisiana State University

Agricultural Center’s Institutional Animal Care and Use Committee and were carried out at the
LSU Reproductive Biology Center, St. Gabriel, LA, USA. Thirty mixed breed beef cows, housed
on pasture with ad libitum access to mixed native grasses supplemented with hay and full access
water were used for oocyte collections through October and November of 2017.
6.2.2

Experimental Design
Oocytes were collected via three different collection methods in an attempt to determine

if the oocyte source affects the ultrastructure of oocytes. Because they are the three most
commonly employed methods of oocyte retrieval in bovine IVP research, oocytes were collected
from live cows via ovum pick-up either at random time points in the estrous cycle (OPU), or
following a super-stimulation protocol (FSH), and oocytes were retrieved post-mortem from
abattoir derived ovaries (PM). Recovered oocytes from all three treatments were then randomly
allocated to one of two treatment groups, where they were either fixed immediately at the
germinal vesicle (GV) stage, or matured in vitro to the metaphase II (MII) stage and then fixed.
All groups of fixed oocytes were subjected to the same protocols and were analyzed by
transmission electron microscopy to determine ultrastructural differences between groups. This
study was specifically designed to analyze differences in cortical granule location, mitochondrial
structure and location, lipidation levels, and vesicle locations and amount.
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This project was designed as a preliminary, descriptive study only.
6.2.3

Super-stimulation and Oocyte Retrieval
Cows assigned to super-stimulation were subjected to a dominant follicle removal (DFR)

where all follicles greater than 6mm in diameter were ablated, using the same methods described
below for transvaginal ultrasound-guided follicle aspiration (TUGA). Super stimulation followed
the same protocols as those outlined in section 5.3.3. A CIDR® (Zoetis Laboratories, USA) was
inserted at the time of DFR and beginning 36 hours later, cows were administered Folltropin®
(Bioniche Animal Health, Athens, GA) im every twelve hours for a total of six doses (200mG).
Twenty-four hours after the last FSH injection CIDRs were removed, and oocyte retrieval was
performed 24 hours after CIDR removal, allowing a 48-hour coasting period between the final
FSH injection and oocyte recovery.
Oocytes collected via either stimulated OPU or traditional OPU were recovered as
cumulus-oocyte complexes (COCs), from live cattle using TUGA, using methods described
above in section 3.3.3. Cows were restrained in a manual squeeze chute, administered 30 mg
xylazine intramuscularly and given a 5mL, 2% lidocaine epidural. Ovaries were palpated rectally
and held against the vaginal wall so follicles could be visualized on ultrasound and aspirated
using the aide of an ultrasound probe that had been inserted vaginally. Once visualized, all
follicles greater than three mm in diameter were aspirated. Follicular fluid was aspirated directly
into a 50mL FalconTM tube that had been primed with collection medium. The aspiration system
was rinsed with collection medium after each ovary to prevent oocytes from being held in the
aspiration lines. Once recovered, oocytes were placed in Hepes-TALP at 38.5°C until further
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processing. The total number of oocytes recovered was recorded as well as their visible grade,
based on cumulus cell enclosure and cytoplasm appearance (Appendix).
For post-mortem collection of oocytes, ovaries were harvested at a local abattoir
following slaughter of cows. They were stored in an insulated cooler to maintain temperature for
a maximum of one hour before being transported 15 minutes to the laboratory. On arrival at the
laboratory, ovaries were trimmed and rinsed three times with warmed saline. All visible follicles
were then aspirated by inserting an 18-guage, 1.5 inch needle connected to a vacuum line. Lines
containing follicular fluid were rinsed with Dulbecco’s phosphate buffered saline to ensure
oocytes were recovered from the collection lines. Once recovered oocytes were rinsed and
moved directly to treatment.
6.2.4

Oocyte Maturation
Oocytes from both OPU and super-stimulation collection methods (that were assigned to

treatment requiring maturation) were rinsed three times in IVM medium (Appendix) before
being transferred in groups of 10-12 to fresh 35µL droplets of IVM medium under oil. They were
then cultured for 22 hours in a humidified incubator at 38.5°C and 5% CO2.
Post-mortem recovered oocytes were purchased from a commercial source and shipped
for further processing. Those assigned to treatments requiring maturation were rinsed three times
before being transferred in groups of 50 to a FalconTM tube containing 2mL of IVM medium, that
had been gassed and equilibrated under 5% CO2 They were then transported overnight in a
portable incubator (MiniTube) and maintained at a constant temperature of 37°C. On arrival in
the laboratory, they were transferred to a humidified incubator at 38.5°C, under 5% CO2 for the
remainder of the 22 hour maturation period.
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Following the completion of maturation, oocytes from all treatment groups were washed
in BO-Wash (IVF Biosciences product #61008) before being vortexed in 200µL of BO-wash to
remove cumulus cells. Oocytes were rinsed two times in fresh BO-wash and two times in 0.1M
phosphate buffer (Appendix) before beginning fixation for electron microscopy.
6.2.5

Fixation and Electron Microscopy
Oocytes were fixed and prepared for transmission electron microscopy following

minimally modified methods previously published (Appendix) (Hyttel et al., 1986; Hyttel and
Madsen, 1987). Oocytes were initially fixed in a 3% glutaraldehyde solution before being
embedded individually in 2 mm cubic blocks of 4% agar. They were then post-fixed 1% osmium
tetroxide for one hour at room temperature, before being washed and stained for one hour in
0.5% uranyle acetate in the dark, at room temperature. Oocytes were washed twice in water
before being dehydrated in five step-wise increasing concentrations of ethanol from 50% to
100%. Alcohol was removed from blocks by incubation in propylene oxide prior to embedding
in epon-araldite resin. Epon polymerization was gradual over three days with a 24-hour
incubation at each of 24°C, 37°C and 60°C. Following polymerization, resin blocks containing
the oocytes were trimmed and oocytes were cut into ultra-thin sections that were stained with
uranyle acetate and lead citrate. Sections were mounted on copper grids and examined on a
Transmission Electron Microscope (JEOL 2011 TEM, JEOL USA, Peabody, MA, USA,
equipped with a Gatan SC10000 CCD camera, Gatan Inc, Warrendale, PA, USA).
6.3

Results
A minimum of two oocytes were analyzed from each treatment group, and a minimum of

three sections of each oocyte was assessed at each two different levels within the ooplasm.
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Results within an oocyte did not appear to show marked differences between imaging sites with
regard to organelle and oolemma characteristics of note. However there were some apparent
differences between both collection methods and maturational status (Table. 6.1).
In the majority of oocytes, microvilli densely covered the extracellular surface of the
oolemma, projecting towards the zona pellucida. In oocytes collected via OPU, both immature
and mature oocytes had a large number of long, thin microvilli, relatively evenly distributed over
the oolemma. Oocytes collected from post mortem ovaries and from OPU following superstimulation exhibited similar patterns among the microvilli of matured oocytes as that seen in
OPU oocytes. However, immature oocytes collected via these methods both had a decreased
density of microvilli, and those microvilli that were present appeared to be shorter and found
only in clusters on the oolemma.
Cortical granules were found more frequently in in vitro matured oocytes than in
immature oocytes, regardless of retrieval method employed. However, in both methods of
recovery from live cattle, even immature oocytes had sparse cortical granules present. In matured
oocytes recovered from abattoir-derived ovaries, or following traditional OPU, cortical granules
were found in a single, relatively continuous row directly below the oolemma (Figure 6.1).
However, oocytes collected following stimulation exhibited an aberrant pattern, whereby
immature oocytes presented a single sub-oolemmal layer of cortical granules, but mature oocytes
were found instead to have peripheral clusters of cortical granules (Figure 6.2).
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Table 6.1. Ultrastructural differences observed in immature and mature bovine oocytes collected
through different retrieval methods.
Immature Oocytes

Mature Oocytes

Characteristic

OPU

PM

Stim

OPU

PM

Stim

CG Number

Rare

None

Rare

Few

Many

Rare

CG Distribution

Peripheral
clusters

—-

Suboolemma
layer

Suboolemma
layer

Suboolemma
layer

Peripheral
clusters

Lipid Density

Rare

Rare

Some

Few

Few

Some

Mitochondrial
Density

Low

High

Moderate

Moderate

Moderate

High

Mitochondrial
Distribution

Peripheral or
diffuse

Peripheral or
diffuse

Clusters

Diffuse or
clusters

Clusters

Peripheral
or clusters

Mitochondrial
Association

Strong

Strong

Strong

Strong

Medium

Strong

Oolemma
Microvilli

Long, thin

Few and
short

Few, variable
length

Long, thin

Long, thin

Long, thin

Vesicle Density

Moderate

High

High

Low

Moderate

Moderate

1

2

3

4
5

Figure 6.1. Transmission electron microscope image of an immature bovine oocyte. 1. Micovilli
are long and thin but are relatively sparse. 2. Mitochondria are found primarily in the peripheral
region of the ooplasm. 3. Cortical granules are present in large clusters in the peripheral region of
the ooplasm. 4. Few mitochondria are scattered in small clusters throughout the cytoplasm. 5.
Vesicles occupy the vast majority of the oocyte volume.
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1

3
4
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Figure 6.2. Transmission electron microscope image of an immature bovine oocyte collected
post mortem. 1. Microvilli are sparse and those present are short. 2. Mitochondria are distributed
evenly throughout the ooplasm. 3. Vesicles are present and many are in close proximity to
mitochondria. 4. Lipids are present but do not occupy a large volume.
While lipid concentrations were low in most oocytes, they were slightly more abundant in
matured oocytes. Where present, lipids were found in close association with mitochondria, often
as mitochondria-lipid clusters (Figure 6.3). Vesicles were also frequently found in close
proximity with mitochondria. However, unlike lipids, vesicles were abundant in oocytes,
occupying the vast majority of the ooplasm. This was especially true in immature oocytes,
regardless of recovery method.
Mitochondria were less abundant than expected across all recovery methods, and this did
not change with maturation. Overall, mitochondrial numbers appeared to be the lowest in
oocytes collected by unstimulated OPU. In addition to frequently being found in association with
lipids and vacuoles, there were three primary mitochondrial distribution patterns found among
the oocytes. In immature oocytes collected from live cattle and matured oocytes collected post
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mortem, mitochondria were frequently found to be either primarily or exclusively in the
peripheral region (Figure 6.1). Immature post-mortem collected oocytes and in vitro matured
oocytes recovered by all three methods frequently had mitochondria found in large clusters
throughout the cytoplasm, most often in association with vacuoles, lipids and endoplasmic
reticulum (Figure 6.3). Finally, select few immature oocytes collected via OPU, both with and
without stimulation, exhibited mitochondria in a diffuse distribution with even distribution
throughout the cytoplasm (Figure 6.2). This diffuse pattern was also found in two of the oocytes
collected by unstimulated OPU following IVM.

1

3

2

Figure 6.3. Transmission electron microscope image of an in vitro matured bovine oocyte. 1.
Microvilli are long and thin, evenly distributed over the oolemma. 2. Cortical granules are
present as a single sub-oolemmal layer. 3. Mitochondria are found in large clusters within the
ooplasm, primarily in association with vacuoles and lipids.
In oocytes of all collection methods, and both maturation levels mitochondria were
primarily found to be in the hooded configuration. However, mitochondrial populations within
each individual oocyte were highly heterogenous (Figure 6.4). As anticipated, there were a
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combination of hooded mitochondria, and those more typical, spherical mitochondria. Spherical
mitochondria were found with transverse cristae and also with only peripheral mitochondria.
Similar in structure to the hooded mitochondria were the visualized vacuolated mitochondria and
ring- or cup-shaped mitochondria. Finally, a portion of the mitochondria found were of irregular
shapes, primarily with peripheral cristae only but otherwise lacking vacuoles to explain their
misshapenness. There was no apparent pattern discovered for any one mitochondrial shape to be
more prevalent in one treatment group. Of the irregularly shaped mitochondria were a small
subset that appeared to be budding or undergoing asymmetrical division (Figure 6.5). These
mitochondria were found in immature oocytes collected via both stimulated and unstimulated
OPU and in in vitro matured oocytes that had been collected by OPU, but not in oocytes
collected post mortem.

Figure 6.4. Mitochondrial populations within oocytes were highly heterogenous. 1. Ring-shaped
mitochondria. 2. Hooded mitochondria. 3. Irregularly-shaped mitochondria. 4. Spherical
mitochondria with peripheral cristae only. 5. Vacuolated mitochondria. 6. Spherical mitochondria
with transverse cristae.
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Figure 6.5. Transmission electron images of budding-type mitochondria found in bovine oocytes
collected by both stimulated (GV) and unstimulated (GV and MII) OPU.
Cumulus cells had a very different ultrastructure from that of the oocytes (Figure 6.6).
Mitochondria were found in high concentrations and were all oblong with transverse cristae. A
high proportion of the cumulus cell cytoplasm was occupied by lipid, though it was not
particularly associated with mitochondria. Finally, though Golgi networks occupied a minor
portion of the ooplasm, they constituted a large portion of the volume of the cumulus cells. Golgi
networks were particularly prevalent in the periphery of the cumulus cells.
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Figure 6.6. Transmission electron microscope image of a cumulus cell found in conjunction with
a mature bovine oocyte. 1. Golgi networks are extensive and found peripherally. 2. Lipids
occupy a relatively large proportion of the cell volume. 3. Mitochondria are found clustered, are
ovoid with transverse cristae.
6.4

Discussion
Transmission electron microscopy allows the benefit of defining multiple aspects of the

oocyte’s ultrastructure simultaneously, without the limitation of interfering wavelengths from
multiple stains. This allows us to gain the most possible information on the organelles and how
their interactions with each other may be mediated by different treatments imposed on the
oocytes. Analyses in this regard found that while oocytes collected from all three recovery
methods had similarities to each other and to the expected ultrastructural organization, there were
some key differences observed.
Although immature PM oocytes were the only ones in which cortical granules (CGs)
were not present, with regards to CG parameters FSH oocytes were discordant with oocytes of
other treatment groups. Cortical granules develop from the Golgi network during oocyte
!91

development and maturation and are normally initially found diffusely throughout the cytoplasm
but in MII oocytes CGs should be found in one or two rows immediately below the oolemma and
form a near-continuous layer due to their density (Hosoe and Shioya, 1997; Shahedi et al., 2013).
This pattern held for oocytes recovered by OPU and post-mortem with density increasing over
maturation concurrent to peripheral migration. However FSH oocytes were discordant in both
regards. Mature oocytes assessed had no more CG visible than their immature counterparts and
while CG were found peripherally in immature FSH oocytes, they were diffuse in the cytoplasm
at MII.
As an oocyte matures, mitochondria migrate from peripheral distribution to a general
dispersed distribution (Hyttel et al., 1986) before becoming granulated and finally clustered in
areas requiring high ATP levels (Wang et al., 2009; Matchatkova et al., 2012). One characteristic
of oocyte maturation is that mitochondria migrate to areas of high energy consumption to
improve efficiency (Mau et al., 2014). Oocytes in this project, both within and between groups,
were highly variable in regards to mitochondrial location. The general pattern exhibited, with the
exception of FSH oocytes, was for peripherally located mitochondria to be most frequently seen
in immature oocytes and for mitochondrial clusters to be more common following maturation.
Oocytes recovered following super-stimulation displayed mitochondrial clusters in both GV and
MII stage oocytes, suggesting a higher degree of mitochondrial maturation was possible during
follicular growth. However, the fact that oocytes with peripherally located mitochondria were
only found in MII oocytes of the FSH group indicates that this advanced development is not
pervasive, and in fact it is likely that mitochondrial development is highly variable within these
oocytes.
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It is anticipated that both lipid and vesicle concentrations increase over the course of
maturation in healthy oocytes, and both should be found in complexes with mitochondria
(Thibault et al., 1987; Shahedi et al., 2013). Vesicle numbers, in particular, are high in in vitro
matured oocytes when compared to in vivo matured oocytes (Thibault et al., 1987). Although
lipid levels were low in all oocytes assessed in this project, this pattern did hold true, though less
notably for FSH oocytes. Vesicles occupied the vast majority of the oocyte volume in most
oocytes. However, oocytes from all retrieval methods had the highest vesicle volume prior to
maturation. This suggests that the Golgi network had already been largely dissociated by the time
oocyte retrieval was performed, which was corroborated by the fact that few Golgi apparatuses
were noted. Lipid was exclusively found in mitohondria-lipid aggregates, suggesting
metabolically active oocytes. High metabolic activity may be one explanation for low lipid levels
visible, if oocytes had already metabolized lipid stores. However, low lipid levels before
fertilization indicate poor competence in bovine oocytes since lipid stores are heavily used for
energy production of embryos. Mitochondria-vesicle aggregates were also commonly found,
especially in oocytes with clustered mitochondria, where the clusters would often form around
vesicles.
As mitochondria aggregate into larger clusters, especially those surrounding lipids, ATP
production is increased (Yu et al., 2010). This was commonly seen in oocytes here, especially
following maturation, indicating high ATP production of MII oocytes from all recovery methods.
However, it is believed that stimulation results in oocytes with impaired mitochondrial function
(Mau et al., 2014). While mitochondrial activity was not measured in this study, both the quantity
of mitochondria and the mitochondrial structures were in line with those seen in oocytes from
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other collection methods. However, mitochondria in this project did show some structural
differences that have not been described in the bovine before, which may be indicative of
irregular function. Previous work has reported that hooded, vacuolated and ring-shaped
mitochondria, as were seen in the current work, are frequent in bovine oocytes, in addition to the
more normal spherical mitochondria (Hyttel and Madsen, 1987; Reader et al., 2017). It is
probable that the ring-shaped, vacuolated, and some of the irregularly shaped oocytes are in fact
hooded mitochondria that have been transected at different angles and planes of the
mitochondrion (Senger and Saake, 1970). As such, it is likely that most of the mitochondria
viewed in the current study, were actually hooded mitochondria. The hood is believed to be a
method of increasing mitochondrial surface area to increase energy production (Senger and
Saake, 1970). This would suggest that oocytes containing increased proportions of hooded or
irregularly shaped mitochondria may be of greater competence than those containing primarily
spheroid mitochondria. Oocytes in all treatments in the current study were found to contain a
large proportion of hooded mitochondria, but the irregularly shaped mitochondria were most
frequent in super-stimulated oocytes. This may be a factor of bisecting hooded mitochondria at
different planes, or it may be a function of the exogenous hormones disrupting the oocyte growth
phase and disturbing mitochondrial development and structure.
Some of those irregularly shaped mitochondria, found in both immature and mature
oocytes collected from live cattle only, appeared to be in the process of budding. As
mitochondria do undergo a massive increase in quantity during oocyte growth and early
development, it is possible that these “budding” mitochondria are a sign of oocytes being
recovered from small follicles prior to the completion of the growth phase. It is possible that
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presence of these mitochondria are a sign that mitochondrial division has not been completed and
that these oocytes are less likely to have the ability to acquire competence, a possible downfall of
collecting oocytes from live cattle where the ability to see and selectively aspirate antral follicles
is limited. It is possible that, since the process of recovering oocytes post mortem allows greater
control of follicle selection than OPU does, this allows for a pool of oocytes with greater
competence. Irregularities in mitochondrial cristae and altered morphology are associated with
poor mitochondrial function and decreased ATP production. Given the importance of
mitochondria in energy production, it is reasonable that oocytes with a greater number of
irregularly shaped, budding mitochondria, are likely to have an overall decreased energy
production.
One reason that the success of IVM is limited is believed to be due to the fact that the
oocytes being matured are from a heterogenous population of developmental phases at the
initiation of culture. Although, super-stimulation provides a more homogenous follicle size at the
time of maturation, there was no notable improvement in oocyte morphology to indicate greater
competence. It has been proposed that one reason for this poor competence of oocytes following
super-stimulation is that the rapid follicular growth supported by high doses of FSH causes
asynchronous follicular growth and oocyte development (Hyttel et al., 1986; Dieleman and
Bevers, 1993). This would result in oocytes of variable developmental levels and qualities,
potentially including those pre-programmed for apoptosis, being exposed to a hormonal
environment, which while stimulatory, may not enhance developmental competence. It is likely
that the combined, abnormal hormonal environment and the stimulation of oocytes with poor
developmental competence, combine to cause the cytoplasmic irregularities that were seen in
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FSH oocytes in this study. It is possible that this difference has the potential to have significant
results on the developmental competence and that further comparative analysis is warranted.
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CHAPTER VII
DISCUSSION
The goal of any in vitro embryo production facility is to maximize the number of
transferable embryos produced from each cohort of oocytes recovered. Current research in the
field aims to maximize embryo production rates through altering the in vitro culture conditions,
aiming to find the optimal media to increase developmental competence of oocytes and the
resultant embryos (O'Doherty et al., 1997; Hussein et al., 2006; Balboula et al., 2010). The
current study, instead, focuses on the innate competence of the oocyte and on attempting to
determine the best methods of recovery to ensure that those oocytes retrieved are of the utmost
competence at the start of the in vitro procedures. This is based on the belief that while embryo
quality and conditions during early development are integral to pregnancy establishment, embryo
production rates rely foremost on the intrinsic oocyte competence and oocyte handling and
maturation conditions (Merton et al., 2003; Lonergan et al., 2006).
As with everything else in oocyte development, the acquisition of cytoplasmic
competence is acquired in a stepwise manner. It is understood that the first such step is the
multiplication of organelles and the completion of mRNA and protein synthesis and their storage
followed by the redistribution of the cytoskeleton polymers and organelles (Sirard et al., 2006a;
Watson, 2007; Ferreira et al., 2009). Studies presented here assessed three molecular markers of
competence; mRNA transcript abundance (section 5), IP3R1 expression (section 4), and
cytoplasmic Ca2+ levels (section 4), the cytoskeletal marker F-actin aggregation (section 3), and
multiple organelle markers including; mitochondria morphology and location (section 3, 4, 6),
cortical granule location (section 6), and lipid and vesicle quantity (section 6). While there was a
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degree in heterogeneity among all variables measured, some changes appeared to occur more
reliably over the course of in vitro maturation than others. Similarly, some factors were easily
affected by oocyte handling and treatment while others appeared to be resilient.
Throughout this series of experiments, the effects of pre-maturation protocols on oocyte
cytoplasmic maturation and competence were analyzed. In the first study, the success of the
expected permissive effect of holding oocytes in meiotic inhibitors on cytoplasmic maturation
completion were tested. While the meiotic inhibitors used in this study, IBMX and forskolin,
were successful at maintaining gap junction communication between oocytes and the
surrounding cumulus cells, this did not appear to improve cytoplasmic maturation, as measured
by mitochondrial relocation and F-actin aggregation. Further, a decreased maturation rate was
observed in oocytes that had been held in inhibitors prior to completing maturation. Results
combine to suggest that rather than improving oocyte competence, this combination of meiotic
inhibitors would be more likely to decrease total embryo production rates.
In the second project, the aim was to assess the effects of follicular environment on
oocyte competence. To do this, oocytes were recovered during three different follicular phases,
(growth, peak, and atresia) with the expectation that the follicular and ovarian effects exerted on
the oocyte population prior to collection would have significant effects on oocyte competence.
While the follicular phase did not impact oocyte recovery rates, or mitochondrial maturation
parameters, it was found that oocytes collected during follicle growth showed higher levels of
IP3R1 expression than those collected from atretic follicles. Meanwhile, while embryo
production was unaffected by follicle growth or atresia, cytoplasmic calcium levels were
negatively correlated with embryo production. Results indicate that there is only a slight benefit
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to collecting oocytes from growing follicles, but that oocyte competence is correlated to calcium
being sequestered within the endoplasmic reticulum and not free within the cytoplasm.
In the third and fourth projects, oocytes were collected using three primary methods,
super-stimulation, ovum pick-up and aspiration from ovaries post-mortem. Since the previous
project failed to show a significant effect of follicular wave phase, unstimulated ovum pick-up
was performed at random time points. Oocytes were then subjected to RNA Seq (in both GV and
MII oocytes), transmission electron microscopy (in both GV and MII oocytes) and in vitro
fertilization to determine the effect of oocyte retrieval method on oocyte competence dynamics.
Overall oocytes collected following super-stimulation were most different in both ultrastructure
and gene expression in MII oocytes. There was no significant difference in embryo development
rates between oocytes collected following super-stimulation and those recovered post-mortem,
but embryo development from OPU oocytes was significantly lower than that of oocytes from
the other two recovery methods. Because of the potential lasting effects of the irregular gene
expression and organelle dynamics in super-stimulated oocytes, it is suggested that post-mortem
retrieved oocytes may be the most probable to be highly developmentally competent.
Results across all three studies indicated that mitochondria in bovine oocytes do not
undergo normal maturational parameters in vitro. Immature oocytes were recovered in all three
experiments, and regardless of treatment, with mitochondria found in any of the described
locations from peripheral, diffuse or clustered. While some significant interaction between
meiotic maturation and mitochondrial progression was observed, this was incomplete and
unaffected by attempts at delaying meiotic maturation, or by oocyte source. Mitochondria were
also found to exhibit anomalous shapes, when viewed on transmission electron microscopy,
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suggesting that oocytes collected and matured in vitro, regardless of collection method, may have
incomplete mitochondrial division, resulting in impaired energy metabolism. If this effect can be
confirmed, it may be possible that this is one of the leading reasons that in vitro embryo
development rates are not higher, in which case further research should be aimed specifically at
improving mitochondrial dynamics in in vitro matured oocytes.
Overall results suggest that use of calcium indicators is a potentially strong method of
detecting competent oocytes, with an expectation that highly competent mature oocytes possess
high levels of sequestered calcium, low levels of cytoplasmic calcium and high expression of
calcium signaling receptors (such as IP3R1). Mitochondrial dynamics, on the other hand, are
poor indicators of maturation as aberrations are frequent. Oocytes collected post-slaughter appear
to be of the highest competence, but when performing OPU timing appears to have little effect
on oocyte developmental ability.

!100

REFERENCES
Abbott,A.L. and T. Ducibella. 2001. Calcium and the control of mammalian corticle
granule exocytosis. Frontiers in Bioscience. 6:D792-D806.
Abdoon,A.S.S., O.M. Kandil, S.M. Zeng, and M. Cui. 2011. Mitochondrial distribution,
ATP-GSH contents, calcium oscillation during in vitro maturation of dromedary camel oocytes.
Theriogenology. 76:1207-1214.
Adona,P.R., P.R.L. Pires, M.D. Quetglas, K.R.L. Schwarz, and C.L.V. Leal. 2008.
Prematuration of bovine oocytes with butyrolactone I: Effects on meiosis progression,
cytoskeleton, organelle distribution and embryo development. Animal Reproduction Science.
108:49-65.
Agung,B., P. Wongriskeao, M. Murakami, H. Watari, and T. Otoi. 2006. The effects of
maturation culture period on the sex ratio of bovine IVF embryos. Reproduction Fertility and
Development. 52:123-127.
Albuz,F.K., M. Sasseville, M. Lane, D.T. Armstrong, J.G. Thompson, and R.B. Gilchrist.
2010. Simulated physiological oocyte maturation (SPOM): a novel in vitro maturation system
that substantially improves embryo yield and pregnancy outcomes. Human Reproduction.
25:2999-3011.
Armstrong,D.T. 2001. Effects of maternal age on oocyte developmental competence.
Theriogenology. 55:1303-1322.
Auclair,S., R. Uzbekov, S. Elis, L. Sanchez, I. Kireev, L. Lardic, R. Dalbies-Tran, and S.
Uzbekova. 2013. Absence of cumulus cells during in vitro maturation affects lipid metabolism in
bovine oocytes. American Journal of Physiology, Endocrinology and Metabolism. 304:E599E613.
Avery,B., A. Hay-Schmidt, P. Hyttel, and T. Greve. 1998. Embryo development, oocyte
morphology, and kinetics of meiotic maturation in bovine oocytes exposed to 6dimethylaminopurine prior to in vitro maturation. Molecular Reproduction and Development.
50:334-344.
Bagg,M.A., M.B. Nottle, D.T. Armstrong, and C.G. Grupen. 2007. Relationship between
follicle size and oocyte developmental competence in prepubertal and adult pigs. Reproduction
Fertility and Development. 19:797-803.
Bagg,M.A., M.B. Nottle, C.G. Grupen, and D.T. Armstrong. 2006. Effect of dibutyryl
cAMP on the cAMP content, meiotic progression, and developmental potential of in vitro
matured pre-pubertal and adult pig oocytes. Molecular Reprocuction and Development.
73:1326-1332.
!101

Bailey,C.L. Effects of dietary conjugated linoleic acid supplementaion on bovine oocyte
lipid metabolist, lipid composition and embryo cryotolerance. Doctoral Dissertation. Baton
Rouge: Louisiana State University, School of Animal Science; 2014
Balboula,A.Z., K. Yamanaka, M. Sakatani, A.O. Hegab, S.M. Zaabel, and M. Takahashi.
2010. Cathepsin B activity is related to the quality of bovine cumulus oocyte complexes and its
inhibition can improve their developmental competence. Molecular Reproduction and
Development. 77:439-448.
Barritt,J.A., M. Kokot, J. Cohen, N. Steuerwald, and C.A. Brenner. 2002. Quantification
of human ooplasmic mitochondria. Reproductive Biomedicine Online. 4:243-247.
Bianchi,V., G. Macchiarelli, A. Borini, M. Lappi, S. Cecconi, S. Miglietta, G. Familiari,
and S.A. Nottola. 2014. Fine morphological assessment of quality of human mature oocytes after
slow freezing or vitrification with a closed device: a comparative analysis. Reproductive Biology
and Endocrinology. 12:110-122.
Bilodeau-Goeseels,S. 2003a. Effects of phosphodiesterase inhibitors on spontaneous
nuclear maturation and cAMP concentrations in bovine oocytes. Theriogenology. 60:1679-1690.
Bilodeau-Goeseels,S. 2003b. Manganese inhibits spontaneous nuclear maturation via
cAMP/protein kinase A pathway in bovine cumulus-enclosed oocytes. Journal of Animal
Veterinary Advances. 2:12-21.
Bilodeau-Goeseels,S. 2011. Cows are not mice: The role of cycllic AMP,
phosphodiesterases, and adenosine monophosphate-activated protein kinase in the maintenance
of the meiotic arrest in bovine oocytes. Molecular Reproduction and Development. 78:734-743.
Bilodeau-Goeseels,S. 2012. Bovine oocyte meiotic inhibition before in vitro maturation
and its value to in vitro embryo production: does it improve developmental competence?
Reproduction in Domestic Animals. 47:687-693.
Bleach,E.C., R.G. Glencross, S.A. Feist, N.P. Groome, and P.G. Knight. 2001. Plasma
inhibin A in heifers: relationship with follicle dynamics, gonadotropins, and steroids during the
estrous cycle and after treatment with bovine folliclular fluid. Biology of Reproduction.
64:743-752.
Blondin,P., K. Coenen, L.A. Guilbault, and M.A. Sirard. 1997. In vitro production of
bovine embryos: developmental competence is acquired before maturation. Theriogenology.
47:1061-1075.
Blondin,P. and M.A. Sirard. 1995. Oocyte and follicular morphology as determining
characteristics for developmental competence in bovine oocytes. Molecular Reproduction and
Development. 41:54-62.

!102

Brackett, B.G., D. Bousquet, M.L. Boice, W.J. Donawick, J.F. Evans, and M.A. Dressel
1982. Normal development following in vitro fertilization in cow. Biology of Reproduction.
27:147-158.
Brevini Gandolfi,T.A.L. and F. Gandolfi. 2001. The maternal legacy to the embryo:
cytoplasmic components and their effects on early development. Theriogenology. 55:1255-1276.
Brevini,T.A., F. Cillo, S. Antonini, V. Tosetti, and F. Gandolfi. 2007. Temporal and spatial
control of gene expression in early embryos of farm animals. Reproduction Fertility and
Development. 19:35-42.
Broadbent,P.J., D.F. Dolman, R.G. Watt, A.K. Smith, and M.F. Franklin. 1997. Effect of
the frequency of follicle aspiration on oocyte yield and subsequent superovulatory response in
cattle. Theriogenology. 47:1027-1040.
Brown,H.M., K.R. Dunning, M.L. Sutton-McDowall, R.B. Gilchrist, J.G. Thompson, and
D.L. Russell. 2017. Failure to launch: aberrant cumulus gene expression during oocyte in vitro
maturation. Reproduction. 153:R109-R120.
Byskov,A.G. 1986. Differentitation of mammalian embryonic gonad. Physiology Review.
66:71-117.
Campello,S., R.A. Lacelle, M. Batella, S. Manes, L. Scorrano, and A. Viola. 2006.
Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. Journal of Experimental
Medicine. 203:2879-2886.
Cavalieri,F.L.B., F. Morotti, M.M. Seneda, A.H.B. Colombo, M.A. Andreazzi, I.P.
Emanuelli, and L.P. Rigolon. 2017. Improvement of bovine in vitro embryo production by
ovarian follicular wave synchronization prior to ovum pick-up. Theriogenology. 1-4.
Chaubal,S.A., L.B. Ferre, J.A. Molina, D.C. Faber, P.E.J. Bols, P. Rezamand, X. Tian,
and X. Yang. 2007. Hormonal treatments for increasing the oocyte and embryo production in an
OPU-IVP system. Theriogenology. 67:719-728.
Chian,R.C. and M.A. Sirard. 1995. Effects of cumulus cells and follicle-stimulating
hormone during in vitro maturation on parthenogenetic activation of bovine oocytes. Molecular
Reproduction and Development. 42:425-431.
Clarke,H.J. 2012. Regulation of mitochondrial DNA accumulation during oocyte growth
and meiotic maturation in the mouse. Reproduction. 144:177-185.
Combelles,C.M., N.A. Cekleniak, C. Racowsky, and D.F. Albertini. 2002. Assessment of
nuclear and cytoplasmic maturation in in-vitro matured human oocytes. Human Reproduction.
17:1006-1016.

!103

Connors,S.A., M. Kanatsu-Shinohara, R.M. Schultz, and G.S. Kopf. 1998. Involvement
of the cytoskeleton in the movement of corticle granules during oocyte maturation and corticle
granule anchoring in mouse eggs. Developmental Biology. 200:103-115.
Coticchio,G., A. Borini, V. Distratis, M. Maione, G. Scaravelli, V. Bianchi, G.
Macchiarelli, and S.A. Nottala. 2010. Qualitative and morphometric analysis of the ultrastructure
of human oocytes cryopreserved by two alternative slow cooling protocols. Journal of Assisted
Reproduction and Genetics. 27:131-140.
Coticchio,G., M. Dal Canto, R. Fadini, M. Mignini Rezini, M.C. Guglielmo, S. Miglietta,
M.G. Palmerini, G. Macchiarellli, and S.A. Nottola. 2016. Ultrastructure of human oocytes after
in vitro maturation. Molecular Human Reproduction. 22:110-118.
Coticchio,G., M. Dal Canto, M. Mignini Rezini, M.C. Guglielmo, F. Brambillasca, D.
Turchi, P.V. Novara, and R. Fadini. 2015. Oocyte maturation: gamete-somatic cells interactions,
meiotic resumption, cytoskeletal dynamics, and cytoplasmic reorganization. Human
Reproduction Update. 21:427-454.
Cotterill,M., S.E. Harris, E. Collado Fernandez, J. Lu, J.D. Huntriss, B.K. Campbell, and
H.M. Picton. 2013. The activity and copy number of mitochondrial DNA in ovine oocytes
throughout oogenesis in vivo and during oocyte maturation in vitro. Molecular Human
Reproduction. 19:444-450.
Cran,D.G. 1985. Qualitative and quantitative structural changes during pig oocyte
maturation. Journal of Reproduction and Fertility. 74:237-245.
Cran,D.G., R.M. Moor, and M.F. Hay. 1980. Fine structure of the sheep oocyte during
antral follicle development. Journal of Reproduction and Fertility. 59:125-132.
Cran,D.G., R.M. Moor, and R.F. Irvine. 1988. Initiation of the cortical reaction in hamster
and sheep oocytes in response to inositol trisphosphate. Journal of Cell Science. 91:139-144.
Critser,E.S., M.L. Leibfried-Rutledge, W.H. Eyestone, D.L. Northey, and N.L. First.
1986. Acquisition of developmental competence during maturation in vitro. Theriogenology.
25:150.
De los Reyes,M., J. Palomino, V.H. Parraguez, M. Hidalgo, and P. Saffie. 2011.
Mitochondrial distribution and meiotic progression in canine oocytes during in vivo and in vitro
maturation. Theriogenology. 75:346-353.
de Wit,A.A.C., Y.A. Wurth, and T. Kruip. 2000. Effect of ovarian phase and follicle
quality on morphology and developmental capacity of the bovine cumulus-oocyte complex.
Journal of Animal Sciences. 78:1277-1283.

!104

Dieleman,S.J. and M.M. Bevers. 1993. Folliculogenesis and oocyte maturation in
superovulated cattle. Molecular Reprocuction and Development. 36:271-273.
Dielman,S.J., P.J. Hendriksen, D. Viuff, P.D. Thomsen, P. Hyttel, and H.M. Knijn. 2002.
Effects of in vivo prematuration and in vivo final maturation on developmental capacity and
quality of pre-implantation embryos. Theriogenology. 57:5-20.
Dode,M.A. and C. Graves. 2002. Involvement of steroid hormones on in vitro maturation
of pig oocutes. Theriogenology. 57:811-821.
Dumollard,R., M. Duchen, and J. Carroll. 2007. The role of mitochondrial function in the
oocyte and embryo. Current Topics in Developmental Biology. 77:21-49.
Dunning,K.R., K. Cashman, D.L. Russell, J.G. Thompson, R.J. Norman, and R.L.
Robker. 2010. Beta-oxidation is essential for mouse oocyte developmental competence and early
embryo development. Biology of Reproduction. 83:909-918.
Dunning,K.R., L.N. Watson, D.J. Sharkey, H.M. Brown, R.J. Norman, J.G. Thompson,
R.L. Robker, and D.L. Russell. 2012. Molecular filtration properties of the mouse expanded
cumulus matrix: controlled supply of metabolites and extracellular signals to cumulus cells and
the oocyte. Biology of Reproduction. 87:89.
Dunning,K.R., L.N. Watson, V.J. Zhang, H.M. Brown, A.M. Kaczmarek, R.L. Robker,
and D.L. Russell. 2015. Activation of mouse cumulus-oocyte complexe maturation in vitro
through EGF-like activity of versican. Biology of Reproduction. 92:116.
Edwards,R. 1965. Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and
human ovarian oocytes. Nature. 208:349-351.
El Shourbagy,S.H., E.C. Spikings, M. Freitas, and J.C. St John. 2006. Mitochondria
directly influence fertilisation outcome in the pig. Reproduction. 131:233-245.
Eppig,J.J., R.M. Schultz, M. O’Brien, and F. Chesnel. 1994. Relationship between the
developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes.
Developmental Biology. 164:1-9.
Fair,T., F. Carter, S. Park, A.C. Evans, and P. Lonergan. 2007. Global gene expression
analysis during bovine oocyte in vitro maturation. Theriogenology. 68:S91-S97.
Fair,T., S.C. Hulshof, P. Hyttel, T. Greve, and M. Boland. 1997. Oocyte ultrastructure in
bovine primordial to early tertiary follicles. Anatomy and Embryology. 195:327-336.
Fair,T., P. Hyttel, and T. Greve. 1995. Bovine oocyte diameter in relation to maturational
competence and transcriptional activity. Molecular Reproduction and Development. 42:437-442.

!105

Fair,T., P. Hyttel, J. Motlik, M. Boland, and P. Lonergan. 2002. Maintenance of meiotic
arrest in bovine oocytes in vitro using butyrolactone I: effects on oocyte ultrastructure and
nucleolus formation. Molecular Reproduction and Development. 62:375-386.
Farmer,S.E. Effect of cAMP modulators on in vitro maturation of bovine oocytes. Master
thesis. Baton Rouge. Louisiana State University, Animal and Dairy Sciences; 2014
Fatehi,A.N., E.C. Zeinstra, R.V. Kooija, B. Colenbrander, and M.M. Bevers. 2002. Effect
of cumulus cell removal of in vitro matured bovine oocytes prior to in vitro fertilization on
subsequent cleavage rate. Theriogenology. 57:1347-1355.
Ferreira,E.M., A.A. Vireque, P.R. Adona, M. FV, R.A. Ferriani, and P.A. Navarro. 2009.
Cytoplasmic maturation of bovine oocytes: structural and biochemical modifications and
acquisition of developental competence. Theriogenology. 71:836-848.
Fukui,Y. and Y. Sakuma. 1980. Maturation of bovine oocytes cultures in vitro: relation to
ovarian activity, follicular size and presence or absence of cumulus cells. Biology of
Reproduction. 22:669-673.
Gasparrini,B., L. Boccia, L. Marchandise, R.D. Palo, F. George, I. Donnay, and L.
Zicarelli. 2006. Enrichment of in vitro maturation medium for buffalo (Bubalus bubalis) oocytes
with thiol compounds: effects of cystine on glutathione synthesis and embryo development.
Theriogenology. 65:275-287.
Gharibi,S.H., M. Hajian, S. Ostadhosseini, S.M. Hosseini, M. Forouzanfar, and M.H.
Nasr-Esfahani. 2013. Effect of phosphodiesterase type 3 inhibitor o nuclear maturation and in
vitro development of ovine oocytes. Theriogenology. 80:302-312.
Gibbons,J.R., W.E. Beal, R.L. Krisher, E.G. Faber, R.E. Pearson, and F.C. Gwazdauskas.
1994. Effects of once versus twice weekly transvaginal aspirations on bovine oocyte recovery
and embryo develoment. Theriogenology. 42:405-419.
Gilchrist,R.B., P.L. Nayudu, Nowshari, MA, and J.K. Hodges. 1995. Meiotic competence
of marmoset monkeys is related to follicle size and oocyte-somatic cell associations. Biology of
Reproduction. 52:1234-1243.
Gilchrist,R.B., L.J. Ritter, and D.T. Armstrong. 2004. Oocyte-somatic cell interactions
during follicle development in mammals. Animal Reproduction Science. 82:431-446.
Gilchrist,R.B. and J.G. Thompson. 2007. Oocyte maturation: Emerging concepts and
technologies to improve developmental potential in vitro. Theriogenology. 67:6-15.
Gilula,N.B., M.L. Epstein, and W.H. Beers. 1978. Cell-to-cell communication and
oculation. A study of the cumulus-oocyte complex. Journal of Cell Biology. 78:58-75.

!106

Ginther,O.J., D.R. Bergfelt, L.J. Kulick, and K. Kot. 2000. Selection of the dominant
follicle in cattle: role of estradiol. Biology of Reproduction. 63:383-389.
Godke,R.A., Sansinena,M., and Youngs,C.R. 2014 Assisted reproductive technologies
and embryo culture methods for farm animals. In Transgenic animal technology, C.A. Pinkert,Ed
Academic Press.
Goodhand,K.L., R.G. Watt, M.E. Stained, J.S.M. Hutchinson, and P.J. Broadbent. 1999.
In vivo oocyte recovery and in vitro embryo production from bovine donors aspirated at different
frequencies or following FSH treatment. Theriogenology. 51:951-961.
Greve,T., K.P. Xu, H. Callesen, and P. Hyttel. 1987. In vivo development of in vitro
fertilized bovine oocytes matured in vivo versus in vitro. Journal of In Vitro Fertilization and
Embryo Transfer. 4:281-285.
Gutnisky,C., S. Morado, G.C. Dalvit, J.G. Thompson, and P.D. Cetica. 2013. Glycolytic
pathway activity: effect on IVM and oxidative metabolism of bovine oocytes. Reproduction
Fertility and Development. 25:1026-1035.
Hagemann,L.J. 1999. Influence of the dominant follicle on oocytes from subordinate
follicles. Theriogenology. 51:449-459.
Hagemann,L.J., S.E. Beaumont, M. Berg, M.J. Donnison, A. Ledgard, A.J. Peterson, A.
Schurmann, and H.R. Tervit. 1999. Development during single IVP of bovine oocytes from
dissected follicles: interactive effects of estrous cycle stage, follicle size and atresia. Molecular
Reproduction and Development. 53:451-458.
Hamano,S. and M. Kuwayama. 1993. In vitro fertilization and development of bovine
oocytes recovered from the ovaries of individual donors: a comparison between the cutting and
aspiration method. Theriogenology. 39:703-712.
Hanada,A., Y. Enya, and T. Suzuki. 1986. Birth of calves by non-surgical transfer of in
vitro fertilized embryos obtained fromoocytes matured in vitro. Japanese Journal of Animal
Reproduction. 32:208.
Hashimoto,S., N. Minami, R. Takakura, and H. Imai. 2002. Bovine immature oocytes
acquire developmental competence during meiotic arrest in vitro. Biology of Reproduction.
66:1696-1701.
Hasler,J.F., W.B. Henderson, P.J. Hurtgen, Z.Q. Jin, A.D. McCauley, S.A. Mower, B.
Neely, L.S. Shuey, J.E. Stokes, and S.A. Trimmer. 1995. Production, freezing and transfer of
bovine IVF embryos and subsequent calving results. Theriogenology. 43:141-151.

!107

Homa,S.T. 1988. Effects of cyclic AMP on the spontaneous meiotic maturation of
cumulus-free bovine oocytes cultured in chemically defined medium. Journal of Experimental
Zoology. 248:222-231.
Hosoe,M. and Y. Shioya. 1997. Distribution of corticle granules in bovine oocytes
classified by cumulus complex. Zygote. 5:371-376.
Hunter,R.H.F., R.A.S. Lawson, and R. LEA. 1972. Maturation, transplantation and
fertilization of oovarian oocytes in cattle. Journal of Reproduction and Fertility. 30:325-328.
Hussein,T.S., J.G. Thompson, and R.B. Gilchrist. 2006. Oocyte-secreted factors enhance
oocyte developmental competence. Developmental Biology. 296:514-521.
Hyttel,P. 1987. Bovine cumulus-oocyte disconnection in vitro. Anatomy and Embryology.
176:41-44.
Hyttel,P. 2011 Electron microscopy of mammalian oocyte development, maturation and
fertilization. In Oocyte maturation and fertilization: A long history for a short event, E. Tosti and
R. Boni,Eds Bentham Science Publishers.
Hyttel,P., H. Callesen, and T. Greve. 1986. Ultrastructural features of preovulatory oocyte
maturation in superovulated cattle. Journal of Reproduction and Fertility. 76:645-656.
Hyttel,P., T. Fair, H. Callesen, and T. Greve. 1997. Oocyte growth capacitation, and final
maturation in cattle. Theriogenology. 47:23-32.
Hyttel,P., T. Greve, and H. Callesen. 1989a. Ultrastructural aspects of oocyte maturation
and fertilization in cattle. Journal of Reproduction and Fertility Supplemental. 38:35-47.
Hyttel,P., T. Greve, and H. Callesen. 1989b. Ultrastructure of oocyte maturation and
fertilization in superovulated cattle. Progress in Clinical Biology Research. 296:287-297.
Hyttel,P. and I. Madsen. 1987. Rapid method to prepare mammalian oocytes and embryos
for transmission electron microscopy. Acta Anatomica. 129:12-14.
Hyttel,P., K.P. Xu, S. Smith, and T. Greve. 1986. Ultrastructure of in vitro oocyte
maturation in cattle. Journal of Reproduction and Fertility. 78:615-625.
Ireland,J.J., R.L. Fogwell, W.D. Oxender, K. Ames, and J.L. Cowley. 1984. Production of
estradiol by each ovary during the estrous cycle of cows. Journal of Animal Sciences.
59:764-771.
Iritani,A. and K. Niwa. 1977. Capacitation of bull spermatozoa and fertilization in vitro
of cattle follicular oocytes matured in culture. Journal of Reproduction and Fertility. 50:119-121.

!108

Ispada,J., C.B. de Lima, M.A. Sirard, P.K. Fontes, M.F.G. Nogueira, K. Annes, and M.P.
Milazzotto. 2018. Genome-wide screening of DNA methylation in bovine blastocysts with
different kinetics of development. Epigenetics and Chromatin. 11
Jeong,W.J., S.J. Cho, H.S. Lee, G.K. Deb, Y.S. Lee, and I.K. Kwon. 2009. Effect of
cytoplasmic lipid content on in vitro developmental efficiency of bovine IVP embryos.
Theriogenology. 72:584-589.
Jimenez-Macedo,A.R., D. Izquierdo, A. Urdaneta, B. Anguita, and M.T. Paramio. 2006.
Effect of roscovitine on nuclear maturation, MPF and MAP kinase activity and embryo
development of prepubertal goat oocytes. Theriogenology. 65:1769-1782.
Jurema,M.W. and D. Nogueira. 2006. In vitro maturation of human oocytes for assisted
reproduction. Fertility and Sterility. 4:281-285.
Kafi,M., F. Mesbah, H. Nili, and A. Khalili. 2005. Chronological and ultrastructural
changed in camel (Camelus dromedarius) oocytes during in vitro maturation. Theriogenology.
63:2458-2470.
Kaneko,H., K. Taya, G. Watanabe, J. Noguchi, K. Kikuchi, A. Shimada, and Y.
Hasegawa. 1997. Inhibin is involved in the suppression of FSH secretion in the growth phase of
the dominant follicle furing the early luteal phase in cows. Domestic Animal Endocrinology.
14:263-271.
Kastrop,P.M., S.C. Hulshof, M.M. Bevers, O.H. Destree, and T.A. Kruip. 1991. The
effects of alpha-amanitin and cycloheximide on nuclear progression, protein synthesis, and
phosphorylation during bovine oocyte maturation in vitro. Molecular Reproduction and
Development. 28:249-254.
Kline,D. and J.T. Kline. 1992. Repetitive calcium transients and the role of calcium in
exocitosis and cell cycle activation in the mouse egg. Developmental Biology. 149:80-89.
Krisher,R.L. 2004. The effect of oocyte quality on development. Journal of Animal
Sciences. 82:E14-E23.
Krisher,R.L. and R.S. Prather. 2012. A role for the Warburg effect in preimplantation
embryo development: metabolic modification to support rapid cell proliferation. Molecular
Reprocuction and Development. 79:311-320.
Kulbeka,M., J. Motlik, R.M. Schultz, and A. Pavlok. 2000. Butyrolactone I reversibility
inhibits maturation of bovine oocytes without influencing chromosome condensation activity.
Biology of Reproduction. 62:292-302.
Labrecque,R. and M.A. Sirard. 2014. The study of mammalian oocyte competence by
transcriptome analysis: progress and challenges. Molecular Human Reproduction. 20:103-116.
!109

Larsen,W.J., S.E. Wert, and G.D. Brunner. 1986. Differential modulation rate of follicle
cell gap junction population at ovulation. Developmental Biology. 112:517-521.
Leal,C.L.V., S. Mamo, T. Fair, and P. Lonergan. 2012. Gene expression in bovine oocytes
and cumulus cells after meiotic inhibition with the cyclin-dependent kinase inhibitor
butyrolactone I. Reproduction in Domestic Animals. 47:615-624.
Lee,S.T., H.J. Han, S.J. Oh, E.J. Lee, J.Y. Han, and J.M. Lim. 2006. Influence of ovarian
hyperstimulation and ovulation induction on the cytoskeletal dynamics and developmental
competence of oocytes. Molecular Reproduction and Development. 73:1022-1033.
Leibfried-Rutledge,M.L., E.S. Critser, W.H. Eyestone, D.L. Northey, and N.L. First.
1987. Development potential of bovine oocytes matured in vitro or in vivo. Biology of
Reproduction. 36:376-383.
Lequarre,A.-S., C. Vigneron, F. Ribaucour, P. Holm, I. Donnay, R. Dalbies-Tran, H.
Callesen, and P. Mermillod. 2005. Influence of antral follicle size on oocyte characteristics and
embryo development in the bovine. Theriogenology. 63:841-859.
Liu,S., Y. Li, H.L. Feng, J.H. Yan, M. Li, S.Y. Ma, and Z.J. Chen. 2010. Dynamic
modulation of cytoskeleton during in vitro maturation in human oocytes. American Journal of
Obstretics and Gynecology. 203:151.e1-151.e7.
Lonergan,P., A. Dinnyes, T. Fair, X. Yang, and M. Boland. 2000. Bovine oocyte and
embryo development following meiotic inhibition with butyrolactone I. Molecular Reproduction
and Development. 57:204-209.
Lonergan,P., I. Faerge, P. Maddox Hyttel, M. Boland, and T. Fair. 2003. Ultrastructural
modifications in bovine oocytes maintained in meiotic arrest in vitro using roscovitine or
butyrolactone. Molecular Reproduction and Development. 64:369-378.
Lonergan,P., T. Fair, D. Concoran, and A.C.O. Evans. 2006. Effect of culture environment
on gene expression and development on gene expression and developmental characteristics in
IVF-derived embryos. Theriogenology. 65:137-152.
Lonergan,P., H. Khatir, C. Carolan, and P. Mermillod. 1997. Bovine blastocyst production
in vitro after inhibition of oocyte meiotic resumption for 24h. Journal of Reproduction and
Fertility. 109:355-365.
Looney,C.R., B.R. Lindsey, C.L. Gonseth, and D.L. Johnson. 1994. Commercial aspects
of oocyte retrieval and in vitro fertilization(IVF) for embryo production in problem cows.
Theriogenology. 41:67-72.

1! 10

Lu,K.H., I. Gordon, M. Gallagher, and H. McGovern. 1987. Pregnancy established in
cattle by transfer of embryos derived from in vitro fertilization of oocytes matured in vitro.
Veterinary Record. 121:259-260.
Luberda,Z. 2005. The role of glutathione in mammalian gametes. Reproductive Biology.
5:5-17.
Luciano,A.M., F. Franciosi, S.C. Modina, and V. Lodde. 2011. Gap junction-mediated
communications regulate chromatin remodeling during bovine growth and differentiation
through cAMP-dependent mechanism(s). Biology of Reproduction. 85:1252-1259.
Luciano,A.M., P. Pocar, E. Milanesi, S. Modina, D. Rieger, A. Lauria, and F. Gandolfi.
1999. Effect of different levels of intracellular cAMP on the in vitro maturation of cattle oocytes
and their subsequent development following in vitro fertilization. Molecular Reproduction and
Development. 54:86-91.
Machatkova,M., K. Krausova, E. Jokesova, and M. Tomanek. 2004. Developmental
competence of bovine oocytes: effects of follicle size and the phase of follicular wave on in vitro
embryo production. Theriogenology. 61:329-335.
Malcutt,C., M. Kurokawa, and R.A. Fissore. 2006. Calcium oscillations and mammalian
egg activation. Journal of Cellular Physiology. 206:565-573.
Mamo,S., F. Carter, P. Lonergan, C.L.V. Leal, A. Al Naib, P. McGettigan, J.P. Mehta,
A.C.O. Evans, and T. Fair. 2011. Sequential analysis of global gene expression profiles in
immature and in vitro matured bovine oocytes: potential molecular markers of oocyte
maturation. BMC Genomics. 12:151-164.
Mao,L., H. Lou, Y. Lou, N. Wang, and F. Jin. 2014. Behaviour of cytoplasmic organelles
and cytoskeleton during oocyte maturation. Reproductive Biomedicine Online. 28:284-299.
Matchatkova,M., M. Jeseta, P. Hulinska, L. Knitlova, L. Nemcova, and J. Kanka. 2012.
Characteristics of bovine oocytes with different meiotic competence in terms of thier
mitochondrial status and expression and nuclear-encoded factors. Reproduction in Domestic
Animals. 47:806-814.
Mau,L., H. Lou, Y. Lou, N. Wang, and F. Jin. 2014. Behaviour of cytoplasmic organelles
and cytoskeleton during oocyte maturation. Reproductive BioMedicine Online. 28:284-299.
May-Panloup,P., M.F. Chretien, C. Jacques, C. Vasseur, Y. Malthiery, and P. Reynier.
2005. Low oocyte mitochondrial DNA content in ovarian insufficiency. Human Reproduction.
20:593-597.

1! 11

Mermillod,P., B. Oussaid, and Y. Cognie. 1999. Aspects of follicular and oocyte
maturation that affect the developmental potential of embryos. Journal of Reproduction and
Fertility Supplemental. 54:449-460.
Merton,J.S., A.P.W. de Roos, E.P.C. Koenen, B.A.J. Roelen, P.L.A.M. Vos, E. Mullaart,
and H.M. Knijn. 2012. Bovine OPU-derived oocytes can be matured in vitro for 16-28 h with
similar developmental capacity. Reproduction in Domestic Animals. 47:1037-1042.
Merton,J.S., A.P.W. de Roos, E. Mullaart, L. de Ruigh, L. Kaal, P.L.A.M. Vos, and S.J.
Dieleman. 2003. Factors affecting oocyte quality and quantity in commercial application of
embryo technologies in the cattle breeding industry. Theriogenology. 59:651-674.
Minami,N., T. Suzuki, and S. Tsukamoto. 2007. Zygotic gene activation and maternal
factors in mammals. Journal of Reproduction and Development. 53:707-715.
Moor,R.M. and A.O. Trounson. 1977. Hormonal and follicular factors affecting
maturation of sheep oocytes in vitro and their subsequent developmental capacity. Journal of
Reproduction and Fertility. 49:101-109.
Morotti,F., B.V. Sanches, J.H. Pontes, A.C. Basso, E.R. Siqueira, L.A. Lisboa, and M.M.
Seneda. 2014. Pregnancy rate and birth rate of calves from a large-scale IVF program using
reverse-sorted semen in Bos indicus, Bos indicus-taurus, and Bos taurus cattle. Theriogenology.
81:696-701.
Nagano,M., S. Katagiri, and Y. Takahashi. 2006. ATP content and maturational/
developmental ability of bovine oocytes with various cytoplasmic morphologies. Zygote.
14:299-304.
Nottala,S.A., C. G, L. De Santis, G. Macchiarelli, M. Maione, S. Bianchi, M. Iaccarino,
C. Flamigni, and B. A. 2008. Ultrastructure of human mature oocytes after slow cooling
cryopreservation with ethylene glycol. Reproductive Biomedicine Online. 17:368-377.
Nottala,S.A., C. G, R. Sciajno, A. Gambardella, M. Maione, S. G, S. Bianchi, G.
Macchiarelli, and B. A. 2009. Ultrastructural markers of quality in human mature oocytes
vitrified using cryoleaf and cryoloop. Reproductive Biomedicine Online. 19:17-27.
Nottala,S.A., C.H. Macabelli, C. G, S. Bianchi, S. Cecconi, L. De Santis, S. G, C.
Flamigni, and B. A. 2007. Ultrastructure of human mature oocytes after slow cooling
cryopreservation using different sucrose concentrations. Human Reproduction. 22:1123-1133.
Nottola,S.A., A. E, C. G, P. MG, C. Lorenzo, S. G, B. A, L.-S. PE, and G. Macchiarelli.
2016. Freeze/thaw stress induces organelle remodeling and membrane recycling in cryopreserved
human mature oocytes. Journal of Assisted Reproduction and Genetics. 33:1559-1570.

1! 12

O’Doherty,E.M., M.G. Wade, J.L. Hill, and M.P. Boland. 1997. Effects of culturing
bovine oocytes either singly or in groups on development to blastocysts. Theriogenology.
48:161-169.
O’Brien,J.K., D. Dwarte, J.P. Ryan, W.M. Maxwell, and G. Evans. 1996. Developmental
capacity, energy metabolism and ultrastructure of mature oocytes from prepubertal and adult
sheep. Reproduction Fertility and Development. 8:1029-1037.
Oliveira,L.H., C.P. Sanches, A.S. Seddon, M.B. Veras, F.A. Lima, P.L.J.J. Monteiro, M.C.
Wiltbank, and R. Sartori. 2016. Short Communication: follicle superstimulation before ocum
pick-up for in vitro embryo production in Holstein cows. Journal of Dairy Science.
99:9307-9312.
Pavlok,A., A. Lucas-Hahn, and H. Niemann. 1992. Fertilization and developmental
competence of bovine oocytes derived from different categories of antral follicles. Molecular
Reproduction and Development. 31:63-67.
Pederson,H.S., H. Callesen, P. Lovendahl, F. Chen, J.R. Nyengaard, N.K. Nikolaisen, P.
Holm, and P. Hyttel. 2016. Ultrastructure and mitochondrial numbers in postpubertal pig
oocytes. Reproduction Fertility and Development. 28:586-598.
Petr,J., J. Rozinek, V. Hruban, F. Jilek, M. Sedmikova, Z. Vanourkova, and Z. Nemecek.
2001. Ultrastructural localization of calcium deposits during in vitro culture of pig oocytes.
Molecular Reproduction and Development. 58:196-204.
Petropoulos,S., D. Edsgard, B. Reinius, Q. Deng, S.P. Panula, S. Codeluppi, A.P. Reyes,
S. Linnarsson, R. Sandberg, and F. Lanner. 2016. Single-cell RNA-Seq reveals lineage and X
chromosome dynamics in human preimplantation embryos. Cell. 165:1012-1026.
Phongnimitr,T., Y. Liang, K. Srirattana, K. Panyawai, N. Sripunya, C. Treetampinich, and
R. Parnpai. 2013. Effect of L-carnitine on maturation, cryo-tolerance and embryo developmental
competence of bovine oocytes. Animal Science Journal. 84:719-725.
Pieterse,M.C., K.A. Kappen, T.A.M. Kruip, and M.A.M. Taverne. 1988. Aspiration of
bovine oocytes during transvaginal ultrasound scanning of the ovaries. Theriogenology.
30:751-762.
Piko,L. and K.D. Taylor. 1987. Amounts of mitochondrial DNA and abundance of some
mitochondrial gene transcripts in early mouse embryos. Developmental Biology. 123:364-374.
Pincus,G. and E.V. Enzmann. 1935. The comparative behavior of mammalian eggs in
vivo and in vitro. Journal of Experimental Medicine. 62:665-675.
Ponderato,N., G. Crotti, P. Turini, R. Duchi, C. Galli, and G. Lazzari. 2002. Embryonic
and foetal development of bovine oocytes treated with a combination of butyrolactone I and
1! 13

roscovitine in an enriched medium prior to IVM and IVF. Molecular Reproduction and
Development. 62:513-518.
Ponderato,N., I. Lagutina, G. Crotti, P. Turini, C. Galli, and G. Lazzari. 2001. Bovine
oocytes treated prior to in vitro maturation with a combination of butyrolactone I and roscovitine
at low doses maintain a normal developmental capacity. Molecular Reproduction and
Development. 60:579-585.
Razza,E., H. Pederson, L. Stroebach, M. Machado, M.F.G. Nogueira, H. Kadarmideen,
H. Callesen, and P. Hyttel. 2015. Prematuration of bovine cumulus-oocyte complexes with with
cyclic adenosine monophosphate modulators affects both oocyte and blastocyst ultrastructure.
Reproduction Fertility and Development. 28:192.
Reader,K.L., N.R. Cox, J.-A.L. Stanton, and J.L. Juengel. 2015. Mitochondria and
vesicles differ between adult and prepubertal sheep oocytes during IVM. Reproduction Fertility
and Development. 27:513-522.
Reader,K.L., J.A.L. Stanton, and J.L. Juengel. 2017. The role of oocyte organells in
determining developmental competence. Biology. 6
Richard,F.J. and M.A. Sirard. 1996. Effects of follicular cells on oocyte maturation 1:
effects of follicular hemisections on bovine oocyte maturation. Biology of Reproduction.
54:16-21.
Rizos,D., F. Ward, P. Duffy, M.P. Boland, and P. Lonergan. 2002. Consequences of
bovine oocyte maturation, fertilization or early embryo development in vitro versus in vivo:
implications for blastocyst yield and blastocyst quality. Molecular Reproduction and
Development. 61:234-248.
Robertson,S.A., G. Mayhofer, and R.F. Seamark. 1996. Overian steroid hormones
regulate granulocyte-macrophage colony-stimulating factor synthesis by uterine epithelial cells
in the mouse. Biology of Reproduction. 54:183-196.
Rosenkrans,C.F.J., G.Q. Zeng, G.T. Mcnamara, P.K. Schoff, and N.L. First. 1993.
Development of bovine embryos in vitro as affected by energy substrates. Biology of
Reproduction. 49:459-462.
Team,R.S. 2016. RStudio: Integrated Development for R.
Saeki,K., Y. Nagao, M. Kishi, and M. Nagai. 1997. Developmental capacity of bovine
oocytes following inhibition of meiotic resumption by cyclohexmide or 6-dimethylaminopurine.
Theriogenology. 48:1161-1172.

1! 14

Salamone,D.F., P. Damiani, R.A. Fissore, J.M. Robl, and R.T. Duby. 2003. Biochemical
and developmental evidence that ooplasmic maturation of prepubertal bovine oocytes is
compromised. Biology of Reproduction. 64:826-833.
Salhab,M., S. Dhorne-Pollet, S. Auclair, C. Guyader-Joly, D. Brisard, R. Dalbies-Tran, J.
Dupont, C. Ponsart, P. Mermillod, and S. Uzbekova. 2013. In vitro maturation of oocytes alters
gene expression and signaling pathways in bovine cumulus cells. Molecular Reproduction and
Development. 80:166-182.
Sathananthan,A.H., A. Trounson, and L. Freeman. 1987. Morphology and fertilizability
of frozen human oocytes. Gamete Research. 16:343-354.
Schramm,R.D., A.M. Paprocki, and C.A. VandeVoort. 2003. Causes of developmental
failure of in vitro matured rhesus monkey oocytes: impairments in embryonic genome activation.
Human Reproduction. 18:826-833.
Schroeder,A.C. and J.J. Eppig. 1984. The developmental capacit of mouse oocytes that
matured spontaneously in vitro is normal. Developmental Biology. 102:493-497.
Seneda,M.M., C.R. Esper, J.M. Garcia, J.A. Oliveira, and R. Vantini. 2001. Relationship
between follicle size and ultrasound-guided transvaginal oocyte recovery. Animal Reproduction
Science. 67:37-43.
Senger,P.L. and R.G. Saake. 1970. Unusual mitochondrial of the bovine oocyte. The
Journal of Cell Biology. 46:405-408.
Shahedi,A., K. MA, M. Soleimani, and S. Morshedizad. 2013. Ultrastructure of in vitro
matured human oocytes. Iranian Red Crescent Medical Journal. 15:e7379.
Shioya,Y., M. Kuwayama, M. Fukushima, S. Iwaski, and A. Hanada. 1988. In vitro
fertilization and cleavage capability of bovine follicular oocytes classified by cumulus cell
matured in vitro. Theriogenology. 30:489-496.
Sirard,M.A. and N.L. First. 1988. In vitro inhibition of oocyte nuclear maturation in the
bovine. Biology of Reproduction. 39:229-234.
Sirard,M.A., H.M. Florman, M.L. Leibfried-Rutledge, F.L. Barnes, M.L. Sims, and N.L.
First. 1989. Timing of nuclear progression and protein synthesis necessary for meiotic maturation
of bovine oocytes. Biology of Reproduction. 40:1257-1263.
Sirard,M.A., L. Picard, M. Dery, K. Coenen, and P. Blondin. 1999. The time interval
between FSH administration and ovarian aspiration influences the development of cattle oocytes.
Theriogenology. 51:699-708.

1! 15

Sirard,M.A., F. Richard, P. Blondin, and C. Robert. 2006a. Contribution of the oocyte to
embryo quality. Theriogenology. 65:126-136.
Sirard,M.A., F. Rishard, P. Blondin, and C. Robert. 2006b. Contribution of the oocyte to
embryo quality. Theriogenology. 65:126-136.
Souza-Fabjan,J.M., Y. Locatelli, N. Duffard, E. Corbin, J.-L. Touze, C. Perreau, J.F.
Beckers, V.J.F. Freitas, and P. Mermillod. 2014. In vitro embryo production in goats:
slaughterhouse and laparoscopic ovum pick up-derived oocytes have different kinetics and
requirements regarding maturation media. Theriogenology. 81:1021-1031.
Sreenan,J.M. 1970. In vitro maturation and attempted fertilization of cattle follicular
oocytes. Journal of Agricultural Science. 75:393-396.
Stojkovic,M., S.A. Machado, P. Sotojkovic, V. Zakhartchenko, P. Hutzler, P.B.
Goncalves, and E. Wolf. 2001. Mitochondrial distribution and adenosine triphosphate content of
bovine oocytes before and after in vitro fertilization and culture. Biology of Reproduction.
64:904-909.
Sun,Q.Y. and S. H. 2006. Regulation of dynamic events by microfilaments during oocyte
maturation and fertilization. Reproduction. 131:193-205.
Sunderland,S.J., M.A. Crowe, M.P. Boland, J.F. Roche, and J.J. Ireland. 1994. Selection,
dominance and atresia of follicles during the oestrus cycle of heifers. Journal of Reproduction
and Fertility. 101:547-555.
Suss,U., K. Wuthrich, and G. Strangzinger. 1988. Chromosome configuration and time
sequence of the first meiotic division in bovine oocyte matured in vitro. Biology of
Reproduction. 38:871-880.
Sutton-McDowall,M.L., R.B. Gilchrist, and J.G. Thompson. 2005. Effect of hexoses and
gonadotropin supplementation on bovine oocyte nuclear maturation during in vitro maturation in
a synthetic follicle medium. Reproduction Fertility and Development. 17:407-415.
Sutton-McDowall,M.L., M. Mitchell, P. Cetica, G. Delvit, M. Pantaleon, M. Lane, R.B.
Gilchrist, and J.G. Thompson. 2006. Glucosamine supplementation during in vitro
maturationinhibits subsequent embryo development: possible role of the hexosamine pathway as
a regulator of developmental competence. Biology of Reproduction. 74:881-888.
Sutton,M.L., R.B. Gilchrist, and J.G. Thompson. 2003. Effects of in-vivo and in-vitro
environments on the metabolism of the cumulus-oocyte complex and its influence on oocyte
developmental capacity. Human Reproduction Update. 9:35-48.
Swain,J.E. and T.B. Pool. 2008. ART failure: oocyte contributions to unsuccessful
fertilization. Human Reproduction Update. 14:431-446.
1! 16

Szollosi,D., V. Desmet, N. Crozet, and C. Brender. 1988. In vitro maturation of sheep
ovarian oocytes. Reproduction Nutrition and Development. 28:1047-1080.
Tarazona,A.M., J.I. zrodriguez, L.F. Restrepo, and M. Olivera-Angel. 2006.
Mitochondrial activity, distribution and segregation in bovine oocytes and in embryos produced
in vitro. Reproduction in Domestic Animals. 41:5-11.
Thibault,C., D. Szollozi, and M. Gerard. 1987. Mammalian oocyte maturation.
Reproduction, Nutrition and Development. 27:865-896.
Thomas,R.E., D.T. Armstrong, and R.B. Gilchrist. 2002. Differential effects of specific
phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation. Developmental
Biology. 244:215-225.
Thomas,R.E., D.T. Armstrong, and R.B. Gilchrist. 2004a. Bovine cumulus cell-oocyte
gap junctional communication during in vitro maturation in response to manipulation of cellspecific cyclic adenosine 3’,5’-monophosphate levels. Biology of Reproduction. 70:548-556.
Thomas,R.E., J.G. Thompson, D.T. Armstrong, and R.B. Gilchrist. 2004b. Effect of
specific phosphodiesterase isoenzyme inhibitors during in vitro maturation of bovine oocytes on
meiotic and developmental capacity. Biology of Reproduction. 71:1142-1149.
Thompson,J.G. 2006. The impact of nutrition of the cumulus oocyte complex and embryo
on subsequent development in ruminants. Journal of Reproduction and Development.
52:169-175.
Thompson,J.G., C. McNaughton, B. Gasparrini, L.T. McGowan, and H.R. Tervit. 2000.
Effect of inhibitors and uncouplers of oxidative phosphorylation during compaction and
blastulation of bovine embryos in vitro. Journal of Reproduction and Fertility. 118:47-55.
Thompson,J.G., A.C. Simpson, P.A. Pugh, O.E. Donnelly, and H.R. Tervit. 1990. Effect
of oxygen concentration on in-vitro development of preimplantation sheep and cattle embryos.
Journal of Reproduction and Fertility. 89:573-578.
Thundathil,J., F. Filion, and L.C. Smith. 2005. Molecular control of mitochondrial
function in preimplantation mouse embryos. Molecular Reproduction and Development.
71:405-413.
Trounson,R., C. Anderiesz, and G. Jones. 2001. Maturation of human oocytes in vitro and
their developmental competence. Reproduction. 121:51-75.
Van Blerkom,J. 2009. Mitochondria in early mammalian development. Seminars in Cell
and Developmental Biology. 20:354-364.

1! 17

Van Wagtendonk-de Leeuw,A.M. 2006. Ovum pick up and in vitro production in the
bovine after use in several generations: a 2005 status. Theriogenology. 65:914-925.
Verlhac,M.H. 2011. Spindle positioning: going against the actin flow. Nature Cell
Biology. 13:1183-1185.
Wakai,T., V. Vanderheyden, S.Y. Yoon, B. Cheon, N. Zhang, J.B. Parys, and R.A. Fissore.
2012. Regulation of inositol 1,4,5-trisphosphate receptor function during mouse oocyte
maturation. Journal of Cellular Physiology. 227:705-717.
Wakefield,S.L., M. Lane, and M. Mitchell. 2011. Impaired mitochondrial function in the
preimplantation embryo perturbs fetal and placental development in the mouse. Biology of
Reproduction. 84:572-580.
Walls,M., S. Junk, J.P. Ryan, and R. Hart. 2012. IVF versus ICSI for the fertilization of
in-vitro matured human oocytes. Reproductive BioMedicine Online. 25:603-607.
Walls,M.L., T. Hunter, J.P. Ryan, J.A. Keelan, E. Nathan, and R.J. Hart. 2015. In vitro
maturation as an alternative to standard in vitro fertilization for patients diagnosed with
polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes.
Human Reproduction. 330:88-96.
Wang,L.Y., D.H. Wang, X.Y. Zou, and C.M. Xu. 2009. Mitochondrial functions on
oocytes and preimplantation embryos. Journal of Zhejiang University Science. 10:483-492.
Ward,F., B. Enright, D. Rizos, M. Boland, and P. Lonergan. 2002. Optimization of in
vitro bovine embryo production: effect of duration of maturation, length of gamete coincubation, sperm concentration and sire. Theriogenology. 57:2105-2117.
Warzych,E., P. Pawlak, M. Pszczola, A. Cieslak, and D. Lechniak. 2017. Prepubertal
heifers versus cows- the differences in the follicular environment. Theriogenology. 87:36-47.
Watson,A.J. 2007. Oocyte cytoplasmic maturation: a key mediator of oocytes and embryo
developmental competence. Journal of Animal Sciences. 85:E1-E3.
Whitaker,M. 2006. Calcium at fertilization and in early development. Physiology Review.
86:25-88.
Wrenzycki,C., D. Herrmann, and H. Niemann. 2007. Messenger RNA in oocytes and
embryos in relation to embryo viability. Theriogenology. 68:S77-S83.
Wrenzycki,C. and H. Stinshoff. 2013. Maturation environment and impact on subsequent
developmental competence of bovine oocytes. Reproduction in Domestic Animals. 48:38-43.

1! 18

Wright,R.W.J. and K.R. Bondioli. 1981. Aspects of in vitro fertilization and embryo
culture in domestic animals. Journal of Animal Sciences. 53:702-729.
Wu,D., Q.C.K. Cheung, L. Wen, and J. Li. 2006. A growth-maturation system that
enhances the meiotic and developmental competence of porcine oocytes isolated from small
follicles. Biology of Reproduction. 75:547-554.
Yu,Y., R. Dumollard, A. Rossbach, F.A. Lai, and K. Swann. 2010. Redistribution of
mitochondria leads to bursts of ATP production during spontaneous mouse oocyte maturation.
Journal of Cellular Physiology. 224:672-680.
Zeng,H.T., W.S. Yeung, M.P. Cheung, P.C. Ho, C.K. Lee, G.L. Zhuang, X.Y. Liang, and
W.S. O. 2009. In vitro-matured rat oocytes have low mitochondrial deoxyribonucleic acid and
adenosine triphosphate contents and have abnormal mitochondrial redistribution. Fertility and
Sterility. 91:900-907.
Zhang,L., S. Jiang, P.J. Wozniak, X. Yang, and R.A. Godke. 1995. Cumulus cell function
during bovine oocyte maturation, fertilization, and embryo development in vitro. Molecular
Reprocuction and Development. 40:338-344.

1! 19

APPENDIX. SUPPLEMENTAL MATERIALS
A.1

Oocyte Grading Scheme

Oocyte Grade Morphological Characteristics
A

Complete enclosure with 3+ layers of cumulus cells, homogenous, dark cytoplasm with no
granularity, small perivitelline space

B

Complete enclosure with 1-2 layers of cumulus cells, dark cytoplasm perhaps with slight
presence of granularity or vacuoles

C

Partial enclosure with cumulus cells, cytoplasm may be light, irregular or containing a moderate
degree of granularity, moderate perivitelline space

D

Fragmented oocyte, or clear degeneration with with high degrees of cytoplasmic irregularities or
discontinuous oolemma, Few to no cumulus cells associated

A.2

Hepes-TALP

Component

Concentration

Source

Hepes TL

0.977

Caisson (IVL01)

Sodium Pyruvate

0.01

Sigma (P-4562) 2.2mg/mL stock solution

Penicillin/Streptomycin

0.01

Gibco (15140)

Bovine Serum Albumin
Fraction V

0.003

Sigma (A4503)

A.3

Pre-IVM medium with FSH and IBMX

Component

Concentration

Source

Hepes TALP

0.99

Stock solution described above

Forskolin

0.001

Sigma F-6886 (100µM stock solution)

IBMX

0.001

Sigma I-7018 (500µM stock solution)

A.4

Maturation Medium Composition

Component

Concentration

Source

TCM-199

0.855

Sigma M4530

Fetal Bovine Serum

0.1

Cellgro 35-010-CV

Sodium Pyruvate

0.01

Sigma P-4562 (stock solution)

L-Glutamine

0.01

Sigma G-8540 (29.2mg/mL stock solution)

FSH

0.005

Bioniche (Folltropin)

EGF

0.01

(50ng/mL)
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Penicillin/Streptomycin

0.01

Gibco 15140

Component

Concentration

Source

TL-Fert

0.894

Caisson IVL02

Penicillamine/ Hypotaurine

0.04

Sigma P-4875 and H-1384 (stock solution)

Heparin

0.04

Sigma H-3149 (stock solution)

Pen/Strep

0.01

Gibco 15130

Sodium pyruvate

0.01

Sigma P-4562 (stock solution)

BSA

0.006

Sigma A-6003

Component

Concentration

Source

SOF

0.932

Caisson IVL05

BSA- Fatty acid free

0.003

Sigma A-6003

BME (essential amino acids)

0.02

Gibco 11140-050 100X

MEM (non-essential amino
acids)

0.01

Gibco 11130-051 50X

Penicillin/streptomycin

0.01

Gibco 15140

Sodium pyruvate

0.02

Sigma P-4562 (stock solution)

L-Glutamine

0.005

Sigma G-8540 (stock solution)

A.5

A.6

A.7

IVF-TALP Medium

SOF- IVC Medium

Ionomycin Activation Medium

Component

Concentration

Source

Hepes-TALP

0.98

See above AppendixB

Ionomycin stock

0.02

Sigma I-0634 (5mM stock)

Hepes-TALP

0.95

See above AppendixB

0.1mM Ionomycin

0.05

Ionomycin working solution from step 1

Step 1 (0.1mM stock);

Step 2 (working solution);
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A.8

DMAP activation Medium

Component

Concentration

Source

SOF

0.99

See above Appendix F

DMAP stock

0.01

Sigma D-2629 (200mM stock)

A.9

Hoechst Working Solution

Component

Concentration

Source

Hoechst stock

0.0035

Stock solution

Hepes-TALP

0.9965

Appendix B

Component

Concentration

Source

PBS

0.9955

Corning Cellgro 21-030-CV

BSA Fraction V

0.001

Sigma A7906

Tween 20

0.001

Sigma P1379

Phenol red

0.001

Sigma 0290

NaOH 1M

~0.15%

Sigma S2770

A.10

PBST-BSA

Add NaOH in 5µL increments, mixing and testing pH after each addition to get a final pH of
~7.4
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A.11

0.1M Phosphate Buffer pH 7.4

Component

Concentration

Source

Sodium phosphate dibasic

0.0276

Sigma S3264

Water

0.9724

Step 1: 0.2M sodium
phosphate dibasic

Step 2: 0.2M sodium
phosphate monobasic
Sodium Phosphate monobasic 0.0536
Water

Sigma Sigma S3139

0.9464

Step 3: 0.1M phosphate
buffer
0.2M sodium phosphate
dibasic solution

0.1

Step 1 above

0.2M sodium phosphate
monobasic solution

0.4

Ste 2 above

Water

0.5

A.12

Epon Resin

Component

Concentration

Epon 812

12.33g

Araldite M 502

9.98g

DDSA

29.93g

DMP 30*

1mL/30mL

Source

Kit Supplied by EMS, product # RT 13940 contains individual bottles of each ingredient.
*Combine first 3 ingredients by careful weight of viscous liquids. Mix well be inverting and
store in fridge. Add DMP 30 at time of final embedding only. Always warm to room temperature
and mix well by inverting before use.
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A.13

Stock Solutions
1.
Dulbecco’s Phosphate Buffered Saline: Add 100 mL of 10X D-PBS solution
(Sigma D-1283) to 900 mL of autoclaved DI water to make 1 L of D-PBS. Store at room
temperature. Add 10 mL of Bovine Calf Serum (HyClone) and 1 mL of Heparin (Sagent
Pharmaceuticals, Schaumburg, IL, USA) to make the D-PBS oocyte collection medium.
2.
Penicillin/Streptomycin: Gibco 15140. Aliquot ≈200 µL of new pen/strep solution
into sterile centrifuge tubes. Store at -20°C until use.
3.
Sodium Pyruvate: Sigma P-4562. Dissolve 22 mg of sodium pyruvate in 10 mL of
sterile Millipore-Q water to make 20mM stock solution. Sterile filter into an aluminum foilwrapped 15 mL conical tube and store at 4°C for up to a month.
4.
L-Glutamine: Sigma G-8540. Make a 100X stock solution with a concentration of
20 mM by dissolving 2.92 g of glutamine in 100 mL of DI water. Aliquot 1.0 mL into sterile
centrifuge tubes and store at -20°C.
5.
FSH: Folltropin-V (Bioniche). Make a 1000X stock solution (5 mg/mL) by
diluting a 400 mg vial of folltropin in 80 mL of DI water. Store at -20°C in 100 µL aliquots.
6.
Forskolin: Forskolin, Sigma F-6886. Make a 10 mM stock solution by adding 244
µL of DMSO (Sigma D-2650) to 10 mg of FSK. Aliquot 5 µL into small centrifuge tube and
store at -20°C until use.
7.
IBMX: 3-Isobutyl-1-methylxanthine, Sigma I-7018. Prepare a 500 mM stock
solution by adding 899 µL of DMSO (Sigma D-2650) to 100 mg of IBMX. Aliquot 5 µL into
small centrifuge tubes and store at -20°C until use.
8.
Hyaluronidase: Sigma H-3506. Prepare a 1 mg/mL solution by dissolving 10 mg
hyaluronidase into 10 mL of HEPES-TALP (see media formulations above). Aliquot 100 µL into
1.5 mL sterile centrifuge tubes. Store at -80°C indefinitely.
9.
Penicillamine/Hypotaurine: Combine 5 mL of 1 mM of Hypotourine and 5 mL of
2 mM Penicillamine to 8 mL of 0.9% saline. Aliquot into 100 µL, store at -20°C.
10.
Heparin: Dissolve H-3149 1 mg Heparin into 20 mL of 0.9% saline and filter.
Store at -20°C
11.

BME essential amino acids: Purchased as 100X stock. Aliquot 100µL and store at

-20°C.
12.
MEM non-essential amino acids: Purchased as 50X stock. Aliquot 200µL and
store at -20°C.
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13.
DMAP: Add 32.63mg 6-DMAP (Sigma D-2629) to 1mL of water to make
200mM stock solution. Heat to boiling to completely dissolve DMSO. Make aliquots of 15µL
and store at -20°C. Aliquots will need to be heated again on thaw to re-suspend DMSO.
14.
Ionomycin: Add 1mg of Ionomycin (Sigma I-0634) to 268µL DMSO (Sigma
D-2650) to make 5mM stock. Make 5µL aliquots and store at -20°C.
15.
Hoechst 33342: Dissolve 25 mg of Hoechst in 25 mL distilled water (1mg/mL
stock concentration) in a 50 mL centrifuge tube. Aliquot in 1 mL microcentrifuge tubes (1 mL /
tube). Store at -20ᵒC for several months. For working solution in embryo culture or holding
media dilute to 1 µg/mL.
16.
Mitotracker deep red: Solubilize mitotracker powder (Molecular Probes M22426)
by dissolving entire vial into 50µL of DMSO (Sigma D2650). Mix 4µL of Mitotracker solution
with 200µL of PBS. Let sit for 5 minutes in dark before use.
17.
PBS+1% BSA: Add 0.1g of BSA Fraction V (Sigma A7906) to 10mL of PBS
(Corning Cellgro 21-030-CV). Vortex to mix and sterile filter. (Increase to 0.2g BSA/10mL PBS
for PBS + 2%BSA).
18.
0.1% Triton X100: Add 5µL of Triton X100 (Sigma T9284) to 5mL of PBS
(Corning Cellgro 21-030-CV). Triton X100 is viscous and needs to be pipetted slowly for
precision.
19.
4% Paraformaldehyde: Mix 2mL of 8% paraformaldehyde (Electron Microscopy
Sciences product #157-8) with 2mL of PBS (Corning cellgro 21-030-CV). For 1%
paraformaldehyde, mix 1mL of 8% paraformaldehyde with 7mL of PBS.
20:Fluo3-AM: Dissolve entire tube of stain (50µg, Molecular Probes F1242) into 44µL of
DMSO (Sigma D2650). Mix 1µL of Fluo3-AM suspension in 49µL calcium free PBS (Corning
cellgro 21-030-CV) to make 5µM working solutions. Make fresh at time of use.
21: 3% Glutaraldehyde: Mix 120µL 25% glutaraldehyde (Sigma G5882) in 880µL 0.1M
sodium phosphate buffer (appendix). Make fresh, day of use.
22: 1% Osmium tetroxide: Dilute 4% Osmium tetroxide (Electron Microscopy Sciences
product #19160) by adding 1mL to 3mL of 0.1M sodium phosphate buffer (appendix). Store at
4°C. Warm fully to room temperature before use
23: 0.5% Uranyle acetate: Dilute 1% uranyle acetate (Electron Microscopy Sciences
product #22400-1) by adding 2mL to 2mL of sterile water. Store protected from light at 4°C.
Warm to room temperature before use, always keeping protected from light.
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A.14 Fixation and Staining Protocol for Detecting Mitochondria and IP3R1
Denude oocytes by vortexing for 2 minutes in 200µL of 1mg/mL hyaluronidase within a 1.7mL
microcentrifuge tube
Recover oocytes and rinse 3 times in Hepes-TALP
Incubate for 30 minutes at 38.5°C in 400nM Mitotracker deep red, in a humidified chamber
Wash 3 times for 5 minutes each in Hepes-TALP
Incubate oocytes for 1 hour at room temperature in 4% paraformaldehyde (PFA)
Move oocytes to 300µL fresh 1% PFA in a 1.7mL microcentrifuge tube and store at 4°C for up to
4 weeks
*All procedures after this point at room temperature unless otherwise noted
** All washes should be performed on a rocking platform
Remove oocytes from PFA, wash 3 times for 5 minutes each in PBS+1%BSA
Incubate 30 minutes in 0.1% Triton X100
Wash 3 times, for 5 minutes each in PBS+1%BSA
Incubate for 2 minutes in PBST
Wash 3 times, for 5 minutes each in PBS+1%BSA
Block for 1 hour in PBS+2%BSA
Incubate for 1 hour in 1° Antibody (Rabbit anti-IP3R1, 1:500)
Wash 3 times, for 5 minutes each in PBS+1%BSA
Incubate for 1 hours in 2° Antibody (Alexafluor 488 conjugates goat anti-rabbit IgG, 1:500)
Wash 3 times, for 5 minutes each in PBS+1%BSA
Mount on a clean, dry slide in minimal media under 10µL Vectashield+DAPI
Seal slides with clear, non-fluorescent nail polish
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A.15 RNA-Seq Protocol
SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing
Oocytes were snap frozen in groups of 4 in a total volume of 2µL of PBS in an 0.5mL
centrifuge tube
Store samples at -80°C until time of use
Follow protocol for Smart Seq v4 Ultra Low Input RNA Kit for Sequencing
(ClonTech, Takara Bio USA, Mountain View CA, USA)
A.

First strand cDNA synthesis
Clean workspace and pipettes with alcohol followed by RNase Away
1.
Thaw 5x Ultra low first strand buffer at RT
Thaw remaining reagents on ice
Thaw samples on ice
Vortex each reagent and spin down for briefly

2.
Prepare stock solution of 10X reaction buffer by mixing 10X Lysis Buffer with
RNase Inhibitor
Component

Volume

10X Lysis Buffer

19µL

RNase Inhibitor

1µL

Total

20µL

Mix Briefly and Spin down (avoid creating bubbles)
3.

Prepare samples to a total volume of 10.5µL in individual RNase free 0.2µL PCR

tubes
Component

Negative Control

Positive Control

Test Sample

10X Reaction Buffer

1µL

1µL

1µL

Nuclease-Free Water

9.5µL

7.5µL

7.5µL

Diluted Control RNA*

-

2 µL

-

Sample

-

-

2µL

Total

10.5µL

10.5µL

10.5µL

* Control RNA concentration is 1µg/µL and needs to be diluted in nuclease-free water with
RNase inhibitor to match the concentration of the test sample.
Vortex gently to mix and incubate at room temperature for 5 minutes
4.

Place Samples on ice
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Add 2µL 3’ SMART-Seq CDS Primer II A (12µM) to each tube
Mix well by gently vortexing and and spin tubes briefly
Component

Volume

Oocytes/ Total RNA in Reaction Buffer (Table 1)

10.5µL

3’ SMART-Seq CDS Primer II A (12 µM)

2µL

Total

12.5µL

5.

Incubate tubes at 72°C in a pre-heated hot-lid thermal cycler for 3 minutes

6.
Prepare enough Master Mix for all reactions plus 10% of total reaction mix
volume, at room temperature
(This should be completed while samples are incubating in step 5)
Component

Volume

5X Ultra Low First-Strand Buffer

4 µL

SMART-Seq v4 Oligonucleotide (48µM)

1 µL

RNase Inhibitor (40 U/µL)

0.5 µL

SMARTScribe Reverse Transcriptase*

2µL

Total volume per reaction

5.5 µL

*SMARTScribe Reverse Transcriptase should only be added to the master mix IMMEDIATELY
prior to use. Make master mix without SMARTScribe Reverse Transcriptase first and add this
later when samples are ready.
Mix well by pipetting up and down, then spin briefly
7.
minutes
8.

Immediately after 3 minute incubation (Step 5), place samples on ice for 2

Preheat thermal cycler to 42°C

9.
Add 7.5µL Master Mix to each reaction tube
Mix contents by gently pipetting and spin briefly
10.
Place tubes on preheated thermal cycler
Program:
42°C 90 min
70°C 10 min
4°C forever
Stopping point: Samples can be stored at 4°C overnight
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B.

cDNA amplification
1.
Thaw PCR reagents on ice (except for enzyme)
Gently vortex and spin down each tube. Store on ice
2.

Prepare enough PCR Master Mix for all reactions plus 10%

Component

Volume

2X SeqAMP PCR Buffer

25µL

PCR Primer II A (12µM)

1µL

SeqAMP DNA Polymerase*

1µL

Nuclease-Free Water

3µL

Total volume per reaction

30µL

* Vortex to mix before adding DNA Polymerase. Thaw and add DNA Polymerase just prior to
use, mix gently by pipetting.
3.
Add 30µL PCR Master Mix to each tube containing 20µL of first-strand cDNA
product from section A
Mix well by pipetting and spin down
4.
Place tubes in a preheated thermal cycler
Program:
16 cycles;
98°C 10s
65°C 30s
68°C 3 min
72°C 10 min
4°C forever
*Stopping point, tubes can be held at 4°C overnight
C.

Amplified cDNA purification
Bring AMPure XP bead aliquots to room temperature for at least 30 minutes, mix
well to disperse
Prepare fresh 80% ethanol for each experiment (400µL per sample)
1.
Add 1µL 10X Lysis buffer to each PCR product from section B.
2.
Vortex AMPure XP beads until evenly mixed, then add 50µL of AMPure XP
beads to each sample
Mix thoroughly by pipetting entire volume up and down at least 10 times
(Beads are viscous, pipette slowly)
Incubate at room temperature for at 10-15 minutes to allow cDNA to bind beads
Briefly spin samples
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3.
Place samples on magnetic separation device for at least 5 minutes, until liquid
appears completely clear with no beads left in supernatant
Keeping samples on magnetic separation device pipette supernatant and discard
4.
Keeping samples on magnetic separation device, wash beads by adding 200 µL of
80% ethanol to each sample without disturbing beads
Wait 30s and carefully remove and discard supernatant
Repeat ethanol wash once more
5.
Briefly spin samples to collect liquid from sides of tube
Place samples on magnetic separation device for 30s then remove all remaining ethanol
with a pipette
6.
Please samples at room temperature for ~5 minutes to dry until pellet is no longer
shiny (but before a crack appears)
7.
Add 17µL Elution Buffer to cover the bead pellet
Remove samples from magnetic separation device and mix thoroughly to re-suspend the
beads
Incubate at room temperature for 5 minutes to rehydrate
Spin briefly to collect liquid from sides of tube
8.

Place samples on magnet for 5 minutes until liquid is completely clear

9.
Transfer clear supernatant that contains cDNA from each tube to a nuclease-free,
low-adhesion tube
Label each tube with sample information
Store at -20°C
*Stopping point. Samples can be stored at -20°C indefinitely
D.

Validation Using Agilent D5000 TapeStation
1.
Equilibrate D5000 reagents at room temperature for 30 minutes
Launch the 4200 TapeStation Controller Software
Flick D5000 screentape device to remove bubbles and load single device and loading tips
into the 4200 TapeStation
Vortex reagents and spin down
2.
Prepare ladder in a tube strip;
Mix 2µL D5000 Sample Buffer and 2µL D5000 Ladder
3.
Prepare samples;
Mix 2µL D5000 Sample Buffer and 2µL DNA sample (for each sample)
Load samples in specific 0.2mL 8-well strip
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Spin down then vortex using IKA vortexer (2000 rpm for 1 min)
Spin down to position samples at bottom of tube
4.
Load samples into Agilent 4200 TapeStation Instrument
Carefully remove caps
Select sample positions on software
Click Start and specify filename to save results
E.

Determine cDNA quantity using Qubit dsDNA HS Assay
Use only Qubit assay tubes (thin-walled 0.5mL PCR tubes)
Label on tube lids
1.
Prepare working solution by adding to each sample tube;
198µL Qubit working solution
2µL Sample (1µL sample/ 199µL Qubit solution if high concentration is anticipated)
2.
Make 2 standards
190µL Qubit working solution
10µL Qubit standard
3.
Mix both working solutions and standards by gentle pipetting
Allow all tubes to incubate at room temperature for 2 minutes
4.
Follow instructions on Qubit Fluorometer to read standards and samples
From home screen select DNA, dsDNA high sensitivity, read standards
Insert tube containing Standard #1 into sample chamber close lid and press read standard
When reading is complete remove Standard #1
Repeat for Standard #2
5.
Press Run Samples
On assay screen select sample volume and units
Read each individual sample, following prompts on screen
Top value displayed in large font on the screen is the concentration of the original sample
Bottom value is the dilution concentration

F.
Nextera XT DNA library preparation
Tagment Genomic DNA
1.
Based on Qubit results dilute each sample in DNase-free water to a total
concentration of 2.5ng/µL
2.
Thaw Tagment DNA Buffer, Tagment DNA enzyme and Genomic DNA on ice
Gently mix by inverting then spin down
Label a new 96-well TCY plate
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3.
Save the following program on a thermal cycler lid
Preheat lid to 55°C
hold 55°C for 5 min
for 10°C
4.

Add 5 µL genomic DNA (total 50ng) to each sample well on the labelled TCY

plate
Add 10µL of Tagment DNA Buffer to each well containing DNA
Add 5µL of Tagment DNA Enzyme to each well containing DNA and buffer
Pipette up and down 10x to mix
Centrifuge at 280G for 1 minute
5.

Place on pre-programmed thermal cycler and run the program (from 3)

6.
Add 5µL of Zymo DNA binding buffer to each sample
Incubate at room temperature for 5 minutes
Amplify Tagmented DNA
1.
Use 2 sets of index primers so that each sample has a unique set
Add 5µL of each index 1 down each column (A unique index #1 per column)
Add 5µL of each index 2 across each row (A unique index #2 per row)
Add 15µL Nextera PCR Master Mix to each sample
Centrifugre 280G for 1 minute
1.
Place of pre-heated thermal cycler and run program;
72°C for 3 minutes
98°C for 30 seconds
12 cycles;
95°C for 10 seconds
55°C for 30 seconds
72°C for 30 seconds
72°C for 5 minutes
10°C hold
Clean up libraries
Bring AMPure XP beads to room temperature prior to use
Vortex AMPure XP beads
1.
Remove plate from thermal cycler and vortex 280G for 1 minute
Transfer 50µL of PCR product from each sample to new 1.5mL tubes
2.

Add 30µL of AMPure XP beads to each sample
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Shake at 1800 rpm for 2 minutes
Incubate at room temperature for 5 minutes
3.
Place on magnetic stand ~2 minutes until fluid is clear
Remove and discard supernatant
4.
Wash 2x with 200µL of fresh 80% ethanol
Incubate for 30 seconds each time
Remove and discard supernatant without disturbing bead pellet
Remove residual ethanol from each well
5.
Air dry pellets on magnet for 15 minutes
Remove from stand
6.
Add 30µL of resuspension buffer to each tube
Shake at 1800 rpm for 2 minutes
Incubate at room temperature for 2 minutes
Place on magnetic stand for 2 minutes until clear
7.
Transfer 50µL of supernatant from each sample to new tubes
Run Qubit and Agilent to verify quality
Store at -80°C
Pool indexed libraries
4.
Transfer 5µL from each well in column 1 of dilution plate to column 1 of pooled
plate
Repeat for each column of dilution plate until all samples are pooled in column 1 of
pooled plate
Ensure to track which samples go into which well to avoid pooling any 2 samples with
the same index
5.
Combine the contents of each well of column 1 into well A2 of pooled plate
Shake at 1800 rpm for 2 minutes
6.

Denature and dilute pooled libraries to a concentration of 4nM

7.

Seal plate and store at -20°C

8.

Sequence on NextSeq 500 Illumina Platform
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A.16 Supplemental Information for RNA Seq Results
A.
Genome Alignment Reads by Treatment
RNA-Seq results from individual samples showing the number or genes read for each sample
and the sample genome qualities. With the exception of sample MO-3, samples were of high
quality with a high proportion of reads aligning with bovine genes.
Sample
Name

Maturation

Recovery
Method

Total Reads

Percent
Aligned

Average
Length

Average
Quality

IO-1

Immature

OPU

27877658

92.64

73.35

34.1

IO-2

Immature

OPU

28924359

93

73.2

34.15

IO-3

Immature

OPU

31806987

93

73.19

34.1

IO-4

Immature

OPU

16668129

93.7

73.66

33.72

IS-1

Immature

FSH

35107502

92.69

73.34
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B.
Heatmap of the 500 Most Variably Expressed Genes
Figure A1. Using the hundred genes with the overall most variable expression between the six

treatment groups, oocyte are categorized by expression on a yellow-to-orange scale with yellow
indicating low expression and dark indicating high expression. Based on the overall pattern of
expression for these 500 genes, oocytes are given a hierarchical ordering, seen on the right,
indicating their similarity in gene expression patterns to each other.

!135

SlM-1
MP-1
SlM-3
MP-3
OPUM-1
MO-1
SlM-2
MP-2
OPUM-2
MO-2
MS-2
STMA-2
STMA-1
MS-1
STMA-4
MS-4
O-PUM-4
MO-4
STMA-3
MS-3
SLIM-4
IP-4
SLIM-3
IP-3
IST-2
IS-2
SLIM-2
IP-2
IMOPU-4
I0-4
IMOPU-1
I0-1
IMOPU-2
I0-2
IMOPU-3
I0-3
OPUM-3
M0-3
IST-1
IS-1
SLIM-1
IP-1

0e+00

IST-3
IS-3
IST-4
IS-4

2e+04

Height

4e+04

6e+04

8e+04

1e+05

Cluster Dendrogram

C.
Cluster Dendogram of Bovine Oocytes Based on Global Gene Expression
Figure A2. Hierarchical relationship between bovine oocytes from different collection sources
distance
hclust (*, "complete")
and maturation levels based on the global differential
gene expression levels.
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D.
Smear Plots Comparing Oocyte Gene Expression
Figure A3. Smear plots comparing gene expression of oocytes between oocyte recovery
methods, within each maturation level. Each dot on the plot indicates one gene, those in red
having significantly different expression levels (at FDR P<0.05). Points falling outside of the
blue indicator lines are those genes that have an expression level difference in excess of two-fold
between the two treatments in question ( values >0 favour the first treatment listed, those <0
favour the second treatment).
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A.17

Fixation Protocol for Transmission Electron Microscopy
Primary Fixation
1.
Fix oocytes for 1.5 hours in freshly prepared 3% glutaraldehyde at room
temperature
2.
Transfer oocytes to a cryovial containing 0.5mL of phosphate buffer and store at
4°C until further processing
Agar embedding
3.
Embed oocytes in 4% agar using a stereomicroscope.
Put oocyte in a minimal drop of phosphate buffer on a clean slide and put a drop of agar
at 45-55°C on top of oocytes. Build up with more agar. Cool and solidify agar by placing directly
on a dry ice pack.
4.
Cut out a small block 2x2x2mm containining each oocyte, using a razor blade
5.
Wash 2x for 5 min each in phosphate buffer, at room temperature
Secondary, post-fixation
6.
Post-fix in 1% oxmium tetroxide for 1 hour at room temperature
7.
Wash 2x for 5 min in phosphate buffer at room temperature
Uranyle block staining
8.
Wash 2x for 5 min each in double distilled water
9.
Stain for 1 hour in 0.5% Uranyle acetate at room temperature, in the dark
10.
Wash 2x for 5 min each in water
Dehydration and embedding (perform incubations on a shaker plate at room temperature)
11.
Incubate 2x for 5 min each in 50% ethanol
12.
Incubate 2x for 5 min each in 70% ethanol *leave in 70% ethanol overnight
13.
Incubate 2x for 5 min each in 80% ethanol
14.
Incubate 2x for 5 min each in 90% ethanol
15.
Incubate 2x for 10 min each in 100% ethanol
16.
Incubate 2x for 5 min each in propylene oxide
17.
Incubate 1 hour in 2:1 propylene oxide: epon araldite
18.
Incubate 1 hour in 1:1 propylene oxide: epon araldite
19.
Incubate 1 hour in 1:2 propylene oxide: epon araldite
20.
Overturn tubes and dry for 30s to remove as much propylene oxide as possible
21.
Incubate overnight in epon araldite
21.
Trim away excess agar from blocks and dry blocks briefly to remove excess Epon
and propylene oxide
22.
Embed in freshly prepared Epon+DMP 30 for 2 hours in moulds room
temperature
23.
Replace media in moulds with fresh Epon+DMP 30, being careful to avoid
bubbles, incubate in moulds at room temperature for 24 hours
24.
Move moulds to 37°C, incubate for 24 hours
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25.
26.

Move moulds to 60°C, incubate for 24 hours
Remove blocks from moulds

Ultra-thin sectioning;
27.
Cut a sequence 70nm sections from each oocyte at the periphery and the
approxiamate equator
28.
Stain sections with uranyle acetate for 15 minutes
29.
Rinse 6x for 30s each by placing sections on water droplets
30.
Stain with lead citrate for 5 min
31.
Rinse 6x for 30s each by placing sections on water droplets
32.
Gently dip sections in sterile water and blot dry
33.
Transfer sections to a copper grid for microscopy
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